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ABSTRACT 
 
Intestinal ischaemia and reperfusion (I/R) contributes to the pathogenesis of 
numerous clinical conditions in all age groups. Many of these diseases, including 
neonatal necrotizing enterocolitis (NEC), result in significant morbidity and 
mortality through multiple organ dysfunction, and available treatment is currently 
limited to supporting vital functions. 
My aims were: to investigate novel therapeutic strategies such as moderate 
hypothermia and peroxynitrite decomposition catalyst FeTMPyP [5,10,15,20-
tetrakis(N-methyl-4'-pyridyl)porphyrinato iron (III)] in experimental models of 
adult and infant intestinal I/R; and to characterise the inflammatory process in 
human NEC, evaluating its relationship with clinical outcome. 
In an adult rat model, total-body moderate hypothermia applied throughout 
ischaemia and reperfusion counteracts oxidative stress in both the intestine and 
distant organs. This suggests that hypothermia could be beneficial as a preventative 
measure when intestinal ischaemia can be foreseen. However, in clinical practice 
therapy can usually be commenced only after ischaemia has occurred. In two sets 
of experiments, I showed that rescue hypothermia applied after mesenteric 
ischaemia improves outcome in both adult and neonatal rats, and this benefit is 
maintained after rewarming. Hypothermic protection could result from prevention 
of multiple organ dysfunction through several different pathways, including 
modulation of hepatic phosphoenergetics, pulmonary inflammatory infiltrate, 
cardiac energy metabolism, and systemic oxidative stress.  
Administration of peroxynitrite decomposition catalyst FeTMPyP as a rescue 
therapy at reperfusion also exerts a protective effect in neonatal rats, possibly via 
inhibition of adhesion molecule expression, leukocyte recruitment, and lipid 
peroxidation in the intestine, leading to prevention of systemic oxidative stress.  
In a study conducted on human specimens from neonates with NEC, tissue 
injury seems to be mediated via increased expression of endothelial adhesion 
molecules ICAM-1 and P-Selectin, leading to macrophage and neutrophil 
infiltration. Endothelial E-Selectin is expressed exclusively in NEC patients, and 
appears to be a marker of rapidly evolving disease and distant organ failure.  
 Index 
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CHAPTER 1 
INTESTINAL ISCHAEMIA AND REPERFUSION INJURY 
 
The purpose of this introductory chapter is to provide an overview of 
intestinal ischaemia and reperfusion (I/R) injury, including some novel therapeutic 
strategies in order to provide a background to the experiments described in later 
chapters.  
 
1.1 ANATOMY AND PHYSIOLOGY OF SPLANCHNIC CIRCULATION 
 
The splanchnic circulation supplies viscera contained in the abdominal 
cavity, including the gastro-intestinal tract (abdominal oesophagus, stomach, 
duodenum, jejunum, ileum, colon, appendix, and rectum), liver, gallbladder and 
biliary tract, pancreas, and spleen. Arterial blood supply to these organs is 
delivered via the coeliac axis, the superior and the inferior mesenteric arteries. 
Venous blood is drained from splanchnic organs into the portal circulation and 
eventually into the inferior vena cava through the hepatic veins. 
The splanchnic circulation accounts for 25% of cardiac output 
(approximately 1.5l/min), and comprises 20-25% of total blood volume (Pastores 
et al, 1996). In resting conditions, the liver receives approximately 100ml 
blood/100g tissue/min, 70% of which is coming from the portal vein, and the 
remainder 30% from the hepatic artery (Clemmesen et al, 1999). Blood inflow to 
the intestine is 50-70ml/100g tissue/min, mostly perfusing the mucosal and 
submucosal layers and only 30% directed to the muscularis and serosa (Lundgren, 
1989). Total blood inflow to splanchnic viscera is, however, highly variable, 
increasing dramatically during digestion, and decreasing significantly during 
exercise or physically stressful situations.  
Tissue oxygenation in the intestine is regulated by modulating blood flow 
and oxygen extraction. Adult intestinal circulation is characterised by 
autoregulation, with flow remaining constant despite fairly large variations in 
arterial inflow pressure. This phenomenon can be explained by the property of 
vascular smooth muscle to be modulated by transmural pressure: an increased 
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transmural pressure will cause vasoconstriction, and vice versa. The autoregulatory 
capacity of villous vasculature is even higher, and villous plasma flow can be 
maintained at baseline levels even when arterial blood pressure is as low as 
30mmHg (Lundgren, 1974). However, intestinal vascular resistance is 
exceptionally low in the neonatal age, which reduces the capacity of this 
vasculature to respond to systemic circulatory perturbations, such as hypotension 
and arterial hypoxemia (Reber et al, 2002). 
At rest, oxygen extraction by splanchnic organs averages only 15-20%, 
corresponding to 50-60ml of oxygen per minute in adults. Relative reductions in 
total blood inflow can be tolerated by the intestine without any functional 
impairment via a more efficient oxygen extraction, a situation known as non-
critical low flow (Samsel et al, 1994). However, once the level of maximal oxygen 
extraction is reached, oxygen consumption becomes flow-dependent and any 
further reduction in blood flow results in a decrease in absolute oxygen 
consumption. At critically-low flow levels below 30ml/100g tissue/min in adults, 
oxygen consumption becomes inadequate to meet metabolic requirements and cells 
shift from aerobic to anaerobic metabolism (Desai et al, 1996).  
 
1.2 CLINICAL CONDITIONS ASSOCIATED WITH INTESTINAL ISCHAEMIA AND 
REPERFUSION INJURY 
 
Intestinal I/R injury plays a major role in the pathogenesis of several 
conditions, including midgut volvulus in neonates; intussusception in infants and 
children; acute arterial mesenteric occlusion in adults; haemodynamic and septic 
shock; and surgical procedures involving arterial clamping in all age groups. I/R 
injury of the intestine is also one of the major factors involved in the pathogenesis 
of necrotizing enterocolitis (NEC) in newborns, as discussed in the following 
chapter. 
 
1.3 NECROTIZING ENTEROCOLITIS 
 
Necrotizing enterocolitis (NEC) is an acquired condition characterised by 
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an initial mucosal injury of the intestine that may progress to transmural bowel 
necrosis. NEC represents the most common life-threatening gastro-intestinal 
disease of neonates, accounting for 5,000-7,000 new cases each year in the United 
States (Reber et al, 2004). Over 90% of infants who develop the disease are born 
preterm, and the risk is inversely related to birth weight and gestational age 
(Llanos et al, 2002). The incidence of NEC in full-term infants is estimated to be 
about 0.05 per 1,000 live births, but is as high as 7% in newborns less than 1,500g 
(Lemons et al, 2001; Bolisetty et al, 2000). The number of new cases per year has 
remained relatively stable in the last decades despite the increase in the number of 
very premature infants, since improvements in neonatal care have reduced the 
incidence in the susceptible population. 
Mortality rates from necrotizing enterocolitis are still extremely high, and 
range from 15% to 30%. Several studies have reported that higher fatality rates are 
associated with lower birth weight and gestational age (Holman et al, 1997; Luig et 
al, 2005). Although most cases of necrotizing enterocolitis can be managed 
medically, an estimated 20-40% of infants undergo surgery (Lin et al, 2006). The 
case fatality rate with surgical intervention is as high as 50%, and is highest for the 
smallest, least mature infants. Mortality for this group is related to underlying 
clinical status and surgical treatment. Furthermore, infants needing surgery can 
develop postoperative complications, including wound dehiscence, intra-
abdominal abscess, and intestinal stricture, and are more prone to the development 
of short bowel syndrome in the long-term (Blakely et al, 2005; Henry et al, 2005). 
  
1.3.1 Pathophysiology 
Pathological examination of surgically resected specimens has shown that 
coagulation (ischaemic) necrosis, inflammation, and bacterial overgrowth are all 
almost invariably present, although with individual variability in the severity of 
these findings (Ballance et al, 1990). Epithelial regeneration, granulation tissue 
formation, and fibrosis are also visible in the majority of specimens, suggesting the 
presence of reparative tissue changes secondary to ongoing tissue injury of at least 
several days duration.  
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However, the true aetiology and the detailed physiological pathways 
leading to such tissue injury in NEC remain poorly understood despite years of 
research. Many theories have attempted to elucidate the full pathogenesis of this 
disease over the last 40 years, without success. These theories and subsequent 
research efforts have centred on what are felt to be the most important contributing 
factors: hypoxic-ischaemic injury, enteral feeds with formula milk, colonisation by 
pathological bacteria, and the developmental immaturity of key functions 
(including circulatory regulation, gastrointestinal motility, digestive ability, 
intestinal barrier function, and immune defence) typical of premature infants. 
 
Immaturity of the gastrointestinal tract 
  The importance of gut immaturity in contributing to the pathogenesis of 
NEC is highlighted by the fact that this condition is almost invariably found in 
premature infants, and their risk for NEC remains high until the post-conceptual 
age of 35 to 36 weeks. The presence of an immature intestine may make it more 
vulnerable to potentially harmful compounds, such as hyperosmolar formulas. In 
addition, an impaired intestinal barrier function may predispose towards abnormal 
colonization by both normal enteric flora and pathogenic bacteria, instigating a 
local inflammatory response that would increase tissue injury. 
Gastric acid and pancreaticobiliary secretions decrease the load of viable 
microorganisms as well as intact dietary protein antigens that reach the small 
intestine (Dinsmore et al, 1997). However, in premature infants both production of 
hydrochloric acid in the stomach (Hyman et al, 1985) and pancreatic production of 
proteolytic enzymes (Lebenthal et al, 1980) are impaired. Reduced activity of 
gastric acid and pancreaticobiliary secretions and their resulting proteolysis may 
increase bacterial load allowing colonization by pathogens, and suppress the 
hydrolysis of toxins.  
Composition and production of the intestinal mucous layer is also altered in 
premature infants. Mucus is a complex gel that covers the surface of the villous 
epithelium. It is comprised primarily of water and electrolytes but also contains 
mucins, glycoproteins, immunoglobulins, lactoferrin and lysozyme. One of the 
functions of mucous gel is to contain bacteria and luminal antigens preventing 
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their contact with enterocytes. However, expression of mucin does not reach 
maturity until 27 weeks gestation (Buisine et al, 1998).  Immaturity of the mucous 
layer may therefore enhance bacterial adherence and bacterial-endothelial 
interactions. 
A reduced production of antimicrobial agents by specialised enterocytes 
may also account for an increased susceptibility to bacterial agents in premature 
infants. Paneth cells are secretory cells located at the base of intestinal crypts that 
produce various peptides, including α-defensins and lysozyme (Eckmann, 2004). 
These substances possess wide antimicrobial properties, and confer protection 
against a wide array of micro-organisms, including viruses, bacteria, fungi, and 
protozoa. Both the number of Paneth cells, and the production of α-defensin are 
reduced in human premature infants compared to adults (Mallow et al, 1996).  
Gastrointestinal motility is also considerably less developed in premature 
infants than in term infants. A coordinated peristaltic activity is fundamental to 
advance enteric contents along the length of the intestinal tract, and ineffective 
propulsion secondary to intestinal dysmotility results in both malabsorption of 
dietary nutrients, and bacterial overgrowth, particularly of anaerobic species. The 
development of peristalsis is a late event in prenatal life, and does not reach a 
mature pattern until 34-35 weeks of gestation (Berseth, 1996; Berseth, 1989). It is 
likely that this immature motility and the resulting impaired intestinal clearance 
contribute to bacterial overgrowth and distension from gases that are the by-
products of fermentation. 
In addition, premature infants have not yet developed the ability to digest 
and absorb nutrients (Lebenthal et al, 1999) and incompletely digested molecules 
(such as acidified casein or short chain fatty acids) could contribute to intestinal 
injury. 
 
Enteral feeding 
  NEC typically develops in infants after being fed, with less than 10% of 
patients who are diagnosed with NEC having never been fed before its onset (Stoll, 
1994). Although the mechanism is not completely understood, enteral feeding has 
been reported to promote NEC by providing a favourable milieu for increased 
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proliferation of potentially pathogenic bacteria (Lee et al, 2003). Incomplete 
digestion and absorption of carbohydrates facilitates bacterial overgrowth, which 
in turn leads to production of carbon dioxide, short-chain organic acids, and 
hydrogen gas by fermentation (Kien, 1990). In the premature infant who has a 
relative lactase deficiency, lactose ingested in the form of milk may be converted 
into short chain fatty acids by bacterial fermentation in the anaerobic environment 
of the colon (Lin, 2004). Overproduction of short chain fatty acids can arise as a 
consequence of significant carbohydrate malabsorption and bacterial overgrowth in 
premature infants, which have been shown to lead to severe mucosal injury in 
experimental animals (Lin et al, 2002). In fact, a randomised study has shown that 
aggressive regimes of enteral nutrition in the first 10 days of life are associated 
with an increased incidence of NEC in preterm infants (Berseth et al, 2003). 
However, clinical evidence supports the advantage of minimal enteral feeding used 
as a trophic agent to stimulate gastrointestinal mucosal development in premature 
infants, possibly by potentiating gut hormones (Kliegman, 1999; La Gamma et al, 
1994). 
A recent meta-analysis has confirmed that feeding with breast milk reduces 
the risk of developing NEC in preterm and low birth weight infants, compared 
with artificial formulas (Quigley et al, 2007). The protective effects of human milk 
are mostly due to the presence of several mediators that enhance innate defences 
against pathogens, including white blood cells, immunoglobulins, lactoferrin, and 
lysozyme (Neu et al, 2005). In addition, breast milk is rich in glutamine, a 
fundamental metabolic substrate for intestinal mucosa that is thought to become 
essential during stressful times (Neu, 1996), and which is not included in standard 
intravenous amino acid solutions due to its poor stability in aqueous solution. 
Human milk also contains growth factors and hormones, including epidermal 
growth factor (EGF), which may directly improve gastrointestinal function by 
promoting gut maturity (Shin et al, 2000). 
 
Hypoxic-ischaemic injury 
The importance of ischaemic injury in the pathogenesis of NEC has long 
been recognised, and is confirmed by the histopathology of the disease. 
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Coagulation necrosis has been found to be more severe than any other findings in 
specimens from NEC patients, and is considered the pathological hallmark of NEC 
(Ballance et al, 1990). Although the exact role, mechanism, and timing of intestinal 
ischaemia are uncertain, recent evidence has suggested that the unique 
characteristics of neonatal intestinal circulation make the gut prone to ischaemic 
insults.  
Several important haemodynamic variables undergo dramatic change 
during the evolution from foetal to newborn life; furthermore, the response of the 
newborn intestine to systemic circulatory perturbations differs from that of the 
adult. Many of the unique features of the newborn intestinal circulation seem 
designed to facilitate postnatal intestinal function. 
Blood flow and oxygen delivery into newborn intestine have been shown to 
be more than twofold greater than during foetal life in the sheep (Edelstone et al, 
1982; Holzman et al, 1985). The rise in intestinal blood flow that occurs between 
foetal and newborn life reflects the intense metabolic activity of the intestine in the 
neonatal period, as it becomes the sole site for nutrient absorption. Experiments in 
a neonatal pig model have shown that intestinal blood flow significantly increases 
between postnatal days 1 and 3 (corresponding to the neonatal period in humans), 
and then plateaus until postnatal day 12 (corresponding to the time of weaning 
from milk to solids) when it begins a progressive decline. Such changes in 
intestinal blood flow reflect the increased metabolic rate of the intestine in the 
neonatal period, and are due to a reduction in intestinal vascular resistance between 
postnatal days 1 and 3, followed by a progressive increase between postnatal days 
12 and 30 (Reber et al, 2002). Since adrenergic nerves do not participate in setting 
basal vascular resistance in newborn intestine (Nowicki et al, 1991), such changes 
in basal intestinal vascular resistance seem to be mediated by an increased 
endothelial production of the potent vasodilator nitric oxide (NO) (Nankervis et al, 
2001), together with a reduced myogenic response and a reduced expression of 
endothelin 1 (ET-1) (Reber et al, 2002), which provide constrictor tone. 
Basal vascular resistance plays an important role in determining the 
capacity of circulation to respond to stress, and the profound differences in the 
intestine of newborn versus adult subjects predict that the responses of these two 
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age groups to systemic circulatory perturbations will also differ. In particular, the 
lack of extrinsic adrenergic innervation in newborn intestine might impair 
baroreflex and chemoreflex responses. Firstly, the intensity of the pressure-flow 
autoregulatory response is essentially absent in neonatal swine compared to adults, 
and only minimal intestinal vasodilatation is possible in response to systemic 
hypotension which is followed by significant decrease in oxygen delivery and 
tissue oxygenation (Nowicki et al, 1988a; Nowicki et al, 1992). In addition, the 
newborn intestinal vasculature responds in a peculiar way to different degrees of 
hypoxemia: mild hypoxemia (oxygen tensions of about 50mmHg) determines 
vasodilatation and increased gut perfusion, whereas severe hypoxemia (oxygen 
tensions <40mmHg) causes vasoconstriction, which is followed by tissue hypoxia 
(Nowicki et al, 1988b). This effect may depend on the essential role of NO in 
regulating vascular resistance in the newborn period, and on the limited NO 
production in the presence of reduced availability of molecular oxygen (Marletta, 
1993; Nankervis et al, 1995).  
Initial research hypothesised that exposure to one or more risk factors (such 
as birth asphyxia, apnoea, umbilical catheterisation, respiratory distress and 
ventilation, patent ductus artheriosus, indomethacin treatment, and polycytaemia) 
might cause intestinal ischaemia as a consequence of the “diving reflex”, a 
physiological adaptation present in marine mammals when blood flow is diverted 
from abdominal organs during hypoxia in order to preserve cerebral oxygenation 
(Kempley et al, 1992). 
Recent studies, however, seem to suggest that the ischaemic injury 
observed in NEC may derive from a primary disruption of endothelial cell function 
resulting in an imbalance between vasodilator and vasoconstrictor mediators 
within the newborn intestinal circulation. In particular, an impairment of 
endothelial production of NO would determine vasoconstriction and subsequent 
reduction of intestinal blood flow instead of the expected intestinal hyperaemia 
typical of the early newborn period. 
Endothelial cell dysfunction results in a loss of the capacity of these cells to 
produce NO. As previously discussed, NO is fundamental in maintaining 
vasodilatation in the newborn intestinal circulation, as proved by the profound 
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vasoconstriction that occurs in newborn, but not adult swine when constitutive NO 
synthesis is inhibited (Nankervis et al, 2001). A decrease in NO production has 
also been shown to increase the activity of vasoconstrictor mediators such as 
norepinephrine, angiotensin II, and ET-1 by affecting their binding affinity to 
cellular receptors (Cahill et al, 1995; Parekh et al, 1996), an effect present in 
newborn but not in adult animals (Nowicki, 1999). In addition, endothelial injury 
could cause loss of endothelin B receptors (ET-B) located on vascular endothelial 
cells, which mediate vasodilatation and are particularly abundant in neonatal life 
(Takasuka et al, 1994). 
 It has been proposed that a partial ischaemic state could initiate endothelial 
dysfunction in newborn intestine. A reduction of blood flow to 10% of baseline 
values followed by reperfusion can selectively damage intestinal endothelial cells 
without affecting the remaining intestinal parenchyma, and this effect is age-
dependent and limited to newborn animals (Nowicki, 1996). Alternative 
mechanisms responsible for the initial endothelial injury include the increased 
production of platelet activating factor (PAF) observed in neonates with NEC 
(Caplan et al, 1990; Hsueh et al, 2003), bacterial translocation from the intestinal 
lumen into the microcirculation with subsequent cell injury by bacterial toxins, and 
exposure of endothelial cells to intraluminal metabolites secondary to mucosal 
disruption by short-chain fatty acids released by fermentation of carbohydrates in 
dysmotile intestine.  
Recent evidence suggests that an increased arterial resistance at the level of 
the microcirculation could be responsible for the ischaemic changes observed in 
the intestine of NEC patients, possibly as a consequence of increased release of 
pro-inflammatory cytokines (Downard et al, 2011). Alternatively, intravascular 
coagulation with thrombotic occlusion of small vessels could contribute to gut 
hypoperfusion (St Peter et al, 2007). In both cases, ischaemia due to reduced blood 
flow at the level of the microcirculation is likely to be a transient and dynamic 
phenomenon that depends on the balance between vasoconstriction and 
vasodilatation, or thrombosis and thrombolysis. This would explain both the 
heterogeneous nature of the ischaemic insult on different parts of the gut at the 
same time point in individual patients, and the spontaneous improvement of the 
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macroscopic appearance of the bowel over time observed in many cases when a 
“second look” laparotomy is performed. 
 
Bacterial colonization 
Abnormal bacterial colonization plays a fundamental role in the 
pathogenesis of NEC. This is supported by several facts. Firstly, NEC does not 
occur in utero, but only after the gastrointestinal tract has been colonised by 
bacterial microflora after the first feed. Secondly, the epidemiological presence of 
outbreaks of NEC, as well as its decreased incidence following preventative 
measures, are suggestive of an infective process (Kosloske, 1994). In addition, 
intramural gas, one of the hallmarks of NEC, results from hydrogen production 
during bacterial fermentation (Hoy et al, 2000). Finally, bacteria are often isolated 
from the blood or peritoneal fluid of infants with NEC (Kosloske et al, 1980).  
However, a direct relationship with a specific pathogen has not been 
established. In fact, bacteria could contribute to intestinal injury as a result of 
bacterial overgrowth of normal flora, or rather for the effect of pathogenic species. 
Early colonization of the gut by Clostridium perfringens is correlated with later 
development of NEC (de la Cochetiere et al, 2004). However, colonisation of the 
intestine by Enterobacteriaceae has also been reported to be abnormally elevated 
in premature infants (Hoy et al, 2000), which could contribute to the inflammatory 
challenge of the intestinal mucosa. Further research is needed to clarify whether 
bacterial species play a primary role in the pathogenesis of NEC, or contribute to 
amplify the magnitude of intestinal injury initially triggered by other mechanisms. 
  
Inflammatory response 
  An efficient inflammatory response is necessary in order to protect the 
intestine from potential pathogens in the microbe-rich environment of the gut. 
However, an uncontrolled activation of the inflammatory response results in 
collateral damage caused by the release of oxidants and proteases by activated 
neutrophils, and other mechanisms as discussed later in this Chapter. Pathological 
studies in intestinal specimens from NEC patients suggest the presence of severe 
chronic and acute inflammation, including significant infiltration of neutrophils 
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(Ballance et al, 1990). Several studies suggest that the inflammatory response to 
physiological stimuli, including interactions with the bacterial flora, may be 
abnormal in the immature gut. Upon stimulation with lipopolysaccharide (LPS) 
and interleukin-1 (IL-1, human foetal intestinal cells exhibit an 8- to 20-fold 
increased production of the pro-inflammatory cytokine interleukin-8 (IL-8) 
compared to mature human enterocytes (Nanthakumar et al, 2000). This excessive 
pro-inflammatory cytokine production after inflammatory stimulation has been 
confirmed in human organ cultures from foetuses. Similarly, IL-8 production in 
immature enterocytes after incubation with Salmonella and Escherichia. Coli is 
also greatly increased over that  in adult intestinal cells (Claud et al, 2004). The 
potential of cord blood cells isolated from the foetal side of the placenta to produce 
pro-inflammatory cytokines such as IL-1, tumour necrosis factor-alphaTNF-
interleukin-6IL-6) after challenge with LPS has also been shown to be age-
dependent,  being highest in preterm infants <32 weeks gestation, and gradually 
lower in mild premature and term babies (Dembinski et al, 2003). 
Numerous clinical studies have shown increased plasma concentrations of 
numerous pro- and anti-inflammatory cytokines in infants with NEC compared to 
age-matched controls, including IL-1, interleukin-1 receptor antagonist (IL-1ra), 
IL-8, interleukin-10 (IL-10), interleukin-18 (IL-18), TNF-, and platelet 
aggregating factor (PAF), confirming the presence of an intense inflammatory 
response at a systemic level during NEC (Harris et al, 2005; Harris et al, 1994; 
Rabinowitz et al, 2001; Edelson et al, 1999). In a recent study of 127 infants, 
patients with confirmed NEC had higher plasma levels of proinflammatory 
cytokines (IL-1, TNF-IL-6) not only compared to controls, but also to age-
matched infants with documented sepsis (Sharma et al, 2007). Although it is not 
clear whether an uncontrolled activation of inflammation could be the primum 
movens leading to intestinal injury, or in turn it is secondary to a different initiating 
insult, it could exacerbate the damage to the intestinal barrier, as well as promoting 
functional impairment of distant organs.  
 
1.3.2 Clinical presentation 
 Age at presentation is inversely related to gestational age at birth, with 
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NEC occurring up to several weeks from birth in severely premature neonates, and 
full-term babies often presenting in the first few days of life (Kanto et al, 1994). 
Infants with NEC can present with both gastrointestinal and systemic signs. In the 
early stages of the disease, feeding intolerance, delayed gastric emptying, 
abdominal distension, vomiting or occult blood in the stools can be present. 
Because these early signs of the disease are non-specific, sepsis may be suspected 
before necrotizing enterocolitis. As the disease progresses, abdominal tenderness, 
ascites, abdominal wall erythema or discolouration, and gross blood in the stools 
may be noticed, together with non-specific signs indicative of progressive 
deterioration such as hyper- or hypothermia, lethargy, apnoea, respiratory distress, 
or poor perfusion. Intestinal perforation is usually followed by signs and symptoms 
of peritonitis, and profound shock. The clinical progression of the disease is 
extremely variable, some infants experiencing a benign disease with mainly 
gastrointestinal symptoms, others a catastrophic illness characterised by sudden 
fulminant onset with respiratory and metabolic acidosis, circulatory compromise, 
disseminated intravascular coagulopathy, and multiple organ failure (Hall et al, 
2004). In 1978, Bell proposed a system for the uniform clinical staging of infants 
with necrotizing enterocolitis (Bell et al, 1978), which has been subsequently 
modified by Walsh and Kliegman (Walsh et al, 1986). Infants were classified as 
having stage I (suspect), stage II (definite), or stage III (advanced) disease, which 
are further subdivided depending on the presence or absence of particular 
prognostic factors (Table 1.1). 
 
1.3.3 Multiple organ dysfunction syndrome in necrotizing enterocolitis 
Although NEC is part of a syndrome characterised by progressive failure of 
multiple organ systems other than the gut, the importance of multiple organ 
dysfunction syndrome (MODS) in contributing to the clinical outcome of patients 
with NEC was first recognised only in 1994 (Morecroft et al, 1994a). In a review 
of 46 infants with NEC, respiratory failure was retrospectively found in over 90% 
of patients, renal failure in 85%, cardiovascular failure in 33% and hepatic failure 
in 15%. Not surprisingly, the number of organs in failure increased with the 
severity of the disease according to Bell’s staging. Moreover, the number of 
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systems involved was also related to outcome, being higher in non-survivors. 
Similar findings were reported in a retrospective review of 50 infants with 
confirmed NEC (Sonntag et al, 1998). Dysfunction of at least one system in 
addition to the gut was present in over 80% of patients, with respiratory (76%), 
microcirculatory (58%), cardiovascular (54%), and hepatic (44%) functions being 
most frequently affected. Mortality was directly related to the number of organs in 
failure, and was particularly high in patients who developed capillary leak 
syndrome. A recent prospective study proved that both the incidence of MODS 
and mortality are higher in infants with NEC than in age-matched patients with 
proven sepsis of other origins (Sharma et al, 2007). This unfavourable outcome 
was accompanied by more severe endotoxaemia, suggested by higher 
concentrations of LPS, and by a more intense inflammatory response, as confirmed 
by higher levels of IL-1β, IL-6 and TNF-.  
 
1.3.4 Diagnosis 
Radiological imaging is essential to confirm the diagnosis in infants with 
clinically suspected NEC, as well as to aid in management (Epelman et al, 2007). 
Supine anterior-posterior abdominal X-rays are usually inspected for signs of the 
disease, although a horizontal view (supine cross-table lateral or a left side down 
decubitus) can be helpful in revealing free intraperitoneal air. Early non-specific 
signs include diffuse distension and asymmetric bowel gas pattern, whereas 
definite signs include pneumatosis intestinalis and portal venous gas. Pneumatosis 
intestinalis, representing intramural gas produced by pathogenic bacteria, is a 
pathognomonic finding and can have a linear appearance when intramural air is 
subserosal, or a bubbly appearance when the intramural air is submucosal. 
Submucosal intramural gas can be confused with stool, although radiographic 
evidence of colonic stool is rare in premature infants. Portal venous gas appears as 
a narrow, linear or branching lucency overlying the liver, representing intestinal 
gas absorbed into the mesenteric circulation. Typical signs indicating intestinal 
perforation include the “football sign” (free gas outlining the falciform ligament, 
showing as a radiolucent area in the shape of an American football in the 
epigastrium on a supine abdominal X-ray) and Rigler’s sign (clear demarcation of 
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both the inner and the outer bowel wall). Free intraperitoneal gas can also be seen 
in the sub-hepatic space or hepatorenal fossa. 
Haematological studies and blood biochemistry tests can help to confirm 
the presence of NEC, or contribute to indicate the severity of the disease, although 
they are not diagnostic (Neu, 2005). Severe or persistent thrombocytopenia, 
neutropenia, coagulopathy, or acidosis indicate advanced disease. 
 
1.3.5 Medical Treatment 
In patients with stage I NEC, the principles of treatment include bowel rest 
with discontinuation of enteral feeds, bowel decompression with a large-bore 
nasogastric tube, and broad-spectrum antibiotics (the choice should be dictated by 
microbiology cultures if available). Close clinical monitoring is essential, and 
serial radiological imaging is recommended to exclude progression of the disease 
even in clinically stable patients. Adjunctive therapy includes support of 
cardiovascular (inotropic support, fluid resuscitation), pulmonary (oxygen, 
mechanical ventilation), haematological (blood product transfusion to correct 
anaemia, thrombocytopenia, or coagulopathy), and nutritional functions (parenteral 
nutrition), as well as correction of acid-base imbalance as clinically indicated. If 
the clinical course and results from radiological and laboratory tests remain 
consistent with suspected NEC, the length of medical treatment (usually 7-10 
days) will be dictated by clinical judgment. Medical treatment is usually required 
for a longer period of time in patients with Bell’s stage II, and if Bell’s stage III 
disease is suspected or confirmed, intensive cardiovascular and respiratory support 
is usually required and surgical intervention should be considered (Hall et al, 
2004).  
 
1.3.6 Surgical treatment 
Despite recent advances in medical treatment, over 40% of neonates with 
confirmed NEC require surgical intervention in the acute stage (Butter et al, 2002). 
The presence of pneumoperitoneum, indicating intestinal perforation, is 
universally considered an absolute indication for surgical intervention (Pierro, 
2005). Progressive deterioration of the clinical status despite aggressive medical 
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support over 12-24 hours, or the finding of a palpable mass with erythema of the 
abdominal wall in a patient with persistent intestinal obstruction or sepsis usually 
also warrants a recourse to surgery. A positive paracentesis is also a valid objective 
indication for operation in infants with NEC, although it is rarely performed 
(Ricketts, 1986). Other findings, including a fixed, dilated loop of bowel on serial 
abdominal radiographs, evidence of portal venous gas, or a positive peritoneal 
culture are regarded as relative indications for surgery. 
The decision to operate is often difficult, and usually requires close 
consultation between neonatologists and surgeons. Particularly problematic is the 
case of infants with suspected NEC who become critically ill despite the lack a 
specific indication for surgery, such as pneumoperitoneum. In these circumstances, 
the potential benefits of an operation need to be weighed against the morbidity and 
possible mortality associated with surgical procedures. Several different options 
have been described for acute NEC, and the choice of surgical procedure is 
contentious. The usual surgical approach consists in a laparotomy. The aims of 
such approach consist in removing all segments of clearly necrotic intestinal 
segments in order to control sepsis, and at the same time preserving as much bowel 
length as possible to prevent short bowel syndrome. These principles explain why 
the decision-making process during laparotomy largely depends on the extent of 
the disease encountered, as well as on the clinical stability of the patient.  
If the disease is focal with necrosis limited to a single intestinal segment, 
resection of the affected segment and creation of one or more enterostomies can be 
performed (Musemeche et al, 1987). This option can be advantageous in unstable 
patients that cannot withstand a longer and more complex procedure. In addition, 
diverting the bowel allows adequate rest for the distal gut in the acute phase of the 
disease. However, the presence of an enterostomy can be associated with fluid and 
electrolyte imbalances, particularly for proximal stomas, as well as with 
difficulties in intestinal absorption once enteral feedings are restarted. In addition, 
complications inherent to the presence of one or more stomas (including prolapse, 
stenosis, and maceration of the surrounding skin) are frequently encountered, that 
may require re-operation (O'Connor et al, 1998). Even in the absence of any 
complication, a second operation is anyway required for the closure of the stoma. 
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Primary resection of the necrotic gut and anastomosis has been proposed in order 
to overcome these potential drawbacks (Ade-Ajayi et al, 1996), although 
fashioning the intestinal anastomosis in a potentially inflamed and ischaemic 
bowel is of concern. Initially restricted to patients in good general conditions and 
with localised disease, this procedure has been extended to micro-premies, patients 
with severe NEC or with multifocal disease (Hall et al, 2005; Fasoli et al, 1999), 
for whom multiple resections and anastomoses may be required. Although no 
conclusive evidence has been provided on the superiority of either approach, 
primary intestinal anastomosis has been shown to be a valid alternative to 
enterostomy (Fasoli et al, 1999).  
If a multifocal form of disease is encountered at laparotomy, with several 
different segments of the intestine appearing necrotic, a “clip and drop” technique 
can be applied (Vaughan et al, 1996). After resection of frankly necrotic bowel 
segments, the ends are clipped and the abdomen is closed. This minimises the 
duration of the surgical procedure in an unstable patient, and is followed by a 
“second look” laparotomy after 48-72 hours, at which time a definitive procedure 
is performed salvaging as much bowel as possible. If pan-intestinal NEC is found, 
with more than 75% of the bowel appearing gangrenous, a proximal jejunostomy 
can be performed. The definitive procedure is then performed after 6-8 weeks in an 
attempt to allow both improvement of general conditions, and partial healing of the 
affected gut. Although a good survival rate has been reported with this technique 
(Sugarman et al, 2001), not removing the necrotic intestine increases the risk of 
development of a progressive systemic inflammatory response and sepsis due to 
bacterial translocation. 
In 1977, Ein et al. proposed the insertion of a peritoneal drainage as a 
definitive treatment for premature newborns with perforated NEC (Ein et al, 1977). 
This was initially designed as a temporary solution to allow drainage of air and 
faecal material and therefore relieve intra-abdominal pressure in patients too 
unstable to undergo laparotomy. Although some infants improve to such an extent 
after insertion of a drain that a laparotomy is no longer necessary, others require a 
laparotomy over the following 12-24 hours. A recent multicentre controlled trial 
where 117 preterm infants with birth weight <1,500g and evidence of perforated 
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NEC were randomised to primary peritoneal drainage or laparotomy failed to show 
any clear benefit of either approach (Moss et al, 2006). In a similar randomised 
controlled trial conducted at Great Ormond Street Hospital for Children NHS Trust 
on 69 infants weighing <1,000g, Rees et al. confirmed that clinical outcome was 
similar in patients initially randomised to receive either laparotomy or peritoneal 
drain (Rees et al, 2008). However, 74% of patients initially treated with a drain 
required delayed laparotomy, suggesting that peritoneal drain is ineffective as 
either temporising measure or definitive treatment, and that a timely “rescue” 
laparotomy should be considered after initial insertion of a drain.   
 
1.3.7 Prevention 
Widely accepted strategies for the prevention of NEC include promotion of 
human milk feeding, and adoption of conservative feeding practices (Reber et al, 
2004). A number of other strategies have been recently investigated, including 
probiotics, oral antibiotics, immunoglobulin supplementation, and prenatal 
steroids.  
The protective effects of human milk versus formula feedings are well 
known. Two large prospective studies have found a lower incidence of NEC in 
preterm infants fed with their own mother’s expressed breast milk compared to 
those fed with formula milk (Lucas et al, 1990; Schanler et al, 1999). A recent 
meta-analysis showed that donor human milk reduces the incidence of NEC 
compared with formula milk in preterm infants (Boyd et al, 2007).  
Since bacterial colonisation plays a crucial role in the pathogenesis of 
NEC, the use of probiotics to counteract pathogenic bacteria appears to be a 
promising therapy. Probiotics are defined as living microorganisms, which upon 
digestion in sufficient numbers exert health benefits beyond basic nutrition 
(Bourlioux et al, 2003). A recent meta-analysis of 12 randomised controlled trials 
showed that supplementation with various probiotics (including Lactobacilli, 
Bifidobacterium, and Saccharomyces) can reduce the incidence of NEC as well as 
improve outcome in premature infants (Deshpande et al, 2007). However, the type 
and dose of bacteria used, the age at initiation of the treatment as well as its 
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duration were profoundly different in the individual studies, and further studies are 
needed to delineate an ideal protocol offering the best protection. 
Several studies have investigated the administration of oral IgG 
(immunoglobulin G) or an IgG and IgA (immunoglobulin A) combination in 
preterm infants in order to reduce the incidence of NEC. However, a meta-analysis 
of three randomised trials including a total of 2,095 neonates failed to show a 
significant reduction in the incidence of NEC, surgery, or mortality (Foster et al, 
2004). 
Prophylactic enteral antibiotics have been shown to reduce both the 
incidence of NEC and NEC-related mortality in a meta-analysis of five randomised 
trials (Bury et al, 2001). However, enteral antibiotic prophylaxis increased the 
incidence of colonisation with resistant bacteria, and larger studies are needed to 
address this issue before routine antibiotic prophylaxis is recommended. 
 
1.3.8 Outcome 
Despite the advances in medical and surgical management of infants with 
NEC, mortality rates are still high and ranging from 15 to 30% (Holman et al, 
2006; Luig et al, 2005).  
 
1.3.9 Animal models of necrotizing enterocolitis 
Several different animal models of NEC have been developed to date, 
although none of them represents an ideal model in terms of consistent 
reproducibility, limited labour- and time-intensity required, and presence of a 
significant developmental component (i.e. manifesting characteristic hallmarks of 
NEC at the appropriate age). 
Animal models based on occlusion and deocclusion of the superior 
mesenteric artery produce biological and pathogenetic changes characteristic of 
NEC. The most extensively studied is a model that utilises adult rats, where 
mesenteric occlusion is usually performed for 30-90min. However, the effects of 
blood flow impairment are more severe in developing rats as compared to adults. 
In weanling (90g) rats, occlusion of the superior mesenteric artery for only 1 
minute carries a mortality of over 60% at 1 week, with almost half the animals 
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presenting signs of intestinal necrosis (Dalsing et al, 1983). In 10-day old rats, 
intestinal permeability is increased after only 10min occlusion of the superior 
mesenteric artery, followed by 30min reperfusion (Langer et al, 1993). A model of 
mesenteric occlusion-deocclusion has also been described in piglets. Interestingly, 
the severity of intestinal injury after 48 hours of mesenteric occlusion is inversely 
related to maturity of the experimental animals, low birth-weight (700-1,200g) 
animals presenting the maximal degree of mucosal injury, normal birth-weight 
(>1,500g) piglets showing less severe damage, and 3-month old animals proving 
much more resiliant to mesenteric ischaemia (Sibbons et al, 1988).  
The main advantage of this method is the high reproducibility of the 
necrotic lesions to the ileum, as well as the facility to modulate the severity of the 
intestinal injury by adjusting the duration of ischaemia and reperfusion. In 
addition, the relationship between immaturity and susceptibility to the ischaemic 
insult mimics the pathophysiology of human disease. However, the pathogenesis 
of NEC arises from multiple mechanisms, and a model based on an impairment of 
blood flow may appear somehow simplistic. 
Systemic administration of different agents, such as TNF-, PAF, and LPS 
alone or in various combinations, have been used to mimic clinical NEC. PAF is 
an endogenous phospholipid mediator produced by enteric bacteria (including 
Escherichia Coli) as well as inflammatory cells, endothelial cells, and platelets 
(Caplan et al, 2005). Intravascular administration of PAF induces rapid 
development of intestinal necrosis at doses as low as 2.5g/kg (Gonzalez-Crussi et 
al, 1983), and profound and irreversible shock at higher doses. In this model, 
necrosis develops in the jejunum and in the caecum, but especially the distal ileum, 
beginning at the villous tip but sometimes extending to the submucosa or even the 
serosa. Systemic administration of LPS and TNF-(Sun et al, 1988) alone can 
also induce similar alterations, but only for doses as high as 1mg/kg and 5mg/kg 
respectively. However, low (0.5mg/kg) doses of LPS act synergistically with low 
doses of PAF to produce significant bowel injury (Hsueh et al, 1986a). Similarly, 
contemporary administration of low doses of TNF- (0.5mg/kg) and LPS 
(200mg/kg), causes profound shock and severe intestinal necrosis in rats (Hsueh et 
al, 1986b).  
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Although this model is highly reproducible, dose-dependent and therefore 
adjustable, and easy to setup, it presents some clear limitations. Firstly, it lacks any 
elective specificity for developing animals. In addition, intestinal injury does not 
develop in the totality of experimental animals. Finally, it is based on the 
activation of single pathogenic pathways, which does not entirely reflect the 
complexity of human disease. 
A more sophisticated model based on various combinations of 
administration of enteral feeds, whole-body hypoxia, and cold stress has also been 
described. The original description of this model comprised a complex stress 
where newborn rat pups were removed from their mothers, stressed briefly with 
asphyxia, colonised with gram-negative enteric bacteria, and fed with artificial 
formula (Barlow et al, 1974). After three days, animals presented abdominal 
distension and discolouration, bloody stools, and respiratory distress, and intestinal 
pathology revealed the presence of severe necrosis very similar to that of human 
NEC. Asphyxia alone (incubation in 100% CO2 for 5min followed by 100% O2 for 
5min) has also been reported to induce intestinal injury in newborn rats, although 
the severity of the lesions are highly variable, ranging from superficial epithelial 
damage with villous shortening to transmural necrosis (Okur et al, 1995). Formula 
feedings alone also induced moderate or severe intestinal injury resembling NEC 
in 70% of neonatal rats (Nadler et al, 2000). Combinations of hypoxia and formula 
feedings by gavage (Ergun et al, 2007); hypoxia and cold stress (Dvorak et al, 
2002); hypoxia, formula feedings, and cold stress (Caplan et al, 1999) have also 
shown to induce intestinal injury in newborn rats.  
The main theoretical advantage of these models, especially the ones 
combining formula feedings and hypoxia, is that the mechanism of injury mimics 
some of the pathogenic factors known to play a role in human NEC. However, 
models involving gavage feeding of neonatal rats are technically complex and 
therefore prone to variability. In addition, a major limitation in models involving 
the use of formula feedings by gavage is the induction of severe weight loss (as 
high as 50% of birth weight after 3 days) (Ergun et al, 2007) in the experimental 
animals, which adds the component of severe malnutrition to the pathogenic 
mechanism. Finally, these models are scarcely reproducible, as proved by the fact 
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that only part of experimental rats develop intestinal injury, and that the degree of 
intestinal injury itself is extremely variable.  
 
1.4 MIDGUT VOLVULUS 
 
The term midgut volvulus refers to the twisting of the portion of intestine 
supplied by the superior mesenteric artery (from  the duodeno-jejunal flexure to the 
mid-transverse colon) around its vascular axis (Millar et al, 2003). Although 
midgut volvulus has been described in the absence of malrotation, the anatomical 
prerequisite for its development is the presence of an abnormal rotation and 
fixation of the intestine. Malrotation arises from the failure of the normal process 
of fixation and rotation of the intestine and the mesentery to the retroperitoneum, 
which takes place between the 10th and 12th gestational week. As a consequence, 
the base of the mesentery is particularly narrow and the ascending and descending 
colon are not attached to the retroperitoneum, which can cause the midgut to twist 
clockwise around the superior mesenteric vessels. Twisting of the mesentery 
results not only in an obstruction to arterial flow, but also in an impairment of 
venous and lymphatic drainage in the superior mesenteric territory.  
 Midgut volvulus is typical of the neonatal age: over 40% of cases are 
diagnosed in the first week, 60% in the first month, and 90% within the first year 
of life (Aiken et al, 2005). Clinical features include bilious vomiting, abdominal 
distension, pain, and bloody stools, typically followed by sepsis and progressive 
deterioration of vital functions. A contrast study of the upper gastrointestinal tract 
is the most effective radiological evaluation, which typically shows an obstruction 
at the level of the third portion of the duodenum (possibly with a distal spiral break 
or corkscrew appearance), and the duodeno-jejunal junction and the proximal 
jejunal loops shifted to the right of the midline (Strouse, 2004). 
Once the diagnosis has been established, urgent surgical correction is 
mandatory because progression to intestinal necrosis carries a high risk of possible 
short bowel syndrome or death. The volvulus is detorted (usually in a counter-
clockwise fashion), therefore re-establishing blood flow to the midgut 
(reperfusion). Segments of intestine appearing frankly necrotic after derotation 
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may need to be resected. The pedicle of the mesentery is then dissected and its 
base is broadened in order to reduce the probability of recurrence.  
Results after surgical correction are usually excellent in the absence of 
necrotic bowel at the time of the procedure. However, in the presence of intestinal 
necrosis, mortality can be in excess of 40% in the acute phase, and short bowel 
syndrome can develop in the long-term (Messineo et al, 1992). 
 
1.5 INTUSSUSCEPTION 
 
Intussusception is the invagination, or telescoping, of a proximal portion of 
intestine (intussusceptum) into the adjacent distal segment (intussuscipiens). 
Increasing compression of the intussusceptum and its blood supply as it progresses 
through the distal bowel causes tissue oedema due to lymphatic and venous 
obstruction, resulting in arterial insufficiency with ischaemic bowel necrosis. 
The vast majority of intussusceptions are ileocolic, the terminal ileum 
passing through the ileocaecal valve into the ascending colon. Intussusception is 
usually idiopathic, but in up to 12% of cases may arise from an anatomic lead point 
(Meckel’s diverticulum, the appendix, carcinoid or lymphoid tumours and others) 
(Meier et al, 1996). Although it can occur at any age, the greatest incidence occurs 
in healthy infants between 3 and 9 months of age (Stringer et al, 1992). Infants 
typically present with sudden colicky abdominal pain in a previously comfortable 
baby. Vomiting and blood-tinged stools (sometimes with a “red currant jelly” 
appearance) are also often reported. Later in the course, patients appear lethargic 
between episodes of pain, and in the absence of appropriate treatment the outcome 
is often fatal as a result of hypovolaemia and sepsis (Meier et al, 1996). 
An urgent ultrasound scan or a contrast enema are mandatory in every case 
where the diagnosis is suspected, and treatment can be attempted by hydrostatic or 
air reduction during the same session. Success rate of these non-invasive 
techniques has increased to over 75% in most centres (Stringer et al, 1992), but 
surgery is still advocated  in case of failure of non-operative reduction or when 
signs of shock or peritonitis are present. Prompt recognition and adequate 
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treatment have dramatically improved outcome in modern practice, and survival 
approaches 100% in recent series (West et al, 1987). 
 
1.6 ACUTE MESENTERIC ARTERIAL OCCLUSION 
 
Acute mesenteric ischaemia is an often lethal condition characterised by an 
acute occlusion of the superior mesenteric artery or one of its major branches, and 
typically affects individuals of advanced age. The majority of cases of arterial 
occlusion result from emboli or arterial thrombi (Stoney et al, 1993). Embolisation 
to the superior mesenteric artery is the most frequent cause of mesenteric 
ischaemia, accounting for the majority of cases. Embolism is particularly frequent 
in patients with recent myocardial infarction, congestive heart failure, or 
arrhythmias. Emboli usually become lodged at major branch points within the 
superior mesenteric artery, typically just beyond the origin of the middle colic 
artery. In these cases, proximal mesenteric perfusion may be maintained resulting 
in a clear demarcation of the affected intestinal segment. Thrombosis of the 
superior mesenteric artery accounts for 25% of cases of acute mesenteric 
ischaemia. Arterial thrombi arise from atherosclerotic occlusive lesions, tend to 
occur at the origins, or very proximal segments, of the mesenteric arteries, and 
generally result in ischaemia of more extensive segments of bowel. In a minority 
of patients, ischaemia is due to nonocclusive disease or mesenteric venous 
thrombosis (Trompeter et al, 2002). 
In recent clinical series of acute mesenteric ischaemia, mortality rates 
remain as high as they were 40 years ago, and  vary between  60% to 100%, 
depending on the source of obstruction (Chang et al, 2006). Diagnosis before the 
occurrence of intestinal infarction is the most important factor in improving 
survival for patients with this condition, which highlights the importance of a high 
index of suspicion.  
The classic clinical presentation of patients with embolic disease is of 
sudden excruciating abdominal pain, which is out of proportion to physical 
examination findings. Only a minority of patients present with the classic triad of 
abdominal pain, fever and blood in the stools. These patients often have a history 
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of cardiac disease which might predispose to embolus formation, such as atrial 
fibrillation or mitral valve disease. Patients with thrombotic disease often report a 
history of chronic abdominal pain and coexistent atherosclerotic disease. Venous 
thrombosis of the visceral vessels can also precipitate an acute ischemic event 
(Chang et al, 2006). Impaired venous return leads to interstitial swelling of the 
intestinal wall, with subsequent compromise of arterial flow and eventual necrosis. 
Etiologic factors for venous thrombosis include portal hypertension, intrabdominal 
sepsis, cirrhosis, pancreatitis, malignancy and trauma.  
Nonocclusive mesenteric ischemia usually presents in a clinical setting of 
extremely low-flow splanchnic circulation, often in the presence of vasopressor use 
(Howard et al, 1996). No vascular occlusion is usually demonstrated because 
pulsatile blood flow is present in larger arteries. Patients with severe cardiac failure 
are at risk for nonocclusive mesenteric ischemia from vasospasm related to 
elevated sympathetic activity or hypovolemia.  
Multiple organ failure is commonly seen in this patient population, which is 
the major determinant of mortality (Harward et al, 1993). 
The presence of leukocytosis, acidosis, and elevated amylase, creatine 
kinase (CK) or lactate dehydrogenase (LDH) levels are neither specific nor 
sensitive. High resolution abdominal computerised tomography (CT) scan with 
contrast is very accurate and specific in delineating not only the extent of visceral 
ischemia, but also the status of flow in the mesenteric vasculature (Cikrit et al, 
1996). Both mesenteric arterial and portal venous blood flow are accurately 
assessed with contrast CT scanning (Ridley et al, 2001). Findings of abnormal 
intestinal wall blood flow, arterial intraluminal defects, or a halo sign in the 
mesenteric veins are very well demonstrated and accurately diagnose the presence 
and the causes of mesenteric ischemia. Visceral CT angiography has largely 
replaced catheter angiography in the work up of acute mesenteric ischemia. 
Although catheter angiography is somewhat more accurate, it is time consuming 
and does not produce significantly more useful results than those of high resolution 
scans with coronal, sagital, and three-dimensional reconstructions. 
The traditional approach to successful management of acute mesenteric 
ischemia from major arterial occlusion is prompt surgical therapy. Embolism in the 
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superior mesenteric artery is retrieved through a transverse incision in the main 
trunk of the artery in the mesentery (Bjorek et al, 2002). Balloon embolectomy 
catheters should also be used proximally and distally, and distal flushing with 
heparinsed saline should be performed. The treatment of choice for proximal 
mesenteric arterial thrombosis is aorto-mesenteric bypass (Sise, 2010). Numerous 
types of bypasses have been described, including antegrade supra-celiac aorto-
mesenteric bypass and retrograde iliac artery to mesenteric artery bypass. Once 
flow has been re-established, the bowel should be reassessed for signs of restored 
perfusion; injection of papaverine into the superior mesenteric artery is a helpful 
adjunct to reduce vasospasm. Obviously necrotic bowel should be resected by 
stapling and dividing at healthy margins. Anastomosis of bowel segments should 
be deferred until reoperation at 24 to 36 hours. Temporary abdominal wall closure 
should be performed, followed by early anticoagulation with intravenous heparin 
in order to prevent re-thrombosis of mesenteric vessels.  
Mesenteric venous thrombosis leading to ischemic bowel is much more 
difficult to manage, and the only choice is systemic anticoagulation coupled with 
resection of necrotic bowel (Sise, 2010). This condition often requires extensive 
bowel resection and survivors are left with shot-gut syndrome.  
Alternative approaches to open surgery include endovascular therapy and 
intraarterial thrombolysis (Chang et al, 2006). Intraarterial injection of fibrinolytics 
in the superior mesenteric artery has been shown to have promising initial results, 
and in many centres it has become the initial treatment of choice for mesenteric 
thromboembolism. 
In cases of nonocclusive ischemia, intraarterial vasodilator therapy with 
papaverine has been largely responsible for the decrease in mortality from 70% in 
the 1980s to 50%-55% during the last decade (Chang et al, 2006). 
 
1.7 CIRCULATORY SHOCK 
 
Circulatory shock is defined as a state of organ hypoperfusion inadequate to 
meet metabolic demands, with resultant cellular dysfunction and death. 
Mechanisms may involve decreased circulating volume (hypovolaemic shock due 
 Chapter 1: Intestinal Ischaemia and Reperfusion Injury 
 46
to haemorrhage, burns, prolonged vomiting or diarrhoea, diabetes and others); 
decreased cardiac output (cardiogenic shock resulting for instance from myocardial 
ischaemia, arrhythmias, or pulmonary embolism); uncontrolled vasodilatation with 
inadequacy of intravascular volume (distributive shock such as in anaphylaxis or 
severe brain or spinal injuries); and reduced venous return (obstructive shock such 
as in pericardial tamponade or pulmonary thromboembolism).  
The intense sympathetic adrenergic stimulation that characterises 
circulatory shock ensures that vital organs are perfused by diverting blood supply 
from the splanchnic circulation, including the liver (that can redistribute up to 1 
litre of blood under cardiovascular stress) and the gut (Chien, 1967; Price et al, 
1966; Vatner, 1974). Interestingly, splanchnic blood flow has been shown to be 
consistently impaired not only during hypovolemic shock, but also up to 1 hour 
after restoration of normal systemic haemodynamics (Edouard et al, 1994). These 
findings suggest that sustained splanchnic vasoconstriction develops as a 
consequence of a transient normotensive hypovolaemia, despite adequate treatment 
with fluid resuscitation and restoration of normal arterial pressure and cardiac 
output. This phenomenon of disproportionate splanchnic vasoconstriction appears 
to be mediated by both autonomic (neurally mediated adrenergic vasoconstriction) 
and local factors (eicosanoids, nitric oxide inhibition). The most important 
mechanism, however, appears to reside in a markedly greater effect of circulating 
vasopressor agents in the mesenteric bed compared to the systemic circulation, in 
particular angiotensin II (Toung et al, 2000; Suvannapura et al, 1988; Aneman et 
al, 2000) and vasopressin (McNeill et al, 1970; Hock et al, 1984). This state of 
hypoperfusion that outlasts the period of insult is the base of cellular changes 
causing mucosal gut damage, resulting in the loss of the intestine’s barrier function 
allowing bacterial translocation, and in the generation of a systemic inflammatory 
response eventually leading to multiple organ dysfunction (Biffl et al, 1996a). 
Common symptoms in patients with cardiocirculatory shock include altered 
mental status, tachycardia, hypotension, and oliguria; other symptoms depend on 
the underlying disease or secondary organ failure. Diagnosis is mostly based on 
clinical evidence of insufficient tissue perfusion with signs of compensatory 
mechanisms (such as tachycardia, tachypnoea, and diaphoresis). Primary treatment 
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focuses on restoring adequate perfusion to provide sufficient oxygen delivery to 
tissues, and supporting vital functions in case of secondary organ compromise. 
Untreated cardiocirculatory shock is usually fatal; even when appropriately treated, 
acute mortality from cardiogenic shock following myocardial infarction, for 
example, is as high as 25% (Jollis et al, 1996). 
 
1.8 SEPSIS 
 
Sepsis is characterised by a whole-body inflammatory state caused by 
systemic infection, mostly due to bacterial or fungal micro-organisms. Due to its 
high incidence (240.4 per 100,000 population per year), significant morbidity, and 
mortality rates of approximately 18% in the United States, sepsis represents a 
critical medical challenge as well as a substantial health care burden (Martin et al, 
2003).  
Unlike in circulatory shock, total splanchnic blood flow does not appear to 
be decreased, but rather increased during sepsis (Dahn et al, 1987; Wilmore et al, 
1980). This may reflect the increased metabolic demand in the early, 
hypermetabolic stages of sepsis when overall oxygen consumption in the 
splanchnic organs is increased (Ruokonen et al, 1993). However, abnormal 
capillary blood flow distribution with decreased perfusion in the microcirculation 
of all layers of the intestinal wall, including villi, has been described following 
inoculation of Escherichia Coli or endotoxin (Theuer et al, 1993; Drazenovic et al, 
1992). These changes are associated with impaired tissue oxygenation and cellular 
ischaemia, as indicated by a rise in the mucosal-arterial PCO2 gap (Mayer et al, 
1999), and by the increased catabolism of high-energy purine compounds (Schmidt 
et al, 1997) despite the maintenance of mesenteric oxygen delivery during 
experimental sepsis. Such microvascular failure is thought to be due to endothelial 
dysfunction following initial hypoperfusion, trauma or even direct endotoxaemic 
damage (Wort et al, 1999; VanderMeer et al, 1995). 
The clinical presentation is often characterised by the presence of 
symptoms related to the underlying infectious process in addition to those typical 
of systemic inflammation (such as fever, tachycardia, tachypnoea, and 
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leukocytosis). A prompt diagnosis followed by initiation of the appropriate therapy 
before the onset of the hypodynamic phase is an essential factor to prevent 
unfavourable outcome. Treatment consists of aggressive fluid replacement, 
appropriate support for organ dysfunction, and eradication of the infection. 
 
1.9 PATHOPHYSIOLOGY OF INTESTINAL ISCHAEMIA AND REPERFUSION  
INJURY 
 
 Ischaemia and reperfusion injury is a complex phenomenon, and its 
pathogenesis, although not completely understood, is certainly multifactorial. 
Evidence suggests that tissue and cell alterations initiated during the ischaemic 
time are aggravated upon reperfusion through a series of interconnected pathways 
(Molls et al, 2004). 
 
1.9.1 Ischaemia 
Intestinal cells are easily injured by episodes of ischaemia, and the intestine 
is probably the most sensitive to ischaemic injury among the internal organs 
(Granger et al, 1986; Yamamoto et al, 2001). When the blood supply to a tissue is 
discontinued, a sequence of chemical events is initiated that leads to cellular 
dysfunction, oedema, and ultimately death. Oxygen as a basic fuel is crucial to cell 
function, and lack of its supply to tissue results in a shift from aerobic to anaerobic 
metabolism (Grace, 1994). Energy efficiency of anaerobic glycolysis is 
considerably lower than that of oxidative phosphorilation, with only 2 molecules 
of adenosine tri-phosphate (ATP) yielded per molecule of glucose, compared to 38 
for aerobic metabolism. As a consequence, energy production for vital cell 
functions can be sustained for only a short period of time, which varies from 
minutes to hours depending on cell type (Chervu et al, 1989). Prolonged ischaemia 
is followed by depletion of cellular energy stores, particularly ATP, as well as by 
progressive acidosis due to increasing levels of by-products of anaerobic 
glycolysis such as lactate (Vejchapipat et al, 2000), eventually resulting in failure 
of cellular homeostasis characterised by ion gradients across the cell membranes 
(McCord, 1987). 
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Although necrosis has long been considered the only mechanism leading to 
cell death in the ischaemic intestine (Park et al, 1990), recent evidence suggests 
that apoptosis also plays a major role in the destruction of intestinal epithelial cells 
(Ikeda et al, 1998). The pathogenic mechanisms leading to apoptotic cell death in 
this setting have not been fully elucidated, however it has been suggested that 
anoikis (disruption of epithelial cell-matrix interactions) may play an important 
part in induction of apoptosis in detached enterocytes. 
 
1.9.2 Reperfusion 
 Restoration of blood circulation to ischaemic tissue is essential to re-
establish oxygen and nutrient supply, and to remove catabolites generated during 
the ischaemic period, therefore preventing the progression of cell injury. However, 
reperfusion is associated with a series of physiological processes which worsen the 
initial injury established during ischaemia. Experimental studies have shown that 
tissue injury, particularly in the mucosa, is more severe following reperfusion of 
the ischaemic gut than after a comparable time of pure ischaemia (Parks et al, 
1986). The pathogenesis of reperfusion injury is complex, and involves activation 
of several pathways often closely interconnected, including production of free 
radicals, release of cytokines and other soluble inflammatory mediators, 
recruitment of inflammatory cells, systemic diffusion of bacteria or their products, 
activation of the complement system, production of vasoactive substances and 
others. 
 
Oxidative and nitrosative stress 
Oxidative and nitrosative stress represent the harmful effects of free 
radicals causing potential biological damage. They are caused by an imbalance 
between the production of reactive oxygen (ROS) and nitrogen (RNS) species and 
a biological system’s ability to readily detoxify the reactive intermediates or easily 
repair the resulting damage. The biologically reactive ROS are the superoxide 
anion (O2-), the perhydroxyl radical (protonated superoxide, HO2-), the hydroxyl 
radical (HO), and hydrogen peroxide (H2O2). RNS include free radical nitric oxide 
(NO) and peroxynitrite anion (ONOO-), which forms from simultaneous 
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generation of NO and O2- (Beckman et al, 1990). ROS and RNS are highly 
unstable due to the presence of unpaired valence shell electrons, and reaction with 
biological compounds results in protein modification, lipid membrane disruption 
and deoxyribonucleic acid (DNA) damage.  
ROS and RNS mediated reactions can cause structural alterations in DNA 
(e.g. nicking, base-pair mutations, rearrangements, deletions, insertions, and 
sequence amplification) (Cuzzocrea et al, 2001b). The hydroxyl radical HO is 
known to react with all components of the DNA molecule, damaging both the 
purine and the pyrimidine bases and also the deoxyribose backbone. NO or, more 
likely, reactive products derived from it, particularly peroxynitrite, are mutagenic 
agents, with the potential to produce nitration, nitrosation, and deamination 
reactions on DNA bases. Reactive species can also attack polyunsaturated fatty 
acid residues of phospholipids, which are extremely vulnerable to oxidation (Siems 
et al, 1995), initiating a series of chain reactions known as lipid peroxidation (see 
Figure1.1). Once formed, peroxyl radicals (ROO) can be rearranged via a 
cyclisation reaction to endoperoxides, with the final product of the peroxidation 
process being malondialdehyde (MDA) (Marnett, 1999). Changes in charge and 
physical structure of phospholipids in biological membranes can disrupt the 
integrity of the cell wall as well as that of other intra-cellular compartments, 
leading to cell death. The side chains of all amino acid residues of proteins, in 
particular cysteine and methionine, are susceptible to oxidation by the action of 
ROS and RNS (Stadtman, 2004). Oxidation of cysteine residues may lead to the 
reversible formation of mixed disulphides between protein thiol groups (-SH) and 
low molecular weight thiols, in particular glutathione (S-glutathiolation). Perhaps 
of more physiological importance, both ROS and RNS can affect signal 
transduction in post-hypoxic cells, and ROS are able to initiate cell death programs 
in the form of apoptosis or necrosis (Zhou et al, 2005; Irani, 2000; Semenza, 
2000).  
Oxidants are produced in excess during reoxygenation, but ROS and RNS 
production also may increase in the reduced state that characterises cellular 
hypoxia. The main sources of ROS during ischaemia and reperfusion include 
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xanthine dehydrogenase-oxidase, mitochondria, and nicotinamide adenine di-
nucleotide phosphate (NADPH) oxidase. 
Xanthine dehydrogenase-oxidase is a highly versatile enzyme which plays 
an important role in the catabolism of purines in mammals, and is particularly 
abundant in the liver and intestine (Krenitsky et al, 1974). Xanthine dehydrogenase 
catalyses the conversion of hypoxanthine to xanthine and uric acid using 
nicotinamide adenine di-nucleotide (NAD+) as an electron acceptor. Under normal 
conditions, the enzyme is mostly in the form of xanthine dehydrogenase, making 
this the preferred pathway for disposal of xanthine. During the ischaemic period, 
cellular ATP is catabolised to yield hypoxanthine, which accumulates in the cell. 
Prolonged hypoxia also triggers the conversion of xanthine dehydrogenase to the 
oxygen radical-producing xanthine oxidase, which uses molecular oxygen instead 
of NAD+ as an electron acceptor (Parks et al, 1988). Superoxide anions are a by-
product of this reaction and may be in turn converted to hydrogen peroxide and 
hydroxyl radicals (Granger et al, 1981). During reperfusion, molecular oxygen is 
reintroduced into the tissue, where it reacts with hypoxanthine and xanthine 
oxidase to produce a burst of oxygen free radicals. Although the mechanism of 
conversion of xanthine dehydrogenase to xanthine oxidase is not yet completely 
understood, it seems to depend on diffusion of Ca2+ into the cell due to ATP 
depletion, and subsequent cleavage of xanthine dehydrogenase to xanthine oxidase 
by a calcium-dependent protease (Harrison, 2002).  
The mitochondrial respiratory chain is one of the most important sites of 
ROS production under physiological conditions, which is increased during cellular 
hypoxia and reoxygenation. The respiratory electron transport chain becomes 
reduced (i.e. the complexes harbour electrons) during anoxia, and the reduced state 
potentiates O2 production. Mitochondria generate excess partially reduced oxygen 
species (primarily O2- and its dismutation product, H2O2) during reoxygenation, 
which react with respiratory chain proteins (especially those containing Fe-S 
centres) or diffuse as H2O2 out of mitochondria (Tong et al, 2000). Two sites in the 
respiratory chain, complex I and complex III, have been suggested to be the major 
ROS sources (Newmeyer et al, 2003). H2O2 produced by mitochondria might also 
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function as a signal transducer, allowing mitochondria to act as oxygen sensors 
that regulate extramitochondrial signalling pathways. 
NADPH oxidase is an enzyme expressed by both phagocytic and non-
phagocytic cell types, including enterocytes (El Hassani et al, 2005), and 
represents an important source of superoxide anions in physiological and 
pathological conditions. The classical phagocyte NADPH oxidase produces 
extracellular superoxide that plays a pivotal role in host defence against microbial 
infections. The non-phagocytic NADPH complex is structurally and functionally 
similar to phagocyte NADPH, resulting in reduction of molecular oxygen to 
generate superoxide (Babior, 2004). However, some features differentiate non-
phagocyte from phagocyte NADPH. In particular, the non-phagocyte NAPDH 
oxidases are constitutively active, producing relatively low levels of ROS under 
basal conditions and generating higher levels of oxidants in response to cytokines. 
Although the role of NADPH oxidase in reperfusion injury of the gut is still 
unclear, some evidence suggests a role for phagocytic NADPH oxidase in 
promoting leukocyte-endothelial interactions (Yusof et al, 2007; Korthuis et al, 
1999). 
Antioxidant defences against ROS and RNS include enzymatic systems, 
such as superoxide dismutase (SOD), glutathione peroxidase, and catalase, and 
non-enzymatic antioxidants, including ascorbic acid (vitamin C), -tocopherol 
(vitamin E), glutathione, carotenoids, and flavonoids.  
Glutathione is a tripeptide composed of three different amino acids: 
glutamate, cysteine and glycine. Two major redox forms of GSH have been 
identified in the cells, i.e. reduced glutathione (GSH) and glutathione disulphide 
(GSSG) (Figure 1.2). Glutathione redox state (2GSSH/GSSG) is a good indicator 
of the cellular redox state, and a measure of oxidative stress in a cell (Nogueira et 
al, 2004). The balance between reduced and oxidised glutathione is essential for 
cells survival, and elevated concentrations of oxidised glutathione may lead to 
oxidation and damage of enzymes. Glutathione is present at high concentrations in 
the cytosol (1-11mmol/l), nuclei (3-15mmol/l), and mitochondria (5-11mmol/l). 
Glutathione exerts protection against oxidative stress through several 
different mechanisms (Masella et al, 2005). Firstly, it is a cofactor of several 
 Chapter 1: Intestinal Ischaemia and Reperfusion Injury 
 53
detoxifying enzymes against oxidative stress, including glutathione peroxidase, 
glutathione transferase, and others. In particular, glutathione peroxidase reduces 
H2O2 (or other peroxides) to H2O by oxidising glutathione as shown below: 
H2O2 + 2GSH  GSSG + 2H2O 
or, in case of other peroxides: 
ROH• + 2GSH  GSSG + RH + H2O 
Re-reduction of the oxidised form of GSSG is then catalysed by glutathione 
reductase through glutathione cycle: 
GSSG + NADPH + H+  2GSH + NADP+ 
An overview of the metabolic pathways involved in the reduction of free 
radicals by glutathione is illustrated in Figure 1.3. 
 The capacity to recycle GSH makes the GSH cycle pivotal to the 
antioxidant defence mechanism of a cell and prevents the depletion of cellular 
thiols.   
In addition, glutathione can directly scavenge free radicals, including 
singlet oxygen and hydroxyl radical. Glutathione participates in amino acid 
transport through the plasma membrane. Finally, glutathione is able to regenerate 
the most important antioxidants, vitamin C and E, back to their active form. The 
potential of glutathione to regenerate the most important antioxidants is linked to 
the redox state of the glutathione disulphide-glutathione couple (Pastore et al, 
2003).  
The ratio of cytoplasmic GSH/GSSG has recently been implicated in a 
range of cellular processes, such as cellular signalling, gene expression and 
apoptosis (Rahman et al, 2005).  
The normal GSH content of a cell is the function of the balance between its 
depletion and synthesis. Cells can either excrete GSSG or reduce it back to GSH in 
the cytoplasm by glutathione reductase as shown above. However, de novo 
synthesis of GSH from its amino acid constituents is essential for the elevation of 
GSH that occurs as an adaptive response to oxidative stress. GSH synthesis 
involves two enzymatic steps catalysed by glutamate cysteine ligase (the rate-
limiting component) and glutathione synthetase (Huang et al, 1993). The de novo 
rate modulation of GSH synthesis also depends on the cellular levels of cysteine.  
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Cytokines 
Cytokines are a group of small water-soluble proteins and glycoproteins 
that are involved in the regulation of both innate and adaptive immune responses. 
At low concentrations, cytokines can influence the cell from which they are 
produced and the surrounding cells in an autocrine and paracrine fashion. When 
released at higher concentrations, however, cytokines can enter the systemic 
circulation and influence the function of distant organs (endocrine effect). 
Cytokines have been traditionally divided into pro- and anti-inflammatory 
depending on their potential to stimulate or inhibit the inflammatory response. 
However, this classification appears artificial and simplistic: given the multiple 
effects of every cytokine, their impact on the inflammatory processes depends on 
the time and site of release, concentration, and on their interaction with the local 
conditions. 
Traditional pro-inflammatory cytokines include interleukin-1, 1, 2, 6, 15 
(IL-1, IL-1, IL-2, IL-6, IL-15), and TNF-, whereas interleukin-4, 10, 12, and 
14 (IL-4, IL-10, IL-12, IL-14), together with soluble IL-1ra are usually considered 
anti-inflammatory. 
TNF- is a powerful proinflammatory mediator that in many inflammatory 
responses, including I/R injury of many organs, serves as a central propagating 
factor (Frangogiannis et al, 2002; Donnahoo et al, 1999; Colletti et al, 1990; 
Seekamp et al, 1993). TNF- promotes the inflammatory response primarily by 
stimulating signal transduction pathways leading to induction of gene expression 
for secondary inflammatory mediators. TNF- activates a number of transcription 
factors regulating inflammatory gene expression including nuclear factor-kappa B 
(NF-kB), activator protein-1 (AP-1), as well as the p38 Map-kinase (MAPK). 
These transcription factors control gene expression for a variety of mediators 
including proinflammatory cytokines (i.e. IL-1, IL-6), chemokines (i.e. IL-8, and 
monocyte chemotactic protein 1 MCP-1), and vascular cell adhesion molecules 
(i.e. selectins, integrins).  
As with many other acute inflammatory responses, TNF- is a central 
mediator in the gut response to I/R. Increased levels of TNF-have been 
demonstrated not only in the intestine (Wada et al, 2001; Souza et al, 2000), but 
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also in the systemic and portal circulation (Yamagishi et al, 2002; Squadrito et al, 
1997; Fu et al, 1997) following mesenteric reperfusion. Mesenteric ischaemia and 
reperfusion injury has been shown to be substantially reduced by pharmacological 
inhibition of TNF-(Esposito et al, 2007; Souza et al, 2007) and similar 
beneficial effects have been achieved using TNF- receptor 1 knockout mice 
(Esposito et al, 2007; Cuzzocrea et al, 2004). This protection may be at least in 
part mediated via inhibition of NF-kB activation, which has been shown to prevent 
tissue injury and mortality following mesenteric reperfusion (Souza et al, 2005). 
IL-6 is an acute phase cytokine that is produced by mononuclear 
phagocytes, fibroblasts, keratinocytes and endothelial cells and plays a central role 
in haematopoiesis, host defence and inflammation (Van, 1990). Clinical levels of 
IL-6 have been correlated with severity of disease in shock, trauma and 
transplanted organ rejection (Biffl et al, 1996b; Waage et al, 1989; Kita et al, 
1994). IL-6 release can be induced by leukocytes in response to various stimuli, 
including LPS, heat shock response and IL-1. Although IL-6 is usually considered 
a pro-inflammatory cytokine, it also exhibits some anti-inflammatory properties, 
including down-regulation of cytokines such as IL-1, TNF- and interferon-
gamma (IFN-, and release of anti-inflammatory mediators such as IL-1ra and 
soluble TNF- receptors (Opal et al, 2000). IL-6 levels in the systemic circulation 
remain unchanged during mesenteric ischaemia, but increase within minutes from 
the onset of reperfusion and remain elevated for several hours (Rocourt et al, 
2007). The splanchnic origin of IL-6 has been suggested both by the increase in 
IL-6 messenger RNA (ribonucleic acid) in intestinal tissue, and by the higher 
levels of the cytokine in the portal and hepatic veins compared to arterial blood. 
IL-10 is a pleiotropic cytokine and its main function is to limit and 
terminate inflammatory responses. IL-10 inhibits the activation and effector 
functions of T-cells, monocytes, and macrophages. It has effects on most 
haematopoietic cells and inhibits chemokine synthesis, nitric oxide production, 
expression of class II major histocompatibility complex (MHC) molecules, and 
proinflammatory cytokines (including TNF-, IL-1, IL-6, IL-8, IL-12). IL-10 
also regulates the growth and differentiation of B-cells, natural killer cells, and 
cytotoxic and helper T-cells. Effects of IL-10 are mediated both via the JAK/STAT 
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(Janus kinase/ signal transducer and activator of transcription) pathway, and 
through inhibition of NF-kB activation (Boehler, 2002). IL-10 appears to play a 
crucial role in coordinating the anti-inflammatory gene response by modulating 
adhesion molecules and inflammatory cytokine gene expression in the early stages 
of reperfusion injury. However, the role of IL-10 is complex and experimental 
attempts at modulating IL-10 expression in animal models of mesenteric 
reperfusion have produced ambiguous results. IL-10 deficient mice showed a 
higher rate of mortality and more severe tissue injury following experimental 
mesenteric reperfusion compared with wild-type animals. This was mediated via 
an increase in proinflammatory cytokines TNF- and IL-6, enhanced adhesion 
molecule expression such as P-selectin and intercellular adhesion molecule 1 
(ICAM-1) and neutrophil infiltration, and development of oxidative and nitrosative 
damage (Zingarelli et al, 2001). Such protective effects have been confirmed by 
exogenously administered IL-10 both before, and 1 hour after the onset of 
reperfusion (Lane et al, 1997). However, other studies have suggested that both 
survival and intestinal injury are similar in wild-type and IL-10 deficient mice 
(Stallion et al, 2002), and that intravenous administration of IL-10 before 
reperfusion resulted in increased tissue damage, possibly via reduced inducible 
nitric oxide synthase ( iNOS) expression (Nussler et al, 2003). 
 
Inflammatory cells 
Infiltration of neutrophils in tissues is believed to be responsible for 
important tissue damage not only at a local level (Sisley et al, 1994; Hernandez et 
al, 1987; Qing et al, 2001), but also in distant organs, such as lungs, liver and heart 
(Vinardi et al, 2003; Horton et al, 1993a; Horie et al, 1996; Simmons et al, 1990; 
Spasic et al, 1993) following intestinal I/R. In particular, neutrophil activation, 
neutrophil-endothelial adhesion and extravasation are fundamental steps in the 
pathophysiology of I/R injury.  
Initial rolling of inflammatory cells along the endothelium is mediated by 
expression of adhesion molecules on the surface of endothelial cells, which is 
followed by firm adhesion and transendothelial migration (Ebnet et al, 1996). 
Evidence has been provided for the contribution of adhesion molecules to 
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leukocyte recruitment in several conditions (including localised inflammation, 
sepsis, and organ ischaemia and reperfusion) in response to the production of 
interleukins, TNF-α, LPS, histamine, PAF and other soluble mediators (Pettersen 
et al, 2002). Accumulation of activated neutrophils is driven by several 
chemoattractants, including C3a and C5a, IL-1 and TNF-α (Moraes et al, 2003), 
and it occurs in the intestinal, hepatic, and pulmonary vascular bed within minutes 
of intestinal reperfusion (Kurtel et al, 1991).  Extravasated neutrophils degranulate 
and release a number of proteases from intracellular granules, including elastase, 
gelatinase, collagenase and cathepsin G. Neutrophil-derived proteases are able to 
directly cause cell death. In addition, mobilisation of azurophilic granules leads to 
the liberation of NADPH oxidase, which generates superoxide that dismutates to 
oxygen and hydrogen peroxide. Furthermore, myeloperoxidase  released from the 
neutrophils azurophilic granules can generate hypochlorous acid (HOCl), another 
diffusible oxidant and chlorinating agent, which gives rise to other toxic species 
such as chloramines (Jaeschke, 2006).  
Inhibition of neutrophil-mediated effects has been reported using 
neutrophil elastase inhibitors (Kotake et al, 2005; Takayama et al, 2001), blockade 
of adhesion molecules such as P-Selectin (Farmer et al, 2005; Carmody et al, 2004; 
Farmer et al, 2002) and ICAM-1 (Gayle et al, 2002; Kuzu et al, 2002), or 
chemokines (including cytokine-induced neutrophil chemoattractant or CINC) 
(Mbachu et al, 2004; Ishii et al, 2000). The fundamental role of neutrophils in 
contributing to mesenteric reperfusion injury is confirmed by the protective effects 
on local and distant organ damage of these strategies. 
Recruitment of CD4+ and CD8+ T-lymphocytes mediated via endothelial 
adhesion molecule MAdCAM-1 ( mucosal addressin cellular adhesion molecule 1) 
has also been proposed to contribute to intestinal reperfusion injury (Shigematsu et 
al, 2002). Mechanisms of T-cell dependent tissue injury include modulation of the 
neutrophil recruitment that occurs hours after reperfusion as well as the increased 
albumin extravasation that occurs within minutes after reperfusion. 
In recent years, activated resident macrophages have been suggested to 
play a key role in the early phases of reperfusion-induced damage to the gut (Chen 
et al, 2004). I/R induced mucosal damage was correlated with activation of gut 
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resident macrophages and upregulation of myeloperoxidase and Early growth 
response factor 1 gene (EGR-1, a transcription factor involved in the inflammatory 
response). Depletion of gut resident macrophages by dichloromethylene 
bisphosphonate (Cl2MBP) significantly reduced mucosal damage. 
 
Adhesion molecules 
The endothelium regulates immune and inflammatory responses by 
controlling the extravasation of leukocytes from the blood into tissues. Leukocytes 
enter inflamed tissue mostly through post-capillary venules that have been 
transiently activated by inflammatory stimuli. Activated endothelial cells express a 
complex series of molecules that is required to capture leukocytes and attract them 
into tissue. In particular, the activated endothelium expresses adhesive molecules 
that help leukocytes to engage the vessel wall in a protein-protein dependent 
interaction.  
The initial interaction of leukocytes with the endothelium lining the vessel 
wall is known as tethering, and the subsequent rotational movement along the 
vessel wall is called rolling. These events are dependent on the selectins, a 
calcium-dependent, type I transmembrane glycoprotein family of adhesion 
molecules comprising E-selectin, P-selectin, and L-selectin, named for the cell 
type in which they were originally identified (endothelium, platelet, and leukocyte)  
(Kansas, 1996). P-selectin (CD62P, cluster of differentiation 62P) is constitutively 
expressed and stored in platelets -granules and endothelial cells Weibel-Palade 
bodies. Within minutes from stimulation by inflammatory mediators (including 
oxidants, LPS, histamine, leukotrienes, or histamine), the Weibel-Palade bodies of 
endothelial cells fuse with the plasma membrane, increasing surface expression of 
P-selectin (Geng et al, 1990). This rapid expression accounts for the role of P-
selectin in mediating early leukocyte recruitment during an inflammatory response. 
In addition, transcription of P-selectin can occur in rodents after activation of 
endothelial cells through expression of NF-kB induced by inflammatory mediators 
such as TNF-, IL-1, IL-4, and LPS (Pan et al, 1998).  
E-selectin (CD62E, cluster of differentiation 62E) expression, on the 
contrary, requires de novo synthesis on endothelial cells, which is induced by 
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various mediators, such as IL-1, LPS, and TNF-a. Expression can occur on the 
endothelial surface as quickly as 2 hours after stimulation and generally decreases 
within 24 hours (Kansas, 1996). Despite delayed expression, E-selectin overlaps 
with P-selectin, helping to enhance leukocyte recruitment during inflammation. In 
fact, E-selectin expression results in a dramatic decrease in rolling velocity, 
therefore enhancing the probability of subsequent adhesion (Kunkel et al, 1996). 
L-Selectin (CD62L, cluster of differentiation 62L) is expressed on most leukocytes 
and mediates rolling in some inflammatory conditions, although its role appears 
secondary to the endothelial selectins (Jung et al, 1999). 
Rolling is mediated by binding of selectins to specific ligands expressed by 
inflammatory cells, such as PSGL-1 (P-Selectin glycoprotein ligand 1).  PSGL-1 is 
expressed on myeloid, lymphoid, and dendritic cells and can serve as a ligand to 
all selectins (Kansas, 1996). Leukocyte rolling on P-selectin is almost completely 
dependent on PSGL-1, and PSGL-1 is also an important ligand for E-selectin 
(Zanardo et al, 2004).  
Following rolling, firm adhesion of leukocytes to endothelial cells is 
mediated by the interactions between integrins and their ligands on endothelial 
cells: ICAM-1, ICAM-2 and vascular cell adhesion molecule 1 (VCAM-1). 
Chemoattractant cytokines (or chemokines) are produced by activated leukocytes, 
macrophages, mast cells, and various tissue cells (including fibroblasts, epidermal 
cells, and endothelial cells) following release of pro-inflammatory cytokines such 
as IL-1, TNF-, or IL-4 (Baggiolini et al, 1994). Chemokines bind specific 
receptors expressed on leukocytes to induce activation, including expression of 
integrins. Integrins consist of a heterodimer of an  and a  subunit, and are 
expressed by leukocytes and other cell types. Approximately 16  subunits and 8  
subunits are known to exist, and various combinations form at least 22 
heterodimers. Leukocyte adhesion to the endothelium is mediated by the 2-
integrins, fundamental for neutrophil infiltration (such as leukocyte function-
associated molecule LFA-1, and macrophage 1 antigen Mac-1), as well as 4-
integrins, which are found primarily on monocytes, lymphocytes, and eosinophils 
(Luo et al, 2007). The ligands for leukocyte integrins are the immunoglobulin 
superfamily members expressed on endothelial cells, ICAM-1 and ICAM-2, and 
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VCAM-1. ICAM-1 and ICAM-2 are endothelial ligands for the leukocyte β2-
integrin LFA-1.  
ICAM-1 is one of the most important adhesive receptors on endothelial 
cells for the firm adhesion of leukocytes, and can recognise several integrins 
including LFA-1 and Mac-1 (Springer, 1994). It is constitutively expressed on the 
endothelium, and it is further upregulated by inflammatory cytokines, including 
TNF-, IL-1, and IL-4. In contrast, ICAM-2 is constitutively expressed and not 
inducible. ICAM-1 mediates firm attachment of leukocytes to the apical 
endothelial surface and the subsequent migration to endothelial cell contacts, a step 
called locomotion (Schenkel et al, 2004). Recent evidence suggests that ICAM-1 
contributes to additional functions, including extravasation of leukocytes by 
diapedesis (transcellular migration) and signal transmission in endothelial cells 
(Yang et al, 2005; Tilghman et al, 2002).  
Unlike ICAM-1, VCAM-1 is not constitutively expressed in most tissues 
but is strongly upregulated through de novo synthesis after stimulation with TNF-
 and IL-1. VCAM-1 binds to both β1 and 4 integrins on monocytes, 
lymphocytes and neutrophils, and is mainly involved in the inflammation-related 
leukocyte migration although its blockade does not prevent leukocyte 
extravasation (Johnston et al, 2000). 
Adhesion of leukocytes to endothelial cells is followed by leukocyte 
emigration. Leukocyte migration is still incompletely understood, although several 
proteins, including PECAM-1 (platelet endothelial cell adhesion molecule 1), 
CD99 (cluster of differentiation 99), junctional adhesion molecules, vascular 
endothelial-cadherins, and other molecules, have been implicated in this process 
(Engelhardt et al, 2004). Migration of adherent leukocytes into the extravascular 
space appears to take place both through intercellular junctions, and in a 
transcellular fashion through the endothelium (Shaw et al, 2001). 
 
Bacterial translocation 
Bacterial translocation is a phenomenon in which live bacteria or their 
products, including LPS and other toxins, cross the intestinal barrier. The human 
intestinal microflora contains 300 to 500 different species of bacteria, located 
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preferentially in the colon (Wiest et al, 2003). Although interaction between the 
host and its microbial guests determines important health benefits, some of these 
bacteria are potential pathogens and can be a source of local and systemic infection 
in case of failure of the mucosal barrier (Steinberg, 2003). The function of the 
barrier depends on the normal intestinal flora (ecological barrier), mucous epithelia 
(mechanical barrier), and secretory IgA and immune cells (immune barrier). 
Maintenance of the barrier relies on the integrity of cellular plasma membranes 
and tight junctions, as well as the elaboration of endothelial and epithelial 
secretory products (Baumgart et al, 2002).  
Intestinal epithelial cell hypoxic injury and subsequent reperfusion induces 
profound disruption of the intestinal barrier function. Translocation might be 
mediated by a three-hit model as proposed by Deitch (Deitch, 2002). The first gut 
insult could be hypoperfusion and ischaemia. Acidosis and overproduction of 
reactive oxygen species determine disarrangement in the mucosal cytoskeleton, 
thus increasing epithelial permeability. Restoration of the intestinal blood flow 
produces a second hit, with migration of neutrophils to the intestinal 
microcirculation, release of cytokines by leukocytes and GALT (Gut-Associated 
Lymphoid Tissue), and generation of prostaglandins, thromboxane, prostacyclins 
and leukotrienes causing increased vascular permeability. The third hit is the loss 
of integrity of the gut barrier function, providing translocation of intestinal 
endotoxins and bacteria, and exposure to immune cells. The majority of these 
bacteria is phagocytosed and contributes to the intestinal inflammatory response. 
However, some translocated bacteria and toxic compounds are drained by the 
mesenteric lymphatic system and are trapped in the intestinal lymph nodes, 
causing an inflammatory reaction. 
Current data suggest two major pathways of gastrointestinal permeability 
through which translocation may occur: transcellular through the enterocytes and 
paracellular using the tight junctions (Ellis, 2004). In the same way, there are two 
major routes that bacterial compounds might gain access to the systemic 
circulation: through the enteric venous system to the portal vein, or following 
lymphatic enteric drainage. Recent evidence suggests that the latter might be the 
principal pathway of translocation (Kaneko et al, 2007). 
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Evidence from experimental studies shows that LPS release into the 
circulation is dramatically increased following reperfusion of the ischaemic gut 
(Yamagishi et al, 2002; Ohara et al, 2001). Following prolonged intestinal 
reperfusion, bacterial colonization has been documented not only in mesenteric 
lymph nodes, but also in distant organs such as liver and spleen (Fu et al, 1997; 
Yao et al, 1995; Ohara et al, 2001; Kucukaydin et al, 2000). The importance of 
bacteria and their products in contributing to reperfusion injury is confirmed by the 
reduction of local and distant organ injury via modulation of the systemic 
inflammatory response achieved via gut decontamination or germ-free 
environment (Sorkine et al, 1997; Souza et al, 2004). 
 
Complement and natural antibodies 
The complement system consists of over 20 small proteins and protein 
fragments normally circulating as inactive zymogens in the blood. Upon activation 
by one of several triggers through the classical, alternative, or mannose-binding-
lectin associated pathway, proteases in the system cleave specific proteins to 
release cytokines and initiate an amplifying cascade of further cleavages. This 
activation cascade finally results in release of opsonising (C3b, C4b, and iC3b) and 
chemotactic (C5a) molecules, as well as in direct cytolytic effect (via formation of 
the membrane attack complex) and activation of the inflammatory cascade through 
generation of anaphilatoxins (C3a and C5a) (Cole et al, 2003). The activation of 
the complement cascade following intestinal I/R may depend on both the classical 
(Woodcock et al, 2000) or the alternative pathway (Stahl et al, 2003). 
It has recently been suggested that the importance of the complement 
system in the pathogenesis of tissue injury is mediated via circulating natural 
antibodies as part of the innate immune response. Innate immune B cells are T 
cell-independent B cells present in the primary, pre-antigen-driven repertoire. 
These innate immune B cells participate in the host response against microbial 
antigens through the generation of natural IgM (immunoglobulin M) antibodies 
that do not require affinity maturation to provide early protection (Milner et al, 
2005). Although beneficial for the host, these cells have also been implicated in the 
pathogenesis of autoreactivity. Recent evidence proves that circulating natural IgM 
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contribute to the pathogenesis of reperfusion injury of several organs, including the 
intestine, by binding to specific self-antigens exposed during ischaemia and 
reperfusion. It has been suggested that brief periods of ischaemia lead to an 
alteration in surface epitopes of self-antigens. Natural IgM would recognize these 
neo-antigens on damaged tissue and, upon binding to the cell surface, initiate 
inflammation by activating complement in the classical pathway (Williams et al, 
1999). Recent experiments have shown that a specific IgM isolated from a single 
hybridoma clone was sufficient to restore reperfusion injury in a mouse model 
(Zhang et al, 2004). This effect was highly specific, because IgM prepared from 20 
other hybridomas did not restore injury. Non-muscle myosin heavy chain type II A 
and C, a highly conserved self-antigen, has been shown to be the target of natural 
IgM that can initiate intestinal I/R injury (Zhang et al, 2006), although 
phospholipids may represent other possible target antigens (Fleming et al, 2004).  
  
Nitric oxide 
Nitric oxide (NO) is a free radical and a highly reactive substance. NO is 
synthesised by a family of enzymes known as NO synthases (NOS) utilising L-
arginine as a precursor. Three isoforms of NOS have been identified and cloned: 
endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS)  
(Albrecht et al, 2003). eNOS is expressed at low concentrations in the mesenteric 
endothelium; under physiological conditions, it regulates intestinal blood flow by 
acting as a vasodilator, and its inhibition results in an increased splanchnic 
vascular resistance (Pique et al, 1992). nNOS is the most abundant isoform in the 
gut, and is expressed in the myenteric plexus (Hoffman et al, 1997). Unlike eNOS 
and nNOS, which are constitutively expressed, iNOS is virtually absent in the 
intestinal mucosa under normal conditions, and is expressed by leukocytes and 
other cell types in response to inflammatory stimuli (e.g. cytokines) and growth 
factors.  
The role of NO in hypoxia and reoxygenation is multifaceted, and still 
largely unclear. On one hand, NO is a cytoprotective agent, and inhibition of NO 
production causes tissue dysfunction in certain models of mesenteric reperfusion. 
However, NO can act as a cytotoxic compound and its blockade can provide 
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beneficial effects. Although apparently paradoxical, these different effects can be 
at least in part explained by the different sites and sources of NO production, as 
well as by the different regulatory mechanisms.  
Intestinal I/R is associated with impaired endothelial function, which would 
result in an overall reduced production in NO (Grace, 1994). Administration of L-
arginine, the precursor for NO synthesis, has been shown to protect from 
mesenteric reperfusion injury in several studies (Kozlov et al, 2002; Ward et al, 
2000; Horie et al, 1997b; Schleiffer et al, 1996), although this is controversial 
(Fukatsu et al, 2004).  
A more clear understanding of the pathophysiology of NO has been 
provided by studies utilising selective inhibitors of the different isoforms of NOS. 
The constitutive isoforms of NOS (nNOS and eNOS) are critical to normal 
physiology, and selective inhibition of these enzymes has consistently been shown 
to be detrimental (Kubes et al, 2000). The induction of iNOS produces large 
amounts of NO, which leads to increased mucosal permeability, causes mucosal 
injury, promotes bacterial translocation, and decreases mesenteric blood flow 
(Suzuki et al, 2000). Consistent with these findings, specific inhibition of this 
enzyme has shown to reduce local and distant organ injury following mesenteric 
reperfusion (Naito et al, 2004; Wu et al, 2002; Chen et al, 2000; Barocelli et al, 
2006; Uchida et al, 2007). Although the molecular bases for the deleterious effects 
of iNOS-derived NO have not been completely elucidated, the generation of 
peroxynitrite from the contemporary release of high amounts of superoxide and 
NO plays a crucial role (Cuzzocrea et al, 2001b). 
 
Endothelins 
Endothelins are potent vasoconstrictors released by the vascular 
endothelium (Ozel et al, 2001). Three active isoforms of endothelin (ET-1, ET-2, 
and ET-3) have been described. Their vasoconstrictive effects are predominantly 
mediated via ET-A receptors present on smooth muscle cells of blood vessels via 
release of calcium ions from intracellular stores. Interaction of endothelins with 
ET-B receptors mediates either vasoconstriction (ET-B2), or vasodilatation (ET-
B1). Intestinal I/R induces an increase in endothelin concentrations in the portal 
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vein, which may exacerbate reperfusion injury (Schlichting et al, 1995), whereas 
inhibition of endothelins by receptor blockade protects against reperfusion injury 
of the gut (Wolfard et al, 2002; Oktar et al, 2002; Wolfard et al, 1999). 
  
1.10 MULTIPLE ORGAN DYSFUNCTION SYNDROME 
 
MODS, also known as multiple organ failure, is characterised by multiple 
and progressive organ dysfunction severe enough to require intervention for 
homeostasis in an acutely ill patient. MODS is one of the leading causes of 
mortality in surgical intensive care units, and accounts for the majority of deaths in 
clinical conditions associated with intestinal I/R in both adults (Sauaia et al, 1995; 
Sharma et al, 2003) and paediatric patients (Carcillo, 2003).  
The pathogenesis of MODS following reperfusion injury of the gut, 
similarly to that of other organs, relies on the development of a systemic 
inflammatory response mediated by ROS and RNS, cytokines, activated 
complement, eicosanoids, and leukocytes as described before. The complete 
disruption of the intestinal mucosal barrier secondary to the ischaemic insult 
determines massive translocation of bacteria and endotoxins from the intestinal 
lumen into the circulation (Deitch, 1990), unlike reperfusion injury in cardiac, 
cerebral, and hepatic disease where this phenomenon is more limited. Once 
initiated, the systemic inflammatory response instigates a self-enhancing vicious 
circle leading to a progressively more severe injury not only to the intestine, but 
also to distant organs such as the lungs, heart, liver, kidneys, and the 
microcirculation (Stallion et al, 2005). 
 
1.10.1  Lungs 
The lung is the most commonly affected vital organ in critically ill patients, 
and acute respiratory distress syndrome (ARDS) usually precedes failure of other 
organs in patients with MODS (Moore et al, 1996). Respiratory failure is 
characterised by pulmonary oedema due to enhanced microvascular permeability 
and increased hydrostatic pressure through the pulmonary capillary bed (Iglesias et 
al, 1998). Using in vivo confocal laser microscopy, macromolecular leak in the 
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interstitial space and the alveoli was observed both during ischaemia and, to a 
much greater extent, upon reperfusion of the intestine. In addition, capillary 
obstruction by stagnating leukocytes or micro-thrombi has been described in the 
pulmonary vasculature as a consequence of mesenteric reperfusion (Mitsuoka et al, 
1999). This pulmonary microvascular injury leads to altered gas exchange with 
altered excretion of carbon dioxide and impaired oxygenation, and subsequent 
hypoxemia and hypercapnia (Nuckton et al, 2002). 
 Inflammatory mediators such as PAF, TNF- and other cytokines, 
eicosanoids, activated complement proteins, chemokines, and iNOS derived NO 
have been shown to contribute to the pathogenesis of pulmonary oedema following 
mesenteric reperfusion (Kostopanagiotou et al, 2007; Yang et al, 2007; Akahori et 
al, 2006; Xiao et al, 1997; Uchida et al, 2007). In addition to soluble mediators, 
neutrophils are believed to play a key role in lung injury, and inhibition of 
neutrophil functions (Kotake et al, 2005) or recruitment (Kuzu et al, 2002) 
effectively reduces intestinal reperfusion-induced pulmonary injury. 
 
1.10.2 Heart 
Cardiac function has been shown to be profoundly affected following 
experimental intestinal I/R, with a progressive impairment in myocardial function, 
which could exacerbate existing intestinal hypoperfusion (Horton et al, 1991; 
Horton et al, 1993a). Intestinal reperfusion injury causes both histological injury 
and functional impairment. Histological damage following mesenteric reperfusion 
is characterised by myocardial interstitial oedema, neutrophil infiltration, and 
myocyte necrosis (Yao et al, 1996; Douzinas et al, 2003). Functional impairment 
in both myocardial contraction and relaxation has been shown to develop as early 
as 2 hours after the onset of intestinal reperfusion, which persists for up to 16 
hours in isolated perfused hearts (Horton et al, 1991).  
Such myocardial dysfunction and injury seems to be mediated via cytokine 
release, free radicals production, and neutrophil activation, since inhibition of these 
pathways by administration of TNF-inhibitors, free radical scavengers 
(superoxide dismutase, catalase, allopurinol) or pentoxifylline (inhibitor of 
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neutrophil adherence and aggregation) prevents cardiac dysfunction (Yao et al, 
1996; Horton et al, 1993a; Horton et al, 1993b; Horton et al, 1991).   
 
1.10.3 Liver 
As previously discussed, venous outflow from the mesenteric circulation is 
filtered through the liver via the portal circulation before entering the inferior vena 
cava, which makes the hepatic parenchyma particularly vulnerable to the 
consequences of intestinal reperfusion injury. Firstly, a reduction in portal blood 
flow to a third of baseline is observed during mesenteric ischaemia (Turnage et al, 
1996). Upon intestinal reperfusion, recovery of hepatic inflow is only partial and 
does not exceed 85% of baseline levels (Nakamura et al, 2001), suggesting the 
presence of alternative mechanisms other than a reduced portal venous return. In 
fact, a substantial reduction in blood flow via the hepatic artery (Turnage et al, 
1996) and reduced sinusoidal perfusion have been documented upon experimental 
mesenteric reperfusion (Horie et al, 1996; Yamagishi et al, 2002).  
Hypoperfusion is accompanied by liver tissue ischaemia, which is 
worsened during mesenteric reperfusion: in rabbits subjected to mesenteric artery 
occlusion-revascularisation, tissue oxygenation index drops to 50% of baseline 
after 90min intestinal ischaemia, and continues to decrease after restoration of 
mesenteric blood flow (Horie et al, 1997a). Histological changes as documented by 
light and electron microscopy include progressive hepatocyte damage with 
cytoplasm oedema and condensation of the nucleus, tissue oedema and 
haemorrhage, leukocyte infiltration, and blood cell aggregates in the sinusoidal 
spaces (Tian et al, 2006; Giakoustidis et al, 2006).  
Using in vivo magnetic resonance spectroscopy,  Vejchapipat et al 
demonstrated that significant liver energy failure is observed upon reperfusion, but 
not during mesenteric ischaemia alone (Vejchapipat et al, 2001). This failure is 
characterised by a 50% decrease in hepatic ATP during mesenteric reperfusion, 
which is the fundamental source of energy for cellular activities, together with an 
increase in end-products of anaerobic metabolism such as succinate and lactate. 
Interestingly, this drop in hepatic ATP levels immediately preceded death of 
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experimental animals, suggesting a possible association between hepatic energy 
failure and mortality. 
Although the exact pathogenesis of such hepatic injury remain unclear, 
several possible mechanisms have been proposed, including bacterial translocation 
and release of cytokines (such as IL-1, IL-6 and TNF-) in the portal circulation 
(Medeiros et al, 2006; Kaplan et al, 2007). In addition, sequestration of neutrophils 
in hepatic sinusoids with plugging by leukocyte and leukocyte-platelets aggregates 
has been shown to contribute to hepatic injury (Horie et al, 1997a). This appears to 
be mediated via expression of endothelial adhesion molecules such as ICAM-1 and 
P-selectin, possibly through up-regulation of transcription factor NF-kB (Tian et 
al, 2006; Yamagishi et al, 2002). 
 
1.10.4 Kidneys 
Although renal failure is common in the clinical setting of mesenteric 
reperfusion injury, few experimental studies focused on the consequences of 
intestinal I/R on the kidneys. Renal blood flow has been shown to be reduced to 
20% of baseline in rats after 60min of mesenteric reperfusion (LaNoue et al, 1996). 
Renal hypoperfusion was accompanied by tissue hypoxia (as confirmed by a 25% 
reduction in cellular ATP levels) and renal tubular dysfunction. Electronic 
microscopy studies revealed the presence of structural alterations of both the 
endothelial cells of the glomerular capillaries, and epithelial cells of the tubules in 
the early phases of mesenteric reperfusion, possibly as a consequence of lipid 
peroxidation in the kidney (Mutlu et al, 2002; Mura et al, 2007). Increased release 
of reactive oxygen species, imbalance in eicosanoid production, and neutrophil-
induced tissue injury have been proposed as possible mechanisms in the 
pathogenesis of renal dysfunction, as confirmed by the protective effects of 
allopurinol and pentoxifylline in experimental models (Rothenbach et al, 1997). 
 
1.11 HYPOTHERMIA IN INTESTINAL ISCHAEMIA AND REPERFUSION INJURY 
 
Therapeutic hypothermia consists in a controlled lowering of core body 
temperature below normal values (<35°C), and can be classified as mild (32 - 34 
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ºC), moderate (28 - 32 ºC), or deep (<28 ºC). Previous studies in rats have 
suggested that application of moderate hypothermia throughout ischaemia and 
reperfusion of the gut can substantially prevent mortality (Vejchapipat et al, 2001), 
and these effects have been shown to persist after rewarming of the experimental 
animals (Kalia et al, 2002b). Unlike most other therapeutic strategies applied 
during ischaemia and reperfusion injury, hypothermia does not act on one single 
target, but it rather modulates several different pathways involved in the 
development of both local and distant organ damage, including modulation of 
metabolism, of the inflammatory response, and of heat shock response. 
The metabolic requirement for oxygen and energetic substrates of the small 
intestine is high because of its absorptive and secretory functions, which is not 
affected by a reduction of body temperature to 32°C in otherwise healthy animals.  
Although whole-body moderate hypothermia has shown to reduce mesenteric 
blood flow in newborn and neonatal piglets (Powell et al, 1999), the oxygen 
delivery to those organs is likely to be enough to meet the decreased metabolic 
demand of splanchnic viscera. This is confirmed by the fact that intestinal and 
hepatic phosphoenergetics were unaffected after 120min of moderate hypothermia 
in sham-operated rats (Vejchapipat et al, 2006b). However, interruption of blood 
supply during ischaemia causes a rapid and dramatic decrease in intestinal 
concentrations of ATP and phosphocreatine in normothermic rats, which drops to 
20% of baseline within 10min from the onset of mesenteric ischaemia (Blum et al, 
1986). Interestingly, restoration of blood supply fully reverts this energetic failure 
only for short ischaemia times, whereas a permanent time-dependent decrease in 
the recovery of high energy phosphoenergetics is observed if the duration of 
ischaemia is superior to 10min. These data suggest that if the initial energy failure 
may be simply due to a lack of oxygen and energetic substrates, and therefore 
reversible upon restoration of perfusion, long periods of hypoperfusion result in 
irreversible derangement of energy metabolism.  
These results have been confirmed in a similar animal model where longer 
ischaemia and reperfusion times were studied (Vejchapipat et al, 2000b; 
Vejchapipat et al, 2001; Vejchapipat et al, 2002). During prolonged intestinal 
ischaemia (90min and 150min), phosphocreatine, ATP, adenosine di-phosphate 
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(ADP), and glucose levels in the ileum dropped substantially, whereas inorganic 
phosphate, succinate, and lactate level markedly increased. This reflects the 
impairment of oxidative phosphorilation, with accumulation of tricarboxylic acid 
cycle intermediates and by-products of anaerobic glycolysis. Prolonged ischaemia 
followed by 60min of intestinal reperfusion was not followed by resynthesis of 
phosphoenergetics in intestinal tissue despite partial recovery of glucose, 
succinate, and lactate, suggesting the presence of severe intestinal damage as 
indicated by irreversible intestinal energy failure.  
Application of whole-body moderate hypothermia (30 to 32°C) throughout 
both the ischaemic and the reperfusion phase resulted in partial recovery of 
intestinal phosphocreatine, ATP, and lactate levels only when a model of 30min of 
ischaemia and 60min of reperfusion was used, whereas for 90min of ischaemia 
followed by 60min of reperfusion no hypothermic protection was observed. 
Interestingly, the preservation of energy metabolism by hypothermia was 
associated with an improvement in reperfusion-induced histological injury in the 
terminal ileum. The beneficial effects of moderate hypothermia on intestinal 
energy metabolism are therefore likely to be ischaemic-time dependent, but the 
mechanism of hypothermic protection is still unclear. Although the temperature-
dependent reduction in metabolic rate is a well-known phenomenon, the small 
decrease in oxygen consumption caused by moderate hypothermia cannot explain 
the ability to preserve the viability of tissue, as the oxygen reserves would still be 
rapidly consumed in the ischaemic state (Kataoka et al, 1998).  
Total-body hypothermia also induced protection from liver energy failure 
in the same animal model, which was associated with improved survival 
(Vejchapipat et al, 2001). In particular, normothermic reperfusion was associated 
with progressive liver energy failure, as indicated by a decrease in ATP together 
with an increase in hepatic inorganic phosphate to ATP ratio. Induction of 
moderate hypothermia throughout the experiment delayed the onset of liver energy 
failure and prevented mortality. Although it is unclear whether this beneficial 
effect is due to primary protection of the intestine, or to a direct effect on the liver, 
hepatic down-regulation of pro-inflammatory and pro-apoptotic signal transducers 
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and activators of transcription (STATs) may be involved in hypothermic protection 
(Parkinson et al, 2004).  
Modulation of the inflammatory response induced by cooling also seems to 
play a crucial role in hypothermic protection. Hypothermia has been reported to 
delay production of cytokines (such as IL-1, TNF-, Il-6) in human 
polymorphonuclear and mononuclear cells in vitro (Fairchild et al, 2000; Kimura 
et al, 2002), and to reduce production of IL1- in human cerebrospinal fluid “in 
vivo” (Marion et al, 1997). In addition, moderate hypothermia inhibits human 
monocytes activities, including chemotaxis, phagocytosis and bacterial killing 
(Kimura et al, 2002). Kalia et al investigated leukocyte adhesion to the villus 
endothelium in rats undergoing 30min superior mesenteric artery occlusion 
followed by 120min reperfusion by utilising in-vivo fluorescence microscopy and 
acridine orange labelled leukocytes (Kalia et al, 2002b). As expected, a rapid, 
sustained, and significant increase in leukocyte adherence within both the mucosal 
capillaries and the supplying arteriole occurred upon mesenteric reperfusion in 
normothermic animals. However, in animals maintained at moderate hypothermia 
throughout mesenteric ischaemia and reperfusion, leukocyte adhesion to the 
endothelium was not only delayed but also of significantly lower magnitude, and 
did not increase following rewarming of hypothermic animals. This effect may be 
explained by the potential of hypothermia to reduce adhesion molecule-mediated 
leukocyte-endothelial interactions, as proved by the reduced levels of soluble 
ICAM-1 (sICAM-1) by hypothermia in a similar animal model (Vejchapipat et al, 
2006a). Down-regulation of pro-inflammatory transcription factor NF-kB and of 
iNOS in the intestine by hypothermia have also been reported in different animal 
models where selective hypothermia of the gut was used, which would contribute 
to reduce the extent of the inflammatory response (Montero et al, 2003; Attuwaybi 
et al, 2003). Interestingly, further experiments in rats showed that the anti-
inflammatory effects of cooling may not be limited to the gut, as suggested by the 
reduction in neutrophil infiltration in the lung following mesenteric reperfusion 
(Vinardi et al, 2003). 
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1.12 CLINICAL APPLICATIONS OF HYPOTHERMIA 
 
The main clinical indications for whole-body therapeutic hypothermia 
include cardiac arrest, neonatal hypoxic ischaemic encephalopathy, traumatic brain 
injury, surgical procedures with cardiopulmonary bypass, and acute liver failure. 
Several clinical studies have suggested that mild induced hypothermia may 
improve neurologic outcome in survivors from cardiac arrest (Cheung et al, 2006). 
Cardiac arrest causes an immediate cessation of blood flow, leading to a rapid 
depletion of cerebral oxygen and ATP stores, and depressed cerebral function. 
There are three phases of cerebral injury after hypoxic insult: early, intermediate 
and late. Therapeutic hypothermia is considered to be neuroprotective by acting at 
each of the 3 stages of injury, perhaps synergistically (Green et al, 2005). 
Immediately after arrest of cardiac activity, cerebral blood flow decreases 
significantly despite ongoing consumption of oxygen and energetic substrates. 
Application of hypothermia in this early stage can improve energy metabolism by 
reducing consumption of oxygen and glucose. The intermediate or latent phase 
occurs in the hours post-arrest, which is characterised by the activation of 
cytotoxic cascades in the brain, including release of free radicals and nitric oxide. 
Hypothermia decreases the release of excitatory amino acids and other neurotoxic 
mediators, and reduces nitric oxide production. The late phase of cerebral injury 
can occur up to 24 hours following cardiac arrest. This stage is characterised by a 
break-down in the blood-brain barrier, development of progressive cerebral 
oedema, and eventually neuronal death. Application of hypothermia defers the 
deterioration of the blood-brain barrier and decreases cerebral oedema (Howes et 
al, 2006). A recent meta-analysis investigated the outcome of 385 survivors of 
cardiac arrest that were randomised to standard or mild hypothermia therapy (core 
body temperature 32-34°C) for 24 hours, when treatment was applied within 6 
hours after arrival at the emergency department (Holzer et al, 2005). The results 
showed that hypothermia substantially increased the chance of survival with 
favourable neurological outcome at discharge from hospital (risk ratio, 1.68; 95% 
confidence interval, 1.29-2.07), with a number-needed-to treat of 6 (95% 
confidence interval, 4-13). A similar protection from hypothermia was observed in 
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the 6 month follow-up. Although potential complications from patients cooling 
have been reported, including increased infection risk, coagulopathy, and 
arrhythmias with depressed cardiac function (Cheung et al, 2006), only a trend 
towards higher incidence of bleeding or sepsis was seen.  
Therapeutic hypothermia has also been widely applied following 
peripartum asphyxia to prevent hypoxic ischaemic encephalopathy in newborn 
infants. Magnetic resonance spectroscopy studies in term infants with evidence of 
intrapartum hypoxia have shown that neuronal death follows a “biphasic” model. 
Cerebral oxidative metabolism appears to be normal shortly after birth followed by 
secondary energy failure, the degree of which predicts both mortality and long-
term neurodevelopmental outcome (Roth et al, 1997). Therefore, a therapeutic 
window of opportunity exists in the interval following resuscitation of the 
asphyxiated newborn before the secondary phase of impaired energy metabolism 
and injury occurs. Experimental studies have shown that hypothermia may confer 
neuroprotection by a number of different mechanisms, including reducing cerebral 
metabolic rate, blunting the inflammatory response, lowering production of 
reactive oxygen and nitrogen species, and down-regulating apoptotic cell death 
(Shankaran et al, 2007).  
Clinically, hypothermia can be induced by two different methods: whole 
body cooling and selective head cooling with mild systemic hypothermia. 
Although selective cooling of the brain offers the theoretical advantage of 
minimising the adverse effects of systemic cooling, it has been shown that 
reducing the temperature of the whole body is essential in order to achieve a 
significant reduction in deep brain temperature (Van Leeuwen et al, 2000). A 
recent meta-analysis reviewed the outcome of 8 randomised controlled trials 
including 683 near-term infants with moderate or severe encephalopathy and 
evidence of intrapartum asphyxia (Jacobs et al, 2007). Therapeutic hypothermia 
resulted in a clinically important reduction in the combined outcome of mortality 
or long-term major neurodevelopmental disability (risk ratio, 0.76; 95% 
confidence interval 0.65-0.89), with a number needed to treat of 7 (95% 
confidence interval 4-14). Cooling also resulted in statistically significant 
reductions in mortality and neurodevelopmental disability in survivors. 
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Interestingly, these benefits were more pronounced in newborns with severe 
encephalopathy compared to those with encephalopathy of moderate degree. 
Reported adverse effects of hypothermia included increased thrombocytopenia, 
and hypotension requiring inotropic support. 
Whole-body hypothermia has also been extensively applied in both adult 
and paediatric patients with traumatic brain injury. However, three meta-analyses 
reported conflicting results with regard to the potential of cooling to reduce the risk 
of mortality and adverse neurological outcome (Alderson et al, 2004; McIntyre et 
al, 2003; Henderson et al, 2003), and hypothermia is not currently recommended 
as a standard of care (Shafi et al, 2006). 
Total body cooling has also been applied for over 50 years in patients 
undergoing coronary artery bypass surgery in order to reduce neurological damage, 
although its efficacy remains controversial. A meta-analysis of 19 randomised 
controlled trials failed to demonstrate a clear advantage of hypothermic versus 
normothermic cardiopulmonary bypass (Rees et al, 2001). Although patients in the 
hypothermia groups showed a reduced stroke rate, this is offset by an increase in 
non stroke related perioperative mortality and myocardial damage. 
Therapeutic hypothermia has also been described in patients with severe 
acute liver failure in an attempt to control intracranial hypertension refractory to 
mannitol (Jalan et al, 2004), and to stabilize intracranial pressure during orthotopic 
liver transplant (Jalan et al, 2003), although further studies are needed before this 
therapy is recommended.  
 
1.13 AIMS OF THE THESIS 
 
The aims of this thesis are: 
 
1. To study the consequences of intestinal reperfusion injury on the 
inflammatory response, oxidative and nitrosative stress, and energy 
metabolism  in the gut and distant organs in experimental models of adult 
and infant intestinal I/R. 
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As discussed previously in this Chapter, there are significant differences 
between adult and newborns in the susceptibility to ischaemic injury, as 
well as in the pathophysiology of the body’s response to mesenteric I/R. In 
addition, there is very little experimental evidence elucidating  the 
pathogenesis of MODS in the newborn period. I therefore designed a series 
of experiments in both adult and developing rats, using a model of 
mesenteric artery occlusion and deocclusion, in order to investigate  the 
potential pathways responsible for both intestinal injury and distant organ 
failure in human diseases associated with intestinal I/R injury. 
 
2. To evaluate the effects of moderate hypothermia as a potential novel 
therapy for intestinal I/R injury in adult and developing experimental 
animal models.  
The effects of hypothermia were investigated both when applied as a 
preventative therapy throughout the ischaemic and reperfusion phase, and 
when applied as a rescue therapy after the onset of reperfusion. As 
discussed in the previous paragraph, the potentials of moderate 
hypothermia as a therapeutic measure in this setting are extremely 
promising due to both its profound effects on multiple different pathways, 
and to the high safety prophile and limited side effects shown in numerous 
neonatal trials. 
 
3. To investigate the potential benefits of 5,10,15,20-tetrakis(N-methyl-4'-
pyridyl)porphyrinato iron (III) (FeTMPyP) in an infant model of  intestinal 
I/R injury. 
FeTMPyP is a recently developed, selective antioxidant acting as a 
peroxynitrite decomposition catalyst. As discussed previously in this 
Chapter, selective scavenging of peroxynitrite offers some theoretical 
advantages over older, less selective antioxidants such as inhibitors of 
superoxide dismutase (SOD), by simply blocking the deleterious effects of 
this “ugly” free radical without interfering with the potentially beneficial 
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functions of other radicals (eg bacterial killing, intracellular signalling and 
others) (Beckman et al, 1996). 
 
4. To further elucidate the pathogenesis of human NEC, with particular focus 
on characterising the inflammatory process in the intestine and evaluating 
its relationship with clinical outcome. 
Although the clinical features of human NEC have been extensively 
described in the literature, the characteristics and role of the inflammatory 
response in the intestine are largely unknown. Contributing to fill this gap 
is particularly important not only to offer a better understanding of the 
pathogenesis of the disease, but also in order to compare the findings of my 
experimental studies in rat models of intestinal I/R with a human condition 
where investigational therapies could be applied. In particular, establishing 
a parallel between the inflammatory response in human disease and 
experimental conditions would reinforce the potential clinical benefits of a 
thereapeutic strategy that proved to modulate it in an animal model. 
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Table 1.1. Modified Bell staging for necrotizing enterocolitis (Walsh et al, 
1986) 
 
Stage Systemic signs Abdominal signs Radiographic signs 
I 
 
Suspected 
NEC 
Temperature 
instability, apnoea, 
bradycardia, lethargy
Gastric retention, 
abdominal 
distension, blood in 
the stools 
Normal or intestinal 
dilation, mild ileus 
IIA 
 
Mild  
NEC 
Same as above Same as above, plus 
marked abdominal 
distension ± 
tenderness, absent 
bowel sounds, 
grossly bloody stools
Intestinal dilation, 
ileus, focal  
pneumatosis 
intestinalis 
IIB 
 
Moderate 
NEC 
Same as above, plus 
mild metabolic 
acidosis and 
thrombocytopenia 
Same as above, plus 
abdominal wall 
oedema and 
tenderness ± 
palpable mass 
Same as IIA, plus 
extensive 
pneumatosis, early 
ascites ± portal vein 
gas 
IIIA 
 
Severe 
NEC 
Same as IIB, plus 
hypotension, 
oliguria, mechanical 
ventilation,  
combined respiratory 
and metabolic 
acidosis, DIC 
Same as above, plus 
worsening wall 
oedema with 
erythema and 
induration 
Same as IIA, plus 
prominent ascites, 
fixed bowel loop 
IIIB 
 
Severe 
NEC 
Same as IIIA,. 
further deterioration 
and shock 
Evidence of 
perforation 
Same as above, plus 
pneumoperitoneum 
 
 DIC: disseminated intravascular coagulation 
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Figure 1.1. Lipid peroxidation and formation of malondialdehyde.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lipid peroxidation of a poly-unsaturated fatty acid leads to the formation of 
malondialdehyde as end-product. 
 (Modieifed from ESA Application note 70-5033, Thermo fisher Scientific, 
Chelmsford, MA). 
Chain breaking antioxidants
(eg glutathione) act here 
to stop propagation of lipid
peroxidation
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Figure 1.2. Molecular structure of reduced and oxidised glutathione. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Molecular structure of [A] reduced, and [B] oxidised glutathione. 
GLUTAMATE CYSTEINE GLYCINE
A
B
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Figure 1.3. Metabolic pathways involved in the reduction of free radicals by 
glutathione.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Free radicals such as H2O2 are inactivated by reduced glutathione through 
glutathione peroxidase. Oxidised glutathione is reduced by glutathione reductase 
using NADPH as substrate. NADPH is in turn regenerated by glucose-6-phosphate 
dehydrogenase, generating 6-phosphogluconate which is metabolised to lactate 
through the hexose monophosphate shunt or pentose phosphate pathway. 
GSH, reduced glutathione; GSSG, oxidised glutathione; G-6-P, glucose-6-
phosphate; 6-PG, 6-phosphogluconate; HMPS, hexose monophosphate shunt or 
pentose phosphate pathway.  
GLUTATHIONE PEROXIDASE
GLUTATHIONE REDUCTASE
GLUCOSE-6-PHOSPHATE DEHYDROGENASE
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CHAPTER 2 
MATERIAL AND METHODS 
 
2.1 ANIMAL MODELS 
 
All experiments were approved under the United Kingdom Home Office 
regulations for Animals (Scientific Procedures) Act 1986. 
 
2.1.1 Intestinal ischaemia and reperfusion in adult rats 
Adult male Sprague-Dawley rats (250 to 300g) were used. The rats were kept 
under standardised conditions for food, water, light, and temperature. General 
anaesthesia was induced and maintained throughout the experiments. In the 
experiments described in Chapter 4, anaesthesia was induced by 2% halothane and 
oxygen and nitrous oxide (50:50) by inhalation for 5min, and confirmed by 
absence of webfoot reflex. Anaesthesia was then maintained by 0.5-1.0% 
halothane inhalation with oxygen and nitrous oxide (50:50) via a nose cone 
(Harvard Apparatus, Holliston, MA, USA). In the experiments described in 
Chapter 6, 3% isoflurane and oxygen and nitrous oxide (50:50) by inhalation for 
5min was used for induction, followed by 2% isoflurane inhalation with oxygen 
and nitrous oxide (50:50) via a nose cone.  
Immediately after induction, a rectal temperature probe connected to a servo 
system (CWE Inc, Ardmore, PA, USA) was placed, and body temperature was 
measured throughout the experiment and maintained within the desired range by 
use of a lamp and a heating blanket controlled by the servo system. 
Once adequacy of general anaesthesia was confirmed by absence of webfoot 
reflex, the peritoneal cavity was entered via a midline laparotomy. The superior 
mesenteric artery was then identified (Figure 2.1A) and dissected (Figure 2.1B), 
and a silicone loop (Surg-I-Loop; Scanlan, MN) was slung around its origin 
(Figure 2.1C and 2.1D). In animals undergoing sham operation, the loop was 
immediately removed without occluding the artery, and arterial pulsation on the 
mesentery was confirmed under direct vision. In rats subjected to intestinal I/R, 
occlusion of the superior mesenteric artery was performed by continuous traction 
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(ischaemia) and removal (reperfusion) of the silicone loop slung around the origin 
of the artery for the assigned duration. The traction was always performed in the 
same direction and with similar tension in every animal, and efficacy of arterial 
occlusion was documented by absence of arterial pulsation in the vascular arcades 
of the mesentery. The peritoneal cavity and the abdominal wall were then closed 
with a single layer running suture. At the end of the period allocated for mesenteric 
ischaemia, the suture was removed and the origin of the superior mesenteric artery 
was once again exposed. In rats undergoing sham operation, pulsation of 
mesenteric arteries was once again confirmed, and the peritoneum and abdominal 
wall were closed with a single layer running suture without performing any further 
intervention. In animals subjected to intestinal I/R, absence of mesenteric flow was 
confirmed before removing the silicone loop from the origin of the superior 
mesenteric artery, and reperfusion was then assessed by visualization of pulsation 
in the vascular arcades of the mesentery. The peritoneum and abdominal wall were 
closed as previously described. At the end of the experiment, the thorax was 
entered via a midline sternotomy, the ascending aorta and the superior vena cava 
were identified and divided, and animals were sacrificed by exsanguination under 
terminal anaesthesia. The appearance of the bowel at different stages of the 
procedure is shown in Figure 2.2. 
 
2.1.2 Intestinal ischaemia and reperfusion in infant rats 
Suckling Sprague-Dawley rats (11-13d, 20-30g, mixed sex) were housed 
with their mother and allowed to suckle freely until the beginning of the 
experiment. General anaesthesia was induced by 3% isoflurane and oxygen and 
nitrous oxide (50:50) by inhalation for 5min, and confirmed by absence of webfoot 
reflex. Anaesthesia was then maintained by 1-1.5% isoflurane inhalation with 
oxygen and nitrous oxide (50:50) via a nose cone (Harvard Apparatus, Holliston, 
MA, USA). Immediately after induction, a rectal temperature probe connected to a 
servo system (CWE Inc, Ardmore, PA, USA) was placed, and body temperature 
was measured throughout the experiment and maintained within the desired range 
by use of a lamp and a heating blanket controlled by the servo system. 
Operative procedures were carried out under microscopic view using an 
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operating microscope (SZ4045, Olympus, Hamburg, Germany) at 10x 
magnification. The peritoneal cavity was accessed through a supraumbilical 
transverse laparotomy (Figure 2.3 A). The superior mesenteric artery was then 
identified (Figure 2.3 B) and dissected (Figure 2.3 C). In rats subjected to sham 
operation, no vascular occlusion was performed and the peritoneum and the 
abdominal wall were closed in one layer with a running suture. In animals 
undergoing intestinal I/R, occlusion of the superior mesenteric artery was 
performed by placing two microvascular clips (S&T AG, Switzerland) at its origin 
(Figure 2.3 D). Complete occlusion of the superior mesenteric artery was 
confirmed under microscopic view by absence of arterial pulsation in the vascular 
arcades of the mesentery. The peritoneal cavity and the abdominal wall were then 
closed with a single layer continuous suture. At the end of ischaemia time, the 
suture was removed and the origin of the superior mesenteric artery was once again 
exposed. In rats undergoing sham operation, pulsation of mesenteric arteries was 
once again assessed under microscopic view, and the peritoneum and abdominal 
wall were closed as previously described. In animals receiving intestinal I/R, 
absence of mesenteric flow was confirmed under microscopic view and the 
microvascular clips at the origin of the superior mesenteric artery were removed. 
Return of vigorous pulsation in the vascular arcades of the mesentery confirmed 
reperfusion of the superior mesenteric artery. The peritoneum and abdominal wall 
were then closed in one layer. At the end of the experiment, the thorax was opened 
through a midline sternotomy, the ascending aorta and the superior vena cava were 
identified and divided, and animals were sacrificed by exsanguination. The 
appearance of the bowel from infant rats at different stages of the procedure is 
shown in Figure 2.4. 
 
2.2 QUANTIFICATION OF MYELOPEROXIDASE 
 
Neutrophil sequestration in lungs and ileum was estimated by measurement 
of myeloperoxidase (MPO) activity as described by Bradley et al (Bradley et al, 
1982). Tissue samples (~0.2g of left lung and ileum 10-15cm from the ileocaecal 
valve) were homogenised using an Ultra-Turrax homogeniser in 10mL 50mmol/l 
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potassium phosphate buffer, pH 6.0, containing 0.5% (wt/vol) 
hexadecyltrimethylammonium bromide, 100μL removed for protein estimation and 
the remainder centrifuged at 40,790g for 30min. A total of 100μL of supernatant 
then was added to 2.9ml buffer containing 0.53mmol/l O-dianisidine hydrochloride 
and 0.0005% hydrogen peroxide and MPO activity followed 
spectrophotometrically at 25°C at a wavelength of 460nm. Myeloperoxidase 
activity was expressed as units (U) per mg protein. 
To exclude any possible influence of circulating neutrophils into MPO 
activity measured in tissue, regression analysis of MPO activity vs. haemoglobin 
content in tissues was performed, and no correlation was found. 
 
2.3 QUANTIFICATION OF PROTEIN 
 
Protein concentration in tissue homogenate was measured by the method of 
Peterson (Peterson, 1977). 10μl of tissue homogenate were mixed with 990μl 
distilled water, 250μl CTC reagent (12.5mmol/L CuSO4, 20mmol/L sodium 
tartrate, 2.12mol/L Na2CO3), 250μl 5%sodium dodecyl sulphate, 250μl 0.8mol/L 
NaOH, and 250μl distilled water, and incubated at room temperature for 10 
minutes. 500μl 16.7% Folin-Ciocalteau reagent in distilled water were added, and 
incubated at room temperature for further 30 minutes. Absorbace was measured 
spectrophotometrically at 725nm and compared to that of standard solutions of 
diluted bovine serum albumin.   
 
2.4 QUANTIFICATION OF MALONDIALDEHYDE 
 
Levels of malondialdehyde (MDA) in plasma and tissues (liver, lungs and 
kidneys) were measured by high-performance liquid chromatography (HPLC). 
Tissue samples (~0.2g of liver, left lung, left kidney and ileum 10-15cm from the 
ileocaecal valve) were homogenised using an Ultra-Turrax homogeniser in 2ml 
50mM potassium phosphate buffer (pH 6.0) containing 0.5% (wt/vol) 
hexadecyltrimethylammonium bromide. Protein concentration of the homogenate 
was measured by the method of Peterson (Peterson, 1977). 25μl of plasma/tissue 
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homogenate were incubated with 2µl 0.2% (wt/vol) butylated hydroxytoluene in 
ethanol and 375μl 1% (vol/vol) phosphoric acid, and then derivatised with 345μl 
15mmol/l 2-thiobarbituric acid at 100ºC for 60min. 200μl of the derivatised 
solution were collected and mixed with 200μl methanol. After addition of 15μl 
1mol/l KH2PO4 and 4μl 2mol/l KOH/2.4mol/l KHCO3 samples were centrifuged 
(13,000rpm for 10min at 4ºC). HPLC was performed on a Hypersil 5μODS column 
at a flow rate of 1ml/min, isocratically with an eluant of 65% 50mmol/l KH2PO4 
(pH 7.0)/35% methanol. Fluorescence was monitored by a Jasco FP-1520 detector 
(excitation wavelength 515nm; emission wavelength 553nm) and values of molar 
concentration were calculated by comparison with reference solutions of MDA-
tetrabutylammonium salt derivatised and analysed in parallel. MDA was expressed 
as μmol/mg protein for tissues and as μmol/l for plasma. 
Under assay conditions, peaks for MDA were well resolved (Figure 2.5 A), 
and the standard curve was linear for values of MDA up to 20 μmol/l (Figure 2.5 
B). Validity of the standard curve was assessed at every assay by linear regression; 
values of r2 >0.9 were considered satisfactory. Intra-assay variability was assessed 
for plasma (n=12, coefficient of variation=4.97%), and intestine (n=12, coefficient 
of variation=4.89%), lung (n=12, coefficient of variation=6.47%), heart (n=12, 
coefficient of variation=5.84%), kidney (n=12, coefficient of variation=5.51%) and 
liver (n=12, coefficient of variation=3.35%) homogenate. 
 
2.5 QUANTIFICATION OF GLUTATHIONE 
 
The concentration of reduced (GSH) and oxidised (GSSG) glutathione  in 
liver, lungs, kidneys and intestine was measured by HPLC as previously described 
by Reed et al (Reed et al, 1980). Tissue samples (0.7-1.0g of liver, right lung, right 
kidney and ileum 15 to 25cm from the ileocaecal valve) were weighed and 
extracted in 2ml 10% perchloric acid/20mmol/l 1,10-phenanthroline, and 100μl 
10mmol/l γ-glutamyl-glutamate internal standard was added. The samples were 
homogenised and centrifuged (3,000rpm for 10min at 4ºC). 250μl of supernatant 
were incubated with 25μl 96.2mmol/l iodoacetic acid (pH 8.5) for 20 min in the 
dark and derivatised overnight in the dark after addiction of 500μl 1% (v/v) 1-
 Chapter 2: Materials and Methods 
 87
fluoro-2,4-dinitrobenzene. After centrifugation of the samples (13,000rpm for 
10min at 4ºC) HPLC was performed at a flow rate of 1.2 ml/min on a Hypersil 
5μAPS-2 column. Initial conditions were: 5% buffer (36% 2M sodium acetate in 
methanol) against 76% methanol followed by a gradient to 31.4% buffer against 
55% methanol over 33min, then to 44% buffer against 45% methanol over 2min 
and to 100% buffer over 15min, which was continued for 5min. Absorbance was 
measured at a wavelength of 359nm by a Jasco MD-910 detector. Molar 
concentration of GSH and GSSG in the samples was calculated according to the 
recovery rate of the internal standard. Concentrations of GSH, GSSG and total 
glutathione (calculated as GSH + 2GSSG) in tissue were expressed as nmol/g wet 
weight. Glutathione redox state was calculated as ratio of GSH/GSSG.  
Under assay conditions peaks for γ-glutamyl-glutamate, GSH and GSSG 
were well resolved in intestine, lungs and liver extracts (Figure 2.6). However, 
analysis of kidney extracts did not yield clearly detectable peaks of GSH and 
GSSG, and data on kidney glutathione content are therefore not available. 
 
2.6 QUANTIFICATION OF NITRATE PLUS NITRITE 
 
The plasma concentration of nitrate plus nitrite (nitrate + nitrite), reflecting 
systemic production of nitric oxide (NO), was measured by HPLC using a novel 
highly sensitive method.  
The stock solution for nitrite was prepared by dissolving 690mg of sodium 
nitrite in 100ml Milli-Q water to obtain a 100mmol/l primary standard. Similarly, a 
100mmol/l stock solution for nitrate was obtained by dissolving 849.9mg of 
sodium nitrate in 100ml Milli-Q water. Nitrite and nitrate standards (200, 150, 125, 
100, 75, 50, 25 and 10μmol/l) were prepared by subsequent dilutions of the relative 
stock solutions. 5μl of standard or plasma was placed in a 400-μl autosampler vial. 
20μl 68.75μmol/l NADPH and 20μl 825U/l nitrate reductase were added to each 
vial. The vials were gently mixed and incubated at room temperature for 180 min 
to allow a complete reduction of nitrate to nitrite (Giovannoni et al, 1997). 63μl of 
480μmol/l N-methyl-4-amino-7-nitrobenzofurazan (MNBDH) in acetonitrile and 
67μl of 20% v/v H3PO4 were added to each vial. The vials were mixed again and 
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derivatised at room temperature for 30 min. 20μl was injected directly into the 
HPLC.  
HPLC of MNBDH was modified from Buldt and Karst (Buldt et al, 1999). 
The flow rate was 0.62ml/min, and a gradient of 50mmol/l ammonium acetate (pH 
7.5) against acetonitrile was run on a Hypersil 5μODS column with a Phenomenex 
SecurityGuard ODS cartridge. Initial conditions were: 45% buffer and 55% 
acetonitrile, for 1.5min, followed by a gradient to 100% acetonitrile 8.5min, which 
was continued for 4min. The column effluent was monitored by a fluorescence 
detector (Jasco FP-1520) at an excitation wavelength of 468nm and an emission 
wavelength of 537nm. Plasma concentrations of nitrate + nitrite were expressed as 
μmol/l. 
Addition of ammonium acetate to 50mM improved peak shape and 
lengthened column life. MNBDH was well resolved from the solvent front and 
from interfering peaks (Figure 2.7 A). The standard curve of nitrite was linear up 
to at least 200μmol/l (Figure 2.7 B). Enzymatic conversion of nitrate to nitrite 
using nitrate reductase was undertaken, based on the conversion conditions used by 
Giovannoni et al (Giovannoni et al, 1997), and the standard curve of nitrate after 
conversion with nitrate reductase was linear and identical to that of nitrite run in 
parallel, reflecting complete conversion of nitrate to nitrite. There was a significant 
peak for nitrite even in the zero standard, equivalent to ~100μmol/l nitrite, which 
presumably originates from nitrite in the reagents, or reaction of MNBDH with 
atmospheric NO. This peak did not originate from nitrite in the Milli-Q water used, 
as blanks run in the absence of the 5l zero standard had an identical sized peak. In 
addition, there was a consistent difference between the zero nitrate standard and 
the zero nitrite standard, equivalent to ~4μmol/l nitrite, presumably due to presence 
of nitrite or nitrate in the NADPH or nitrate reductase used for the enzymatic 
conversion. Due to these confounding factors, it is important to run suitable 
standards in parallel with each set of samples analysed.  
Using this method, control adult rat plasma had a nitrate + nitrite 
concentration of 45.5±2.4μmol/l (n=10) and 11-13d old rats 101.5±7.0μmol/l 
(n=3). Adult human plasma from healthy volunteers had a nitrate + nitrite 
concentration of 67.4±10.1μmol/l (n=6), whereas children studied before elective 
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operation for gastro-oesophageal reflux had a nitrate + nitrite concentration of 
44.1±7.3μmol/l (n=6). 
Intra-assay variability, as assessed by measuring the average coefficient of 
variation of adult human plasma samples run in duplicate in the same assay (n=5), 
was 5.44%. Inter-assay variability, as assessed by measuring the average 
coefficient of variation of adult human plasma samples run on two different days 
(n=5), was 3.67%. 
 
2.7 QUANTIFICATION OF TNF-  
  
Concentration of TNF-α in plasma was measured with a rat TNF-α ELISA 
kit (BioSource International, Camarillo, CA, USA), and optical density was read at 
450nm on a microtitre plate reader against a series of reference solutions 
(minimum detectable dose=4pg/ml). TNF-α concentration in plasma were 
expressed as pg/ml. 
 
2.8 QUANTIFICATION OF PHOSPHOENERGETICS 
 
Concentrations of adenosine tri-phosphate (ATP), adenosine di-phosphate 
(ADP), and adenosine mono-phosphate (AMP) were measured in liver extracts by 
HPLC (Figure 328). 
A liver sample (~0.03g) was ground under liquid nitrogen and extracted 
with 600μl 12% perchloric acid in a mortar. The homogenate was centrifuged at 
13,000rpm for 10min and the supernatant was collected and neutralised to pH 4.0-
6.0 with 2mol/l KOH/2.4mol/l KHCO3. The samples were centrifuged at 
13,000rpm for 10min; 100μl of supernatant was analysed by HPLC at 0.7 ml/min 
on a HyPurity Aquastar 5μODS column, isocratically with an eluant of 120μmol/l 
KH2PO4 pH6.0. Absorbance was measured at a wavelength of 260nm by a Jasco 
MD-910 detector. Values of molar concentration of ATP, ADP, and AMP in the 
samples were calculated by comparison with reference solutions (Sigma-Aldrich 
Co. Poole, Dorset, UK) analysed in parallel. Concentrations of ATP, ADP and 
AMP in liver were expressed as μmol/g wet weight. Total adenine nucleotides 
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concentration was calculated as ATP+ADP+AMP, and liver energy charge as 
(ATP+½ADP)/ (ATP+ADP+AMP).  
Concentrations of inorganic phosphate were measured in the supernatant 
using a commercially available kit (Sigma-Aldrich Co. Poole, Dorset, UK) and 
expressed as μmol/g wet weight. 
 
2.9 QUANTIFICATION OF CARNITINE PALMITOYL TRANSFERASE ACTIVITY 
 
Activity of carnitine palmitoyl transferase I (CPT I) or total carnitine 
palmitoyl transferase (CPT) activity were measured in cardiac tissue obtained at 
the end of experiments.  
 
2.9.1 Assay for carnitine palmitoyl transferase I activity 
At the end of the experiment, the chest was opened and heart was 
immediately removed and placed in ice-cold medium containing 120mmol/l KCl, 
20mmol/l 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 5mmol/l 
MgCl2, 1mmol/l ethylene glycol tetraacetic acid (EGTA), 5mg/mL fatty acid free 
bovine serum albumin (BSA) pH 7.4 followed by homogenisation in a polytron 
homogenizer and isolation of mitochondria by differential centrifugation  as 
previously described (Eaton et al, 1993). Heart mitochondria were greater than 
90% intact as judged by citrate synthase latency (Shepherd et al, 1969).  
CPT I activity was measured radiochemically as previously described 
(Grantham et al, 1986; Fukumoto et al, 2002a) in a medium consisting of 80mmol/l 
KCl, 10mmol/l HEPES, 5mmol/l MgCl2, 2.5mmol/l KH2PO4, 1mmol/l EGTA, 
30mmol/l phosphocreatine, 20mmol/l creatine, 31U/mL creatine phosphokinase, 
1mmol/l ATP, 0.1mmol/l coenzyme A (CoA), 0.62μmol/l myxothiazol, 135μmol/l 
palmitoyl-CoA, and 1mmol/l 3H-carnitine pH 7.2. CPT I activity was calculated in 
terms of nmol/min/U citrate synthase.  
Citrate synthase activity was measured by adding: 10l mithocondria 
suspension diluted 1:10 in a medium consisting of 250mmol/L sucrose, 2mmol/L 
HEPES, and 0.1mmol/L EGTA pH 7.4; 10l 5mmol/L Acetil-CoA in 50mmol/L 
KH2PO4 pH 5.3; 10l 10mmol/L DTNB (5,5’-dithiobis-(2-nitrobenzoic acid) in 
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Tris (2-amino-2-hydroxymethil-propane-1,3-diol) HCl; 5l 0.05mol/L oxaloacetic 
acid in Tris-HCl; and 955l Tris-HCl. Absorbace was measured at 412nm by 
spectrophotometry before and after adding 10l Triton 10% to evaluate integrity of 
mitochondria (at least 90% intact mitochondria was considered adequate). 
 
2.9.2 Assay for total carnitine palmitoyl transferase activity 
At the end of the experiment, the chest was opened and the heart was 
immediately removed and freeze-clamped in liquid nitrogen to arrest the 
metabolism, and then stored at -80°C until analysis. Heart samples were thawed 
and homogenised with a polytron homogeniser in a medium consisting of 
80mmol/l KCl, 10mmol/l HEPES, 5mmol/l MgCl2, 2.5mmol/l KH2PO4, 1mmol/l 
EGTA, 30mmol/l phosphocreatine, 20mmol/l creatine, 31U/mL creatine 
phosphokinase, 1mmol/l ATP, 0.1mmol/l CoA, 0.62μmol/l myxothiazol (pH 7.2). 
Three cycles of freezing in liquid nitrogen and thawing were performed to ensure 
blowing of mitochondrial membranes. 135μmol/l palmitoyl-CoA, and 1mmol/l 3H-
carnitine were then added to the homogenate, and total CPT activity was measured 
as previously described and calculated in terms of nmol/min/U citrate synthase. 
Citrate synthase activity was measured by adding: 10l 5mmol/L Acetil-
CoA in 50mmol/L KH2PO4 pH 5.3; 10l 10mmol/L DTNB in Tris-HCl; 10l 
Triton 10%; 100l heart homogenate diluted 1/100 in a medium consisting of 
250mmol/L sucrose, 2mmol/L HEPES, and 0.1mmol/L EGTA pH 7.4; 5l 
0.05mol/L oxaloacetic acid in Tris-HCl; and  865l Tris-HCl. Absorbace was 
measured at 412nm by spectrophotometry. 
 
2.10 HISTOLOGICAL INJURY IN THE ILEUM 
 
Terminal ileum (5 to 10cm from the ileocaecal valve) was fixed in 10% 
formaldehyde for 24 hours and embedded in paraffin. 5μm sections were cut and 
stained with haematoxylin and eosin.  
Histological injury was evaluated and graded blindly by three investigators 
(including the author) using a well established scoring system (Figure 2.9) 
(Vejchapipat et al, 2002): 1) Normal mucosal villi; 2) Development of mucosal 
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slough at villous tips; 3) Extension of the sub-epithelial space with the epithelial 
layer lifting up in sheets, presence of a few denuded villous tips, and mild capillary 
congestion; 4) Denuded villi with exposed lamina propria, dilated, exposed 
capillaries with evidence of haemorrhage, and increased cellularity of the lamina 
propria; 5) Digestion and disintegration of the lamina propria and presence of 
haemorrhage and ulceration.  
 
2.11 ADHESION MOLECULE EXPRESSION IN THE ILEUM 
 
Immunostaining for P-Selectin (CD62P), ICAM-1 (CD54, cluster of 
differentiation 54) and V-CAM-1 (CD106, cluster of differentiation 106) were 
performed on 5μm sections of paraffin-embedded terminal ileum obtained as 
described previously.  
 
2.11.1 P-selectin (CD62P) 
Antigen retrieval was achieved by microwave heating in 1% citrate buffer 
pH 6.0. After blockade of endogenous peroxidase activity with 3% hydrogen 
peroxide in phosphate buffered saline (PBS) and incubation with 10% normal goat 
serum, sections were incubated with primary antibody [P-Selectin (CD62P), BD 
Biosciences, San Jose, CA, USA, 1:200 dilution in PBS] overnight at 4°C, after 
which anti-rabbit labelled polymer horseradish peroxidase (HRP) and 
diaminobenzidine (DAB) (EnVision, DakoCytomation, Cambridge, UK) were 
applied. 
 
2.11.2 ICAM-1 (CD54) 
After microwave heating in 1% citrate buffer pH 6.0, blockade of 
endogenous peroxidase activity and incubation with 10% normal goat serum were 
performed. Primary antibody [ICAM-1 (CD54), Endogen, Woburn, MA, USA, 
1:2,000 dilution in PBS] was applied for 60min at room temperature, and sections 
were incubated with anti-mouse labelled polymer HRP and DAB (EnVision, 
DakoCytomation, Cambridge, UK). 
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2.11.3 VCAM-1 (CD106) 
Sections underwent blockade of endogenous peroxidase activity and 
incubation with 10% normal goat serum and were incubated with VCAM-1 
primary antibody [VCAM-1 (CD106), BD PharMingen, San Diego, Ca, USA, 
1:15,000 dilution in PBS] for 60min at room temperature. Anti-mouse labelled 
polymer HRP and DAB were then applied. 
 
2.10.4 Quantification of adhesion molecule expression 
Expression of P-selectin, ICAM-1 and VCAM-1 was assessed by grading 
the staining intensity of the endothelium of subepithelial vessels. The specimens 
were scored blindly by three investigators (including the author) on a semi-
quantitative scale based both on the number of positive vessels and on the intensity 
of the staining: 1) Weak staining; 2) Mild staining; 3) Moderate staining; 4) Strong 
staining. 
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Figure 2.1. Surgical procedure in adult rats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After accessing the peritoneum through a midline incision, the superior 
mesenteric artery (arrow) is identified [A] and dissected at its origin form the 
abdominal aorta [B]. A silicon loop (Surg-I-Loop; Scanlan, MN) is then passed 
behind the origin of the superior mesenteric artery [C] and slung around the artery 
[D].  
A B
C D
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Figure 2.2. Appearance of the bowel from adult rats at different stages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[A] Normal blood perfusion is present at the beginning of the experiment, 
before intestinal ischaemia is performed. [B] At the end of the ischaemic phase, 
prolonged absence of blood flow results in diffuse pallor of the ileum, with initial 
signs of necrosis (top left corner). [C] Diffuse hyperaemia and congestion of blood 
vessels is visible at the very beginning of reperfusion, which is confirmed by 
vigorous pulsation of the arterial arcades of the mesentery. [D] At the end of the 
reperfusion phase, most of the terminal ileum appears frankly necrotic with 
evidence of intraluminal haemorrhage (top right corner), whereas the colon (to the 
left) appears relatively preserved. 
A B
C D
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Figure 2.3. Surgical procedure in infant rats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After accessing the peritoneal cavity through a supraumbilical transverse 
laparotomy, the stomach (dashed arrow) and the small intestine (arrow) are 
retracted [A]. Under microscopic view (magnification 10x), the superior 
mesenteric artery (arrow) is identified [B] and dissected at its origin form the 
abdominal aorta [C], and the first of two microvascular clips (S&T AG, 
Switzerland) is then placed around the origin of the superior mesenteric artery 
(arrow) [D].  
 
A B
C D
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Figure 2.4. Appearance of the bowel from infant rats at different stages.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[A] Normal blood perfusion is present at the beginning of the experiment, 
before intestinal ischaemia is performed. [B] At the end of the ischaemic phase, 
prolonged absence of blood flow results in diffuse pallor of the ileum, with initial 
signs of necrosis (top right corner). [C] Diffuse hyperaemia and congestion of 
blood vessels is visible at the very beginning of reperfusion, which is confirmed by 
vigorous pulsation of the arterial arcades of the mesentery under microscopic view. 
[D] At the end of the reperfusion phase, part of the terminal ileum appears frankly 
necrotic with evidence of intraluminal haemorrhage. 
A B
C D
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Figure 2.5. Malondialdehyde assay for rat plasma sample. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[A] Chromatogram of malondialdehyde (MDA) assay for rat plasma 
sample. Sample was derivatised and run as described. The peak for MDA is 
indicated by the arrow. [B] Standard curve for MDA. Samples were derivatised 
and run as described. Curve fitting was by linear regression (r2=0.9997). 
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Figure 2.6. Glutathione assay for rat intestine sample. 
 
 
 
 
 
 
 
 
 
 
 
Chromatogram for glutathione assay for rat intestine sample. The sample was 
derivatised and run as described. The peaks for γ-glutamyl-glutamate (GGG), 
reduced glutathione (GSH), and oxidised glutathione (GSSG) are indicated by 
arrows.  
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Figure 2.7. Nitrate plus nitrite assay for rat plasma sample. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[A] Chromatogram for nitrate plus nitrite for rat plasma sample. The 
sample was derivatised and run as described. [B] Standard curves of [■] nitrite and 
[▼] nitrate. Samples were derivatised and run as described in the materials and 
methods. Curve fitting was by linear regression (nitrate: r2=0.9935; nitrite: 
r2=0.9914). 
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Figure 2.8. Phosphoenergetics assay for rat liver sample. 
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Chromatogram for phosphoenergetics assay for rat liver sample. The sample 
was derivatised and run as described. The peaks for adenosine tri-phosphate 
(ATP), adenosine di-phosphate (ADP), and adenosine mono-phosphate (AMP) are 
indicated by arrows.  
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Figure 2.9. Grading of histological injury in the ileum. 
 
 
 
 
Grading of histological injury on haematoxylin and eosin stained terminal 
ileum (samples are from adult rats) (Vejchapipat et al, 2002). Grade 1: normal 
mucosa [A]; Grade 2: mucosal slough at villous tips [B]; Grade 3:  denuded villous 
tips, and mild capillary congestion [C]; Grade 4: denuded villi, and dilated 
capillaries [D]; Grade 5:  haemorrhage and ulceration [E].  
A B C 
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CHAPTER 3 
MODERATE HYPOTHERMIA AS A PREVENTATIVE TREATMENT 
FOR ADULT INTESTINAL ISCHAEMIA AND REPERFUSION INJURY 
 
3.1 BACKGROUND 
 
Intestinal I/R injury represents a major clinical problem in infants, children 
and adults. Diseases associated with this condition include necrotizing 
enterocolitis, midgut volvulus, acute mesenteric arterial occlusion, haemodynamic 
shock and sepsis (Schoenberg et al, 1993), as discussed in Chapter 1. Intestinal I/R 
can also occur as a consequence of surgical procedures such as cardiopulmonary 
bypass, aortic aneurysm repair and intestinal transplantation (Soong et al, 1994; 
Gennaro et al, 1993; Sola et al, 2001).  
A life threatening consequence of intestinal I/R is the development of MODS 
(Neary et al, 1999) characterised by impairment of respiratory (Harward et al, 
1993; Iglesias et al, 1998), cardiocirculatory (Horton et al, 1991), hepatic 
(Vejchapipat et al, 2001; Turnage et al, 1996) and renal (LaNoue et al, 1996) 
function. The pathogenesis of multiple organ failure after intestinal I/R is 
multifactorial, and the development of a systemic inflammatory response with 
subsequent oxidative injury appears to play a pivotal role in this setting (Cuzzocrea 
et al, 2000; Kalia et al, 2001). When the amount of reactive oxygen and nitrogen 
species produced by different sources overwhelms the scavenging potential of 
endogenous antioxidant systems (Li et al, 2002), leading to a state of oxidative 
stress, cell injury and death develop as a consequence of protein modification, lipid 
membrane disruption and DNA damage (Tan et al, 1999; Cuzzocrea et al, 2001b).  
Previous studies have shown that hypothermia during experimental intestinal 
I/R injury prevents liver bioenergetic failure and mortality (Vejchapipat et al, 
2001), and that hypothermia is beneficial not only in reducing local damage 
(Hassoun et al, 2002; Vejchapipat et al, 2002; Kalia et al, 2002b), but also in 
decreasing lung neutrophil infiltration (Vinardi et al, 2003), and the effect on 
mortality has been confirmed (Kalia et al, 2001).  
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The purpose of this study was to investigate the consequences of intestinal 
I/R and the effects of whole-body moderate hypothermia on systemic oxidative 
stress in an adult rat model, by measuring the extent of lipid peroxidation and the 
content of glutathione, and by assessing systemic production of NO.  
 
3.2 MATERIAL AND METHODS 
 
3.2.1 Study design 
 Young adult male Sprague-Dawley rats weighing between 250 and 300g 
were used. Animals were kept under standard conditions for food, water, light and 
temperature, and had access to standard rat chow and water ad libitum until the 
beginning of the experiment. 
 Animals were randomly assigned to one of four experimental groups (n=10 
per group): 
A) Control Normothermia: sham operation for 180min at normothermia 
B) I/R Normothermia: 60min intestinal ischaemia, followed by 120min 
reperfusion at normothermia 
C) Control Hypothermia: sham operation for 180min at moderate hypothermia  
D) I/R Hypothermia: 60min intestinal ischaemia, followed by 120min reperfusion 
at moderate hypothermia 
Rectal temperature was monitored continuously throughout the experiment 
from induction of anaesthesia. Normothermia (rectal temperature between 36 and 
38°C) was maintained by use of a heating blanket and lamp as described in 
Chapter 2. Moderate hypothermia (rectal temperature between 30 and 32ºC) was 
induced immediately after induction of anaesthesia by exposing the rats to an 
environmental temperature of 22 to 23ºC, with warming by a heating blanket and 
lamp to prevent excessive cooling. All animals were allowed to stabilise for a 
period of 30min after anaesthesia and monitoring had been established, in order to 
achieve the desired rectal temperature.  
 
3.2.2 Surgical Procedure 
General anaesthesia was performed by inhalation of halothane in an oxygen 
and nitrous oxide mixture as described in Chapter 2. 
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Once adequacy of general anaesthesia was confirmed, superior mesenteric 
artery ischaemia and reperfusion, and sham operation were performed as described 
in Chapter 2.  
At the end of the experiment, the thorax was entered via a midline 
sternotomy, the ascending aorta and the superior vena cava were identified and 
divided, and animals were sacrificed by exsanguination under terminal anaesthesia.  
 
3.2.3 Tissue extraction and metabolite measurement 
Immediately after sacrifice, the heart was removed and placed in ice-cold 
medium for CPT I activity measurement. A blood sample was collected from the 
thorax into a heparin tube and centrifuged at 3,000rpm for 5 min at 4ºC; plasma 
was separated and stored at -70ºC. Lungs, liver, kidneys and two samples of 
terminal ileum (10 to 15cm and 15 to 25cm from the ileocaecal valve) were 
removed and stored at -70ºC until analysis. 
Levels of MDA in plasma, terminal ileum, liver, lungs and kidneys were 
measured. The concentration of GSH and GSSG in liver, lungs, kidneys and 
intestine was measured by HPLC. Plasma concentration of nitrate plus nitrite, 
reflecting systemic production of NO, was measured by HPLC. CPT I activity in 
the heart was measured by radiochemical assay; heart samples from 8 rats per 
group only were analysed. Assays for MDA, glutathione, nitrate plus nitrite, and 
CPT I were performed as described in Chapter 2. 
 
3.2.4 Statistical analysis 
Data are expressed as mean  SEM (standard error of the mean). One-way 
analysis of variance (ANOVA) with Tukey post hoc test was used for group 
comparison. Linear regression was used to analyse the relationship between levels 
of MDA and nitrate plus nitrite concentration in plasma. Results showing p values 
<0.05 were considered significant.  
 Chapter 3: Moderate Hypothermia as a Preventative Treatment for Adult Intestinal I/R Injury 
 107
 
3.3 RESULTS 
 
3.3.1 Lipid peroxidation 
Intestinal I/R at normothermia caused a marked increase in malondialdehyde 
in plasma (Figure 431), ileum (Figure 3.2 A) and lungs (Figure 3.2 B) compared to 
controls. Moderate hypothermia prevented the effects of reperfusion injury: the 
degree of lipid peroxidation in plasma, ileum and lungs after hypothermic I/R was 
significantly lower than after normothermic I/R and comparable to both 
normothermic and hypothermic controls (Figure 3.1, Figure 3.2 A, Figure 3.2 B).  
In kidneys, a slight but statistically not significant increase in MDA levels 
was observed following intestinal reperfusion (Figure 3.2 C). However, 
hypothermic I/R animals had significantly decreased kidney MDA compared to I/R 
normothermia.  
Consequences of intestinal reperfusion in the liver differed from plasma, 
ileum, lungs and kidneys: lipid peroxidation was not increased in animals 
undergoing intestinal I/R compared to controls (Figure 3.2 D).  
 
3.3.2 Glutathione content 
Intestinal levels of reduced, oxidised and total glutathione (Figure 3.3 A, B, 
C) were profoundly decreased in normothermic animals as a consequence of 
intestinal ischaemia and reperfusion injury, reflecting a marked impairment in 
cellular antioxidant status. Hypothermic I/R rats showed a milder reduction in gut 
GSH compared to normothermic I/R animals, and levels of GSSG comparable to 
those of normothermic controls (Figure 3.3 A, B). Unexpectedly, moderate 
hypothermia induced an increase in ileal GSH and total glutathione content in the 
absence of intestinal ischaemia (Figure 3.3 A, C). Glutathione redox state was 
grossly affected in the ileum after I/R at normothermia with respect to controls, 
whereas it was unaffected in hypothermic I/R rats (Figure 3.3 D). Ischaemia and 
reperfusion injury did not affect glutathione levels in either liver or lungs.  
Although no decrease in liver glutathione levels or redox state was observed 
following intestinal reperfusion (Figure 3.4), moderate hypothermia had a similar 
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effect on liver glutathione levels to that observed in ileum: a significant increase in 
total glutathione (Figure 3.4 C) was observed, which was mostly due to an increase 
in GSSG (Figure 3.4 B).   
Glutathione content in lungs was unaffected by either intestinal reperfusion, 
or moderate hypothermia (Figure 3.5).   
 
3.3.3 Systemic nitric oxide production  
There was a significant increase in systemic nitric oxide production (as 
indicated by plasma nitrate + nitrite concentration) following normothermic 
intestinal I/R with respect to controls (Figure 3.6). This effect was not observed at 
moderate hypothermia: NO synthesis in rats undergoing hypothermic I/R was 
similar to that of controls at either hypothermia or normothermia (Figure 3.6). 
Interestingly, a highly significant positive correlation was observed between 
systemic NO production and plasma levels of MDA between all samples (Figure 
3.7).  
 
3.3.4 Carnitine palmitoyl transferase I activity in the heart 
The activity of cardiac CPT I was significantly impaired after I/R at 
normothermia compared to normothermic control animals (Figure 3.8). However, 
moderate hypothermia appeared to prevent this effect: CPT I activity in 
hypothermic rats subjected to I/R was considerably higher than in normothermic 
I/R animals and similar to controls at both normothermia and moderate 
hypothermia. In control rats, no significant differences were observed between 
animals maintained at normothermia and moderate hypothermia. 
 
4.4 DISCUSSION 
 
Restoration of blood circulation to ischaemic tissue is essential to re-establish 
oxygen and nutrient supply and therefore to prevent the progression of cell injury. 
However, reperfusion is associated with a series of physiological processes that 
can ultimately lead to paradoxical tissue damage, as previously discussed in 
Chapter 1. As soon as reoxygenation is restored after a period of anoxia, a wide 
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range of ROS (such as hydrogen peroxide, superoxide, hydroxyl and perhydroxyl 
radicals) and RNS (nitric oxide, peroxynitrite) species are produced by activated 
neutrophils (Cuzzocrea et al, 2001b), xanthine oxidase (Terada et al, 1992), 
mitochondria and other intracellular sources (Li et al, 2002). Reactive species are 
highly unstable molecules that can oxidise membrane phospholipids through the 
self-propagating chain reaction process of lipid peroxidation (Tribble et al, 1987) 
and damage other biomolecules, including proteins and nucleic acids (Cuzzocrea et 
al, 2001b). Biological protection against these reactive species consists of an 
integrated system of enzymatic and chemical antioxidants for detoxification of 
oxidative and nitrosative compounds, but an imbalance between oxidant 
production and antioxidant defences can result in oxidative stress and subsequent 
tissue damage (Comhair et al, 2002). Following visceral I/R injury, oxidative stress 
develops not only at a local level (Hassoun et al, 2002; Sola et al, 2000) but also in 
distant organs as a consequence of systemic inflammatory response driven by 
activation of neutrophils and production of inflammatory mediators (Foulds et al, 
1998; Barry et al, 1997; Carden et al, 1993).  
The increase in lipid peroxidation end-products in plasma observed in this 
experiment confirms this hypothesis, but the degree of lipid peroxidation is 
different in the organs I studied. Intestine and lungs exhibited a profound degree of 
lipid peroxidation following reperfusion, whereas in kidneys only a mild 
enhancement in lipid peroxidation was noticed and no difference was seen in liver. 
These divergent effects may reflect a different degree of inflammatory infiltrate in 
distant organs, as suggested by an increase in TNF- in the lungs, but not in liver 
and kidneys, after intestinal I/R (Rahat et al, 2001). Alternatively, the antioxidant 
defences of liver and kidney may be sufficient to prevent lipid peroxidation of 
biological membranes. This hypothesis is supported by the finding that although 
intestinal glutathione status is profoundly decreased by I/R, that of liver is 
unaltered. This is also supported by the observation that in a model of intestinal I/R 
in which hepatic glutathione status was altered, hepatic lipid peroxidation also 
occurred (Turnage et al, 1991). Glutathione is active in the reduced form, and 
becomes oxidised as it protects against reactive species. Oxidised glutathione can 
be recycled back to reduced, active, glutathione, so that in tissues undergoing 
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oxidative stress, the total glutathione pool may be unaltered, but the reduced vs. 
oxidised redox state is altered. Intestinal I/R induced not only a decrease in the 
amount of reduced glutathione and in glutathione redox state, but also a diminution 
of the total pool of glutathione. This phenomenon has been previously observed in 
intestinal reperfusion injury (Gibson et al, 1993; Bhaskar et al, 1995) and reflects 
an irreversible loss of glutathione, possibly by reaction of reduced glutathione with 
hypochlorous acid (Pullar et al, 2001) or degradation to cystine (Bhaskar et al, 
1995).  
Nitric oxide is an endogenously produced reactive molecule with important 
biological functions such as regulation of vascular contractility. In addition to these 
regulatory functions, it may have other deleterious effects, for example 
overproduction can lead to cellular damage, either directly, through combination 
with superoxide to produce the potently cytotoxic peroxynitrite, or by the end 
products of its production, nitrate and nitrite. These facets of NO are also observed 
in intestinal reperfusion injury: NO may have local beneficial effects within the 
intestine during I/R, via mechanism including vasodilatation and inhibition of 
leukocyte adherence to the endothelium (Chan et al, 1999; Horie et al, 1998; Kalia 
et al, 2002a) whereas systemic effects of NO and/ or its end products are 
deleterious and can lead to multiple organ dysfunction (Yang et al, 2002). I did not 
measure local NO production or nitric oxide synthase activity in this model, but 
instead measured plasma nitrate plus nitrite as a measure of systemic NO 
production. The systemic deleterious effects of nitric oxide and/or its products are 
supported in this study by the strong positive correlation between plasma nitrite + 
nitrate with plasma MDA (Figure 3.7).  
Hypothermia exerted a crucial effect in maintaining intestinal antioxidant 
potential: preservation of the endogenous pool of reduced glutathione is critical to 
antioxidant defences (Rahman et al, 2000) and a decrease in glutathione redox state 
has been suggested to be connected to the development of apoptotic and necrotic 
cell death (Schafer et al, 2001). In fact, glutathione redox state is considered to be 
the primary determinant of cell redox state, because it is 3 to 4 orders of magnitude 
more abundant than the other redox couples (such as NADH/NAD+, 
NADPH/NADP+, cysteine/cystine, thioredoxinred/thioredoxinoxid, gltaredoxinred, 
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glutaredoxinoxid), and because it has a low standard redox potential. In turn, cell 
reduction potential plays a crucial role in regulating cellular status, including 
transition to proliferation, differentiation, apoptosis, and necrosis - the latter being 
associated with high values of cell reduction potential (and therefore low values of 
redox state) (Schafer et al, 2001). A reduction in the amount of oxidants, due to a 
decrease in leukocyte activation (Vinardi et al, 2003) and cytokine pro-
inflammatory response (Williams et al, 2002)  may in part explain the protective 
effect of hypothermia observed in my study, but the increase in intestinal and 
hepatic glutathione concentrations observed in hypothermic controls compared to 
normothermic controls suggests the existence of an alternative mechanism. The 
finding that hypothermia alone increased gut glutathione levels is novel. Previous 
studies have suggested that intestinal glutathione may be depleted during chronic 
cold stress (Kaushik et al, 2003; Simmons et al, 1990; Spasic et al, 1993). 
However, the intestinal activity of -glutamyl-cysteine synthetase, the rate-
controlling enzyme of glutathione synthesis, appears to be able to be upregulated 
acutely in response to water immersion stress (Alptekin et al, 1996) so that 
increased glutathione synthesis could be responsible for the increased glutathione 
concentration observed. The improved glutathione status of hypothermic animals 
undergoing intestinal I/R injury may play an important role in prevention of 
propagation of a systemic inflammatory response, as well as decreasing localised 
tissue damage.  
Average reduced glutathione concentrations in my experiment was 380 
nmol/g wet weight in the small bowel, 890 nmol/g wet weight in the liver, and 275 
nmol/g wet weight in the lung, and average glutathione redox state was 3.6, 2.1, 
and 0.9 respectively. Absolute values of reduced glutathione concentration in rat 
tissues vary significantly in the literature, from as low as 1.3 (Jewell et al, 1999) to 
as high as 1580 nmol/g wet weight (Kuhn et al, 2000). However, glutathione redox 
state is more consistent, and typically between 4:1 and 10:1 in rat small intestine 
when calculated as [GSH]/2*[GSSG] (Tian J et al, 2007; Tian J et al, 2009; Wu et 
al, 2004), and comprised between 15:1 and 50:1 at a cellular level (Schafer et al, 
2001). Values of glutathione redox state averaged 3.6 in control animals in my 
study, which is lower than what reported by most authors but comparable to what 
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reported in some series (Wu et al, 2004). Although partial oxidation of glutathione 
may have possibly occurred from the time of animal sacrifice to the time of sample 
analysis in my experiments as a consequence of both autoxidation and enzyme-
catalysed degradation, this is unlikely given the stability of reduced glutathione 
when stored at -80ºC (Lin SK et al, 2006).  
The beneficial effects of moderate hypothermia on lipid peroxidation in 
plasma, lungs and kidneys may depend on the potential of hypothermia to reduce 
leukocyte adherence to the endothelium and neutrophil infiltration in local and 
distal organs following intestinal I/R (Vinardi et al, 2003; Kalia et al, 2001). In 
addition, hypothermia has been shown to decrease production of reactive oxygen 
species by stimulated neutrophils “in vitro” (Sung et al, 1985; Akriotis et al, 1985) 
and to suppress production of pro-inflammatory cytokines after I/R injury (Qing et 
al, 2001; Kato et al, 2002). Since whole-body moderate hypothermia was applied 
in this model, the protective effects observed in distal organs may depend either on 
the prevention of leukocytes activation and priming in the ileum, or in the 
reduction of neutrophils recruitment and functions in distant organs.  
Previous studies have shown that after intestinal I/R, the isolated perfused 
heart has impaired contractile function, which can be prevented by free-radical 
scavengers and inhibitors of neutrophil adherence (Horton et al, 1991; Horton et al, 
1993a; Horton et al, 1993b). I/R injury causes release of cytokines and endotoxin 
into the portal and systemic circulation (Williams et al, 2002) and this is thought to 
cause recruitment of neutrophils into distal tissues (Schmeling et al, 1989; Vinardi 
et al, 2003), induction of nitric oxide synthase (Cain et al, 1999), and free radical 
production. The reaction of nitric oxide and superoxide produces peroxynitrite, 
which is thought to be important in the pathogenesis of myocardial dysfunction 
due to inflammatory causes (Ferdinandy et al, 2000; Flesch et al, 1999; Ferdinandy 
et al, 1999; Khadour et al, 2002; Schulz et al, 1997), decreasing cardiac contractile 
function by uncoupling ATP production from mechanical work (Schulz et al, 
1997).  
Fatty acid oxidation is central to cardiac metabolism (Eaton, 2002), 
providing around 75% of cardiac ATP requirements under most conditions (Neely 
et al, 1974). CPT I and CPT II control passage of long-chain fatty acids through the 
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external and internal mitochondrial membrane, and therefore their access to the 
inner mitochondrial milieu where they become the substrate of the -oxidation 
pathway (Figure 3.9). CPT I is important in the control of fatty acid oxidation in 
the heart, as in other tissues (Eaton, 2002), and it has been previously shown that 
cardiac CPT I activity is impaired during neonatal sepsis and by peroxynitrite 
(Fukumoto et al, 2002a) and that this impairment is due to oxidative modification 
of the enzyme (Fukumoto et al, 2002b). It is possible that intestinal reperfusion 
injury, by triggering a systemic inflammatory response leading to the development 
of oxidative stress at a systemic level, would inhibit cardiac CPT I activity 
similarly to neonatal endotoxaemia. This is supported by the increase in plasma 
MDA and nitric oxide production secondary to normothermic intestinal reperfusion 
observed in the present experiment. In this study, cardiac CPT I activity was 
markedly inhibited by intestinal I/R injury; this would be predicted to decrease 
myocardial fatty acid oxidation and increase the reliance of the heart on other 
substrates such as glucose, lactate and ketone bodies. This effect may make the 
heart more vulnerable to variation in nutritional supply following intestinal I/R.   
Intestinal I/R in this model induces intestinal histological changes and energy 
failure, as well as liver energy failure (Vejchapipat et al, 2002; Vejchapipat et al, 
2001; Vejchapipat et al, 2000; Vinardi et al, 2003). In the present experiment, I 
have additionally shown that CPT I activity was impaired by the effects of 
intestinal I/R. These suggest that the balance of substrate utilisation was shifted 
from fatty acid oxidation to either carbohydrate or ketone body utilisation. Using 
the same animal model, it has been previously shown that moderate hypothermia 
has beneficial effects on liver function (Vejchapipat et al, 2001) and gut histology 
(Vejchapipat et al, 2002). Interestingly, moderate hypothermia prevented the 
inhibition of cardiac CPT I activity after intestinal I/R, together with previous 
studies showing the benefits of hypothermia to the gut, liver and lungs, supporting 
the potential clinical utility of moderate hypothermia in amelioration of multi-
system organ failure due to intestinal I/R injury. 
Protection against oxidative damage achieved during ischaemia and early 
reperfusion may remain effective even after restoration of a normothermic status, 
although the effects of rewarming on animals undergoing hypothermic I/R were 
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not evaluated in this study. Restoration of normothermia did not influence 
mortality and did not jeopardise hypothermia-induced reduction of leukocyte 
adhesion in intestinal mucosa in a similar animal model (Kalia et al, 2001), 
suggesting that benefits conferred by hypothermia may persist upon rewarming.  
 
4.5 CONCLUSIONS 
 
This study has shown that intestinal I/R is associated with an increase in lipid 
peroxidation in plasma, ileum, lungs and, to a lesser extent, kidneys; with a 
depletion of the intestinal pool of reduced glutathione; with an enhanced systemic 
nitric oxide production; and with impaired fatty acid metabolism in the heart. 
Total-body moderate hypothermia applied throughout I/R proved to be effective in 
counteracting these changes, precluding the development of systemic oxidative 
stress and therefore preventing the progression of multiple organ failure by 
blocking one of its major pathways. These results suggest that moderate 
hypothermia could be beneficial in clinical conditions associated with intestinal I/R 
injury, especially when intestinal ischaemia can be foreseen and hypothermia can 
be applied at the beginning of the ischaemic injury.  
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Figure 3.1. Malondialdehyde  concentration in plasma. 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of malondialdehyde (MDA) in plasma. Animals (n=10 per 
group) underwent sham operation (Control) or intestinal ischaemia and reperfusion 
(I/R) at either normothermia (Normothermia) or moderate hypothermia 
(Hypothermia). Data are expressed as μmol/l and results are reported as mean  
SEM. One-way ANOVA with Tukey post hoc test was used for group comparison. 
* I/R Normothermia: P<0.001 vs. Control Normothermia; P<0.001 vs. Control 
Hypothermia; P=0.002 vs. I/R Hypothermia.  
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Figure 3.2. Malondialdehyde concentration in ileum, lungs, kidneys, and 
liver. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of malondialdehyde (MDA) in ileum [A], lungs [B], kidneys 
[C], and liver [D]. Animals (n=10 per group) underwent sham operation (Control) 
or intestinal ischaemia and reperfusion (I/R) at either normothermia 
(Normothermia) or moderate hypothermia (Hypothermia). Data are expressed as 
nmol/mg protein and results are reported as mean  SEM. One-way ANOVA with 
Tukey post hoc test was used for group comparison. 
[A]: * I/R Normothermia: P=0.007 vs. Control Normothermia; P=0.010 vs. 
Control Hypothermia; P=0.011 vs. I/R Hypothermia. 
[B]: * I/R Normothermia: P<0.001 vs. Control Normothermia; P<0.001 vs. 
Control Hypothermia; P<0.001 vs. I/R Hypothermia. 
[C]: *  I/R Normothermia: P = 0.006 vs. Control Hypothermia; P = 0.035 vs. I/R 
Hypothermia.  
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 Figure 3.3. Glutathione concentration in ileum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of reduced (GSH) [A], oxidised (GSSG) [B], and total 
(calculated as GSH + 2*GSSG) [C] glutathione, and glutathione redox state 
(calculated as GSH/2*GSSG) [D] in ileum. Animals (n=10 per group) underwent 
sham operation (Control) or intestinal ischaemia and reperfusion (I/R) at either 
normothermia (Normothermia) or moderate hypothermia (Hypothermia). 
Concentrations of GSH, GSSG and total glutathione are expressed as nmol/g wet 
weight. Results are reported as mean  SEM; one-way ANOVA with Tukey post 
hoc test was used for group comparison. 
[A]:  * I/R Normothermia: P<0.001 vs. Control Normothermia; P<0.001 vs. C 
Hypothermia; P=0.048 vs. I/R Hypothermia. 
 † Control Hypothermia: P<0.001 vs. Control Normothermia; P<0.001 vs. 
I/R Hypothermia. 
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 ‡ I/R Hypothermia: P=0.044 vs. Control Normothermia. 
[B]: * I/R Normothermia: P=0.029 vs. Control Normothermia; P<0.001 vs. 
Control Hypothermia. 
 †  Control Hypothermia: P=0.002 vs. I/R Hypothermia. 
[C]: * I/R Normothermia: P<0.001 vs. Control Normothermia; P<0.001 vs. 
Control Hypothermia. 
 † Control Hypothermia: P=0.001 vs. Control Normothermia; P<0.001 vs. I/R 
Hypothermia. 
 ‡  I/R Hypothermia: P=0.047 vs. Control Normothermia. 
[D]: * I/R Normothermia: P<0.001 vs. Control Normothermia; P<0.001 vs. 
Control Hypothermia; P=0.006 vs. I/R Hypothermia. 
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Figure 3.4. Glutathione concentration  in liver. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of reduced (GSH) [A], oxidised (GSSG) [B], and total 
(calculated as GSH + 2*GSSG) [C] glutathione, and glutathione redox state 
(calculated as GSH/2*GSSG) [D] in liver. Animals (n=10 per group) underwent 
sham operation (Control) or intestinal ischaemia and reperfusion (I/R) at either 
normothermia (Normothermia) or moderate hypothermia (Hypothermia). 
Concentrations of GSH, GSSG and total glutathione are expressed as nmol/g wet 
weight. Results are reported as mean  SEM; one-way ANOVA with Tukey post 
hoc test was used for group comparison. 
[B]: * Control Hypothermia: P<0.001 vs. Control Normothermia; P=0.003 vs. 
I/R Normothermia. 
  † I/R Hypothermia: P=0.002 vs. Control Normothermia; P=0.013 vs. I/R 
Normothermia. 
[C]: * Control Hypothermia: P=0.21 vs. Control Normothermia. 
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 Figure 3.5. Glutathione concentration in lungs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of reduced (GSH) [A], oxidised (GSSG) [B], and total 
(calculated as GSH + 2*GSSG) [C] glutathione, and glutathione redox state 
(calculated as GSH/2*GSSG) [D] in lungs. Animals (n=10 per group) underwent 
sham operation (Control) or intestinal ischaemia and reperfusion (I/R) at either 
normothermia (Normothermia) or moderate hypothermia (Hypothermia). 
Concentrations of GSH, GSSG and total glutathione are expressed as nmol/g wet 
weight. Results are reported as mean  SEM; one-way ANOVA with Tukey post 
hoc test was used for group comparison. 
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Figure 3.6. Nitrate plus nitrite concentration in plasma. 
 
 
 
 
 
 
 
 
 
 
 
 
Systemic production of nitric oxide measured as concentration of nitrate plus 
nitrite in plasma. Animals (n=10 per group) underwent sham operation (Control) or 
intestinal ischaemia and reperfusion (I/R) at either normothermia (Normothermia) 
or moderate hypothermia (Hypothermia). Data are expressed as μmol/l and results 
are reported as mean  SEM. One-way ANOVA with Tukey post hoc test was used 
for group comparison.  
* I/R Normothermia: P<0.001 vs. Control Normothermia; P<0.001 vs. Control 
Hypothermia; P<0.001 vs. I/R Hypothermia.  
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Figure 3.7. Correlation between nitrate plus nitrite and malondialdehyde 
concentration in plasma. 
 
 
 
 
 
 
 
 
 
 
 
 
Correlation between nitrate plus nitrite in plasma (expressed as μmol/l) and 
malondialdehyde (MDA, expressed as μmol/l) concentration in plasma (linear 
regression analysis indicated a correlation with r2=0.630; p<0.0001).  
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Figure 3.8. Carnitine palmitoyl transferase I activity in the heart. 
 
 
 
 
 
 
 
 
 
 
 
 
Carnitine palmitoyl transferase I (CPT I) activity in the heart. Animals (n=8 
per group) underwent sham operation (Control) or intestinal ischaemia and 
reperfusion (I/R) at either normothermia (Normothermia) or moderate hypothermia 
(Hypothermia). Data are expressed as mmol/min/U citrate synthase (CS) and 
results are reported as mean  SEM. One-way ANOVA with Tukey post hoc test 
was used for group comparison.  
* I/R Normothermia: p=0.012 vs. Control Normothermia; p<0.001 vs. Control 
Hypothermia; p<0.001 vs. I/R Hypothermia 
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Figure 3.9. Role of carnitine palmitoyl transferase I and II (CPT I and CPT 
II) in mitochondrial long-chain fatty acid uptake (Lee et al, 
2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schematic representation of mitochondrial long-chain-fatty-acid uptake. 
CPT I is a point for control and regulation of fatty acid oxidation via modulation of 
its activity.  CAT, carnitine-acylcarnitine-translocase; CPT I, carnitine-palmitoyl-
transferase I; CPT II, carnitine-palmitoyl-transferase II; IMM, inner mitochondrial 
membrane; LCFA, long-chain fatty acids; OMM, outer mitochondrial membrane. 
(Modified from Lee et al, 2004). 
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CHAPTER 4 
FeTMPyP AS A TREATMENT FOR INFANT INTESTINAL ISCHAEMIA 
AND REPERFUSION INJURY 
 
4.1 BACKGROUND 
 
As previously discussed, intestinal I/R is an important component of the 
pathogenesis of several life threatening conditions in adults (Schoenberg et al, 
1993). In addition, newborns and infants are at risk from the consequences of 
intestinal I/R, which is involved in the pathogenesis of necrotizing enterocolitis 
(Eaton et al, 2004), can cause intestinal necrosis following midgut volvulus (Clark, 
2000)  or intussusception (Fallat, 2000), and can result from splanchnic 
hypoperfusion during sepsis (Fink, 1993) or after hemorrhage (Moore, 1999).  As 
discussed in Chapter 1, MODS is a well-recognised and potentially lethal 
complication of paediatric conditions associated with intestinal I/R injury 
(Morecroft et al, 1994a). In particular, respiratory failure has been shown to be a 
crucial determinant of early mortality in clinical conditions associated with 
intestinal reperfusion injury in the neonatal and paediatric age such as NEC and 
sepsis (Sonntag et al, 1998; Smith et al, 1991; Morecroft et al, 1994a).  
Although there has been little work concerning intestinal I/R injury in 
developing animals, experimental studies in adult animal models have shown that 
the development of an inflammatory response plays a pivotal role in the 
pathogenesis of the injury to the intestine and distant organs (Cuzzocrea et al, 
2000; Chung et al, 2001). In particular, infiltration of neutrophils and their 
subsequent action is believed to be responsible for tissue damage not only within 
the intestine itself (Sisley et al, 1994; Hernandez et al, 1987), but also in distant 
organs, such as lungs, liver and heart (Schmeling et al, 1989; Simpson et al, 1993; 
Vinardi et al, 2003; Horie et al, 1996) following intestinal I/R, and neutrophil 
infiltration correlates with histological damage in human NEC (see Chapter 7). 
Leukocyte-endothelial cell interactions represent a crucial step in migration of 
leukocytes from the bloodstream into tissues, which is mediated by several 
adhesion molecules expressed by activated endothelium (including P-selectin, 
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ICAM-1 and VCAM-1) in response to the production of interleukins, TNF-α, LPS, 
histamine, PAF and other soluble mediators (Carlos et al, 1994).  
Tissue injury occurs following neutrophil infiltration as a consequence of the 
release of a wide array of enzymes by activated neutrophils (Moraes et al, 2003). 
In addition, the production of reactive oxygen species by activated neutrophils 
(Cuzzocrea et al, 2001b), as well as from xanthine oxidase and other intracellular 
sources, can lead to a state of oxidative stress once the scavenging potential of 
endogenous antioxidant systems is overwhelmed (Li et al, 2002), resulting in 
protein modification, lipid membrane disruption and DNA damage (Tan et al, 
1999; Cuzzocrea et al, 2001b).  
Of the variety of ROS and RNS generated during oxidative stress, 
peroxynitrite is thought to be one of the most reactive (see Chapter 1). 
Peroxynitrite is produced by the spontaneous combination of NO and superoxide 
released during reperfusion (Beckman et al, 1990; Cuzzocrea et al, 2001b) and it is 
believed to be responsible for a significant proportion of deleterious effects 
previously attributed to NO or superoxide alone, including DNA strand scission 
(Groves et al, 1995; Szabo et al, 1997), lipid peroxidation (Rubbo et al, 1994) and 
enzyme inactivation (Radi et al, 1994; Fukumoto et al, 2004a; Castro et al, 1994). 
Peroxynitrite decomposition catalysts are a class of porphyrin-containing 
compounds that catalyse the decomposition of peroxynitrite to non-radical nitrate 
and nitrite (Figure 4.1). In particular, 5,10,15,20-tetrakis(N-methyl-4'-
pyridyl)porphyrinato iron (III) (FeTMPyP, Figure 4.2) has been shown to 
effectively reduce intestinal injury in experimental endotoxaemia and to improve 
cerebral I/R injury (Salvemini et al, 2001; Thiyagarajan et al, 2004; Thiyagarajan 
et al, 2004). Part of the protective effect of FeTMPyP may be exerted via an 
interruption of the inflammatory cascade by preventing activation of NF-kB (Kang 
et al, 2001). A similar compound, 5,10,15,20-tetrakis (2,4,6-trimethyl-3,5-
disulfonatophenyl)-porphyrinato iron (III) (FeTMPS) has been shown to reduce 
local injury following intestinal I/R in adult rats (Cuzzocrea et al, 2000).  
The aim of this study was to characterise intestinal and pulmonary injury in 
an infant rat model of intestinal I/R, and to evaluate the effects of FeTMPyP as a 
possible therapeutic agent. 
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4.2 MATERIALS AND METHODS 
 
4.2.1 Study design 
 Suckling mixed-sex Sprague-Dawley rats of 11-13 days of age weighing 
between 20 and 30g were used. The suckling rats were kept with their dams and 
allowed to suckle freely until anaesthetised. The family groups were kept under 
standard conditions for food, light and temperature. 
 Animals were randomly assigned to one of three experimental groups 
(n=11 per group): 
A) Control Saline: sham operation for 130min with saline infusion  
B) I/R Saline: 40min intestinal ischaemia, followed by 90min reperfusion with 
saline infusion  
C) I/R FeTMPyP: 40min intestinal ischaemia, followed by 90min reperfusion 
with FeTMPyP infusion 
Core body temperature was monitored throughout the experiment via a rectal 
probe since induction of anaesthesia, and was maintained within normal values for 
suckling rats of this age (i.e. between 34 and 36°C) (Bertin et al, 1993) using a 
heating blanket and lamp.  
 
4.2.2 Surgical Procedure 
General anaesthesia was performed by inhalation of isoflurane in an oxygen 
and nitrous oxide mixture as described in Chapter 2.  
Intestinal ischaemia and reperfusion, and sham operation were performed as 
described in Chapter 2. 
Immediately after occlusion of the superior mesenteric artery, the right 
femoral vessels were exposed through a longitudinal incision, and a 0.16mm 
polyimide catheter (Cole-Parmer, Vernon Hills, IL, USA) was inserted in the right 
femoral vein for fluid infusion. Five minutes before the end of ischaemia, rats 
received either 5ml/kg 0.9% saline (Control Saline group and  I/R Saline group), or 
30mg/kg FeTMPyP (Calbiochem, Nottingham, UK) in 5ml/kg 0.9% saline (I/R 
FeTMPyP group) through the femoral line.  
One minute before the end of the experiment, all animals were infused with 
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1,000IU/kg sodium heparin (Sigma-Aldrich Co., Poole, UK) in 5ml/kg 0.9% 
saline. At the end of the experiment, the thorax was opened through a midline 
sternotomy, the ascending aorta and the superior vena cava were identified and 
divided, and animals were sacrificed by exsanguination. 
  
4.2.3 Tissue extraction and metabolite measurement 
Immediately after sacrifice, the heart was removed and placed in ice-cold 
medium for total CPT activity measurement. A blood sample was collected from 
the thorax, transferred into a heparin tube and centrifuged (3000rpm for 5min at 
4ºC), and plasma was stored at -70°C until analysis. Small intestine (10-25cm from 
the ileocaecal valve) and lungs were also removed and stored at -70°C. Terminal 
ileum (5 to 10cm from the ileocaecal valve) was fixed in 10% formaldehyde for 24 
hours and embedded in paraffin. 
Myeloperoxidase activity in ileum and lungs was measured by 
spectrophotometry. Levels of malondialdehyde in terminal ileum, lungs and heart 
were determined by HPLC. The concentration of reduced and oxidised glutathione 
in ileum was measured by HPLC. Plasma concentration of nitrate plus nitrite, 
reflecting systemic production of nitric oxide, was quantified by HPLC. Total 
carnitine palmitoyl transferase activity in the heart was measured by radiochemical 
assay. Assays for MDA, glutathione, nitrate plus nitrite, and total CPT activity 
were performed as described in Chapter 2. 
Haematoxylin and eosin staining, and immunostaining for P-Selectin, ICAM-
1, and VCAM-1 were performed on 5m sections from paraffin embedded samples 
of terminal ileum as described in Chapter 2. The degree of histological injury and 
the level of expression of each adhesion molecule were assessed semi-
quantitatively as specified in Chapter 2. 
 
4.2.4 Statistical analysis 
Continuous variables are expressed as mean  SEM and compared by one-
way ANOVA with Tukey post hoc test. Data referring to discrete variables are 
expressed as median [interquartile range], and Kruskal-Wallis test was used for 
group comparison. Linear regression was used to evaluate the correlation between 
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levels of MDA and glutathione in the ileum; and Spearman R to assess the 
relationships between histological injury, P-Selectin and ICAM-1 expression, and 
MPO activity. Results showing p values <0.05 were considered significant.  
 
4.3 RESULTS 
 
4.3.1 Histological injury 
Ileal histology was normal in all control animals (Figure 4.3, 4.4 A). All 
animals subjected to intestinal I/R and saline infusion showed evidence of 
microscopical tissue damage: the degree of histological injury varied from 
presence of mucosal slough at villous tips (Grade 2) to complete disintegration of 
the lamina propria (Grade 5), with the majority of samples showing denuded villi 
with exposed but still intact lamina propria (Grade 4, Figure 4.3, 4.4 B). Rats 
undergoing intestinal I/R and FeTMPyP administration (Figure 4.3, 4.4 C) showed 
overall a somehow milder degree of histological damage compared to the I/R plus 
saline group: in few animals the ileum appeared microscopically normal (Grade 1), 
and in no one there was evidence of destruction of the lamina propria. Congestion 
of blood vessels and evidence of haemorrhage also developed as a consequence of 
intestinal reperfusion, which were more frequent and severe in rats receiving saline 
than in those treated with the scavenger. However, statistical analysis of 
histological injury according to the grading system used showed no difference 
between the I/R plus saline and I/R plus FeTMPyP groups (Figure 4.3). 
 
4.3.2 P-Selectin expression 
Expression of P-Selectin on blood vessels was weak in most specimens from 
control rats (Figure 4.5, Figure 4.6 A). Intestinal I/R induced a significant increase 
in the expression of P-Selectin, most animals showing moderate to strong staining 
(Figure 4.5). Vessels expressing P-Selectin were evenly distributed within the 
specimens, and staining was particularly intense on medium-sized vessels of the 
submucosa (Figure 4.6 B). However, expression of P-Selectin on I/R rats receiving 
FeTMPyP showed only a non-significant trend towards increase as compared to 
controls (Figure 4.5).  
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A strong positive correlation was found between intensity of expression of P-
Selectin on blood vessels and degree of histological injury in the ileum (r =0.580; 
p=0.0004). In addition, the degree of P-Selectin expression in the ileum also 
correlated with the extent of intestinal neutrophil infiltration as assessed by MPO 
activity (r =0.554; p=0.0008). 
 
4.3.3 ICAM-1 expression 
 Mild expression of ICAM-1, particularly on medium-size vessels of the 
submucosa, was evident in the ileum of most rats from the control group, reflecting 
constitutive expression of ICAM-1 (Figure 4.8 A). However, ICAM-1 expression 
was increased following intestinal I/R in animals receiving both saline and 
FeTMPyP (Figure 4.7), which showed a more diffuse and intense staining on 
medium-sized vessels in the submucosa (Figure 4.8 B). In addition, in the latter 
two groups considerable expression of ICAM-1 was observed also on the 
microcirculation, particularly in the submucosa, which was virtually absent in 
specimens from control rats. 
 
4.3.4 VCAM-1 expression 
  Expression of VCAM-1 was variable in ileum specimens from control 
animals (Figure 4.9). In most specimens, VCAM-1 was expressed in a patchy 
pattern, and staining was present not only on medium size vessels, but also on the 
microcirculation in the submucosa (Figure 4.10 A, 4.10 B). Rats undergoing 
intestinal I/R, both with and without FeTMPyP, did not show any quantitative 
increase in VCAM-1 expression (Figure 4.9), and the type and location of 
positively stained vessels was also similar to that of controls (Figure 4.10 C). 
 
4.3.5 Neutrophil infiltration 
Following intestinal I/R, neutrophil infiltration was greatly increased not 
only in the ileum (Figure 4.11 A), but also in the lungs (Figure 4.11 B), as 
indicated by myeloperoxidase activity. FeTMPyP administration prevented the 
infiltration of neutrophils in the ileum: I/R animals receiving the scavenger showed 
levels of MPO comparable to controls, and significantly lower than I/R animals 
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resuscitated with saline (Figure 4.11 A). However, FeTMPyP did not affect the 
degree of neutrophil infiltration in the lungs, and pulmonary MPO activity was 
similar in I/R animals receiving either the scavenger or saline (Figure 4.11 B). 
 
4.3.6 Lipid peroxidation 
Intestinal ischaemia and reperfusion was also associated with an increase in 
lipid peroxidation in both intestine and lungs in animals that received infusion of 
saline compared to controls, but this effect was prevented by administration of 
FeTMPyP (Figure 4.12 A, 4.12 B). Interestingly, no differences in cardiac levels of 
malondialdehyde were observed in the heart following intestinal reperfusion 
(Figure 4.12 C). Quantification of MDA levels in plasma was attempted, however 
no reliable measurement could be obtained due to interfering peaks possibly 
generated by FeTMPyP in solution. 
 
4.3.7 Glutathione content 
A profound depletion in intestinal total glutathione levels was observed 
following intestinal I/R in rats infused with saline only as compared to controls 
(Figure 4.13 C). This effect appeared to be due to a decrease in both reduced 
(Figure 4.13 A) and oxidised glutathione (Figure 4.13 B). Administration of 
FeTMPyP partially prevented the decrease in glutathione concentration caused by 
intestinal I/R: concentrations of total and oxidised glutathione were significantly 
higher in I/R animals treated with the scavenger compared to those receiving 
saline, and a trend towards increase was seen in reduced glutathione. However, no 
differences were seen in glutathione redox state in the ileum (Figure 4.13 D), 
indicating that cell redox potential was unaffected by intestinal reperfusion injury. 
Interestingly, intestinal levels of total glutathione negatively correlated with 
MDA concentration (r2=0.195; p=0.010), suggesting an association between a 
decrease in antioxidant potential and development of lipid peroxidation. 
 
4.3.8 Systemic nitric oxide production 
An increase in nitric oxide production was observed as a consequence of 
intestinal I/R in animals receiving saline infusion with respect to controls (Figure 
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4.14). Administration of the peroxynitrite decomposition catalyst effectively 
reduced nitric oxide synthesis, and levels of nitrate plus nitrite in I/R rats receiving 
FeTMPyP were comparable to controls. 
 
4.3.9 Total carnitine palmitoyl transferase activity in the heart 
Values of total CPT activity were similar in all experimental groups, 
suggesting influx of fatty acids into the mitochondria was unaffected in this model 
of intestinal I/R (Figure  4.15) 
 
4.4 DISCUSSION 
  
I/R of the intestine is known to cause a cascade of local (intestinal) and distal 
(liver, lung, heart, kidney) damage and organ failure which may be triggered by 
neutrophil infiltration with subsequent release of proteolytic enzymes and reactive 
oxygen and nitrogen species. Therapeutic strategies that have been shown to 
prevent organ damage in intestinal I/R appear to exert their effects via this 
neutrophil infiltration - free radical - organ damage axis. Examples of this are 
moderate hypothermia (See Chapter 3 and Vinardi et al, 2003), agents such as anti-
adhesion molecule antibodies or other methods to deplete neutrophils (Hernandez 
et al, 1987; Horie et al, 1996; Sisley et al, 1994) and scavengers of ROS and RNS 
(Cuzzocrea et al, 2000; Cuzzocrea et al, 2001a; Naito et al, 2004). However, many 
ROS and RNS have important physiological roles such as maintenance of vascular 
tone (nitric oxide) and bacterial killing (superoxide) so that deleterious as well as 
beneficial effects could result from their administration. Peroxynitrite, on the other 
hand, is a reactive species with no well-defined physiological function so could 
potentially be a more useful valid pharmacological target. 
The compound which I used in this study is one of a large group of transition 
metal based agents which scavenge a variety of reactive nitrogen and oxygen 
species, and the dose chosen (30mg/kg) showed to be effective in a model of 
endotoxin-induced intestinal injury (Salvemini et al, 1999). Some of this group of 
compounds are already in use in clinical trials for relief of dermatological pain. 
Although FeTMPyP is very specific for scavenging peroxynitrite, it appears to 
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interrupt the cycle of adhesion molecule expression, neutrophil infiltration, 
antioxidant depletion, free radical production and histological damage. This 
finding supports a role for peroxynitrite in initiating this cascade. My results in the 
current study in infant rats, using FeTMPyP, are broadly similar to those of 
Cuzzocrea et al in adult rat intestinal I/R injury, using a related peroxynitrite 
scavenger, FeTMPS (Cuzzocrea et al, 2000). There are, however, some differences 
between these studies, in addition to the use of infant rats and a different 
peroxynitrite decomposition catalyst. Cuzzocrea et al administered the scavenger 
after only 15min of ischaemia (30min before reperfusion), whereas I administered 
the scavenger 5min before reperfusion (after 35min of ischaemia). Potential 
clinical use of peroxynitrite decomposition catalysts would probably involve 
administration close to the initiation, or even after commencement, of reperfusion 
(e.g. surgery for midgut volvulus). Interestingly, in a rat middle cerebral artery 
occlusion model of stroke, FeTMPyP was protective even when given 6 hours after 
the acute insult (Thiyagarajan et al, 2004), suggesting that administration could be 
effective even when applied later, although I did not test this in my model.  
In the present study, I additionally showed a protective effect of FeTMPyP 
against lipid peroxidation in the lungs, which is important as multiple organ failure 
is an important consequence of diseases involving intestinal reperfusion injury.  
Although peroxynitrite scavengers decreased both ileal P-selectin expression 
and neutrophil infiltration in my study and that of Cuzzocrea, in their study, the 
peroxynitrite scavenger prevented up-regulation of ICAM expression, whereas in 
my study, it had no effect. Findings from the current study suggest that prevention 
of P-selectin expression, and therefore of early neutrophil rolling, is sufficient to 
attenuate neutrophil infiltration, even when the elevated ICAM-1 expression, 
which mediates later firm adhesion, is unaltered. In other studies using 
peroxynitrite scavengers, it has been shown that removal of peroxynitrite can 
prevent plasma leakage into the intestinal tract in endotoxaemia (Salvemini et al, 
1999). Other similar effects have been observed using structurally-related 
superoxide dismutase mimetics (Salvemini et al, 1999; Cuzzocrea et al, 2001a) 
which, by scavenging superoxide, would also prevent peroxynitrite formation, as 
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peroxynitrite can be physiologically generated by the reaction of superoxide with 
nitric oxide. 
In the current study, total carnitine palmitoyl transferase (CPT) activity was 
not impaired following 40min mesenteric ischaemia and 90min reperfusion. The 
shorter time frame used in this study as compared to the experiment described in 
Chapter 3 could account for this difference, and animals could have been sacrificed 
before potential alterations of CPT activity (e.g. tyrosine nitration of CPT I by 
peroxynitrite) ensue. This is consistent with previous studies from my group, 
where alterations in cardiac CPT I activity were observed at 2 hours following 
intraperitoneal injection of LPS in infant rats (Fukumoto et al, 2002a; Fukumoto et 
al, 2002b).  
In the current experiment, as FeTMPyP was administered systemically, it 
was impossible to determine whether the effects of FeTMPyP administration on 
distal organs and systemic measures are secondarily mediated via the effect of 
FeTMPyP on the intestine, or whether FeTMPyP is also acting systemically. 
Interestingly, FeTMPyP decreased neutrophil infiltration and lipid peroxidation in 
the intestine, but lipid peroxidation in the lungs was decreased despite neutrophil 
infiltration in the lungs remaining elevated, suggesting that FeTMPyP could be 
acting locally in the lung to prevent peroxynitrite-initiated lipid peroxidation. 
However, FeTMPyP catalyses the decomposition of peroxynitrite to nitrate, so that 
if the effects of FeTMPyP were systemic, one could expect an increase in plasma 
nitrate plus nitrite, rather than the decrease we observed in the current study. The 
observed decrease suggests that FeTMPyP may be primarily effective locally in the 
intestine, thus preventing a systemic inflammatory response. In addition, this  
prevention of lipid peroxidation in the ileum by FeTMPyP seems to be unrelated to 
major antioxidant systems, since a similar decrease in both reduced, oxidized, and 
total glutathione concentrations was observed following mesenteric reperfusion in 
animals receiving saline and in those treated with FeTMPyP. Further experiments 
would be required to determine the mechanism of action.  
Although quantification of tissue or plasma nitrotyrosine levels would have 
contributed to support the role of peroxynitrite-induced nitrosative stress in this 
model of intestinal I/R, the partial protection achieved by FeTMPyP in this study 
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can be entirely attributed to the decomposition of peroxynitrite (Cuzzocrea et al, 
2001b), since this compound does not exert catalase or superoxide dismutase 
activity (Salvemini et al, 1999). In fact, immunostaining for nitrotyrosine was 
attempted on paraffin-embedded sections of small intestine from experimental 
animals, however no reliable staining could be obtained despite several different 
modalities of antigen retrieval. 
Various compounds of this class of porphyrin derivatives have been 
synthesised, and a closely related compound, M-40403, which is specific for 
scavenging superoxide, is currently being tested in phase II clinical trials for 
inflammatory conditions and pain (Di Napoli et al, 2005). M-40403 contains Mn 
rather than Fe at the catalytic centre, as metabolism of Fe-containing porphyrins 
could potentially lead to the generation of harmful Fe-centered radicals. However, 
all the metal-centered porphyrin compounds are very stable and there are no 
reports of pro-oxidant activities “in vivo”. A further potential problem with 
antioxidant therapy is interference with the bacterial killing process and increased 
susceptibility to infection. Peroxynitrite is toxic to bacteria and may be involved 
with bacterial killing following phagocytosis (Fang, 2004; Zhu et al, 1992). In 
addition, it may have other physiological roles (Ferdinandy, 2006), so that 
scavenging peroxynitrite may have other effects in addition to prevention of the 
inflammatory process.  
  
5.5 CONCLUSIONS 
 
Superior mesenteric artery ischaemia and reperfusion was characterised by 
significant alterations not only in the gut, but also in distant organs in my infant rat 
model. Upregulation of endothelial adhesion molecules (P-Selectin and ICAM-1) 
was detected in the distal ileum, which was accompanied by increased 
inflammatory cell infiltration and development of oxidative stress, ultimately 
resulting in tissue injury and disruption of mucosal architecture. Recruitment of 
neutrophils and development of lipid peroxidation of biological membranes were 
observed in the lungs, together with an increased in nitrosative stress at a systemic 
level.  
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Systemic administration of FeTMPyP at reperfusion exerted a protective 
effect on the gut, reducing neutrophil infiltration and lipid peroxidation in the 
intestine, possibly via inhibition of P-Selectin expression on vascular endothelium, 
although it did not reduce the extent of histological injury. The use of this 
peroxynitrite decomposition catalyst afforded protection also to distant organs, 
preventing the development of oxidative stress in the lungs and inhibiting systemic 
overproduction of nitric oxide.  
Peroxynitrite decomposition scavengers have been shown to be effective in a 
variety of models, and are promising candidates for clinical trials to prevent 
systemic inflammatory response syndrome, especially given the apparently relative 
broad window of opportunity for their use. However, careful clinical studies are 
required to determine whether there is increased susceptibility to infection and/or 
other side effects. 
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Figure 4.1. Proposed mechanism of action for peroxynitrite decomposition 
catalyst FeTMPyP (Salvemini et al, 1998). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schematic representation of the proposed chemical mechanism for 
peroxynitrite decomposition catalyst FeTMPyP. The predominant product of 
FeTMPyP mediated decomposition of peroxynitrite is nitrate (>90%), with a minor 
amount of nitrite also formed (approximately 7%). Spontaneous reaction of 
peroxynitrite with H+, on the contrary, produces both nitrate (approximately 65%) 
and nitrite (approximately 35%). 
(Modified from Salvemini et al, 1998). 
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Figure 4.2. Molecular structure of peroxynitrite decomposition catalyst 
FeTMPyP.  
 
 
 
 
 
 
 
 
 
 
 
 
Molecular structure of peroxyinitrite decomposition catalyst FeTMPyP 
(5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato iron (III)), containing an 
iron molecule in a porphyrin ring. 
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Figure 4.3.  Histological injury in ileum. 
 
 
 
 
 
 
 
 
 
 
Grade of histological injury in the ileum (5=maximum, 1=minimum). 
Animals (n=11 per group) underwent sham operation with saline infusion (Control 
Saline) or intestinal ischaemia and reperfusion with infusion of either saline (I/R 
Saline) or FeTMPyP solution (I/R FeTMPyP). Results were compared using 
Kruskal-Wallis with Dunn’s multiple comparison test.  
*  I/R Saline: P<0.001 vs. Control Saline. 
†  I/R FeTMPyP: P<0.05 vs. Control Saline.  
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Figure 4.4. Histological appearance of terminal ileum. 
 
 
 
Specimens of terminal ileum were stained with haematoxylin and eosin, and 
are from: Control Saline [A]; I/R Saline [B]; I/R FeTMPyP [C]. Magnification is 
x100. 
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Figure 4.5. P-Selectin expression in ileum. 
 
 
 
 
 
 
 
 
 
 
 
 
Grade of P-Selectin expression the ileum (4=maximum, 1=minimum). 
Animals (n=11 per group) underwent sham operation with saline infusion (Control 
Saline) or intestinal ischaemia and reperfusion with infusion of either saline (I/R 
Saline) or FeTMPyP solution (I/R FeTMPyP). Results were compared using 
Kruskal-Wallis with Dunn’s multiple comparison test.  
*  I/R Saline: P<0.01 vs. Control Saline. 
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Figure 4.6. Histological appearance of P-Selectin expression in ileum. 
 
 
 
Specimens of terminal ileum were immunostained for P-Selectin and 
counterstained with haematoxylin as described in Chapter 2. Specimens are from: 
Control Saline [A]; I/R Saline [B]. Magnification is x400. 
A 
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Figure 4.7. ICAM-1 expression in ileum. 
 
 
 
 
 
 
 
 
 
 
 
 
Grade of ICAM-1 expression the ileum (4=maximum, 1=minimum). 
Animals (n=11 per group) underwent sham operation with saline infusion (Control 
Saline) or intestinal ischaemia and reperfusion with infusion of either saline (I/R 
Saline) or FeTMPyP solution (I/R FeTMPyP). Results were compared using 
Kruskal-Wallis with Dunn’s multiple comparison test.  
*  I/R Saline: P<0.01 vs. Control Saline. 
†  I/R FeTMPyP: P<0.01 vs. Control Saline.  
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Figure 4.8. Histological appearance of ICAM-1 expression in ileum. 
 
 
 
Specimens of terminal ileum were immunostained for ICAM-1 and 
counterstained with haematoxylin as described in Chapter 2. Specimens are from: 
Control Saline [A]; I/R Saline [B]. Magnification is x400. 
A 
B 
 Chapter 4: FeTMPyP as a Treatment for Infant Intestinal I/R Injury 
 146
Figure 4.9. VCAM-1 expression in ileum. 
 
 
 
 
 
 
 
 
 
 
 
 
Grade of VCAM-1 expression the ileum (4=maximum, 1=minimum). 
Animals (n=11 per group) underwent sham operation with saline infusion (Control 
Saline) or intestinal ischaemia and reperfusion with infusion of either saline (I/R 
Saline) or FeTMPyP solution (I/R FeTMPyP). Results were compared using 
Kruskal-Wallis with Dunn’s multiple comparison test.  
1
2
3
4
Control
Saline
I/R
Saline
I/R
FeTMPyP
G
ra
de
G
ra
de
 Chapter 4: FeTMPyP as a Treatment for Infant Intestinal I/R Injury 
 147
B A 
Figure 4.10. Histological appearance of VCAM-1 expression in ileum. 
 
 
 
 
Specimens of terminal ileum were immunostained for VCAM-1 and 
counterstained with haematoxylin as described in Chapter 2. Specimens are from: 
Control Saline [A,B]; I/R Saline [C]. Magnification is x400. 
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Figure 4.11. Neutrophil infiltration in ileum and lungs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neutrophil infiltration, assessed as myeloperoxidase activity (MPO) in ileum 
[A], and lungs [B]. Animals (n=11 per group) underwent sham operation with 
saline infusion (Control Saline) or intestinal ischaemia and reperfusion with 
infusion of either saline (I/R Saline) or FeTMPyP solution (I/R FeTMPyP). Data 
are expressed as nmol/mg protein and results are reported as mean  SEM. One-
way ANOVA with Tukey post hoc test was used for group comparison.  
[A]: * I/R Saline: P < 0.001 vs. Control Saline; P = 0.006 vs. I/R FeTMPyP. 
  †  I/R Saline: P = 0.009 vs. Control Saline.  
[B]: * I /R FeTMPyP: P = 0.004 vs. Control Saline.   
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Figure 4.12. Malondialdehyde  concentration in ileum, lungs and heart. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of malondialdehyde (MDA) in ileum [A], lungs [B], and heart 
[C]. Animals (n=11 per group) underwent sham operation with saline infusion 
(Control Saline) or intestinal ischaemia and reperfusion with infusion of either 
saline (I/R Saline) or FeTMPyP solution (I/R FeTMPyP). Data are expressed as 
nmol/mg protein and results are reported as mean  SEM. One-way ANOVA with 
Tukey post hoc test was used for group comparison.  
[A]: *  I/R Saline: P = 0.001 vs. Control Saline; P = 0.003 vs. I/R FeTMPyP. 
[B]: *  I/R Saline: P = 0.002 vs. Control Saline; P = 0.007 vs. I/R FeTMPyP.   
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Figure 4.13. Glutathione concentration in ileum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of reduced (GSH) [A], oxidised (GSSG) [B], and total 
(calculated as GSH + 2*GSSG) [C] glutathione, and glutathione redox state 
(calculated as GSH/2*GSSG) [D] in ileum. Animals (n=11 per group) underwent 
sham operation with saline infusion (Control Saline) or intestinal ischaemia and 
reperfusion with infusion of either saline (I/R Saline) or FeTMPyP solution (I/R 
FeTMPyP). Concentrations of GSH, GSSG and total glutathione are expressed as 
nmol/g wet weight. Results are reported as mean  SEM; one-way ANOVA with 
Tukey post hoc test was used for group comparison.  
[A]: *  I/R Saline: P<0.001 vs. Control Saline. 
 †  I/R FeTMPyP: P<0.001 vs. Control Saline. 
[B]: * I/R Saline: P<0.001 vs. Control Saline. 
 †  I/R FeTMPyP: P<0.001 vs. Control Saline; P=0.001 vs. I/R Saline. 
[C]: *  I/R Saline: P<0.001 vs. Control Saline. 
 †  I/R FeTMPyP: P<0.001 vs. Control Saline; P=0.007 vs. I/R Saline. 
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Figure 4.14. Nitrate plus nitrite concentration in plasma. 
 
 
 
 
 
 
 
 
 
 
 
 
Systemic production of nitric oxide measured as concentration of nitrate plus 
nitrite in plasma. Animals (n=11 per group) underwent sham operation with saline 
infusion (Control Saline) or intestinal ischaemia and reperfusion with infusion of 
either saline (I/R Saline) or FeTMPyP solution (I/R FeTMPyP). Data are expressed 
as μmol/l and results are reported as mean  SEM. One-way ANOVA with Tukey 
post hoc test was used for group comparison.  
*  I/R Saline: P = 0.041 vs. Control Saline.  
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Figure 4.15. Total carnitine palmitoyl transferase activity in the heart. 
 
 
 
 
 
 
 
 
 
 
 
 
Total carnitine palmitoyl transferase (CPT) activity in the heart Animals 
(n=11 per group) underwent sham operation with saline infusion (Control Saline) 
or intestinal ischaemia and reperfusion with infusion of either saline (I/R Saline) or 
FeTMPyP solution (I/R FeTMPyP). Data are expressed as mmol/min/U citrate 
synthase (CS) and results are reported as mean  SEM. One-way ANOVA with 
Tukey post hoc test was used for group comparison.  
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CHAPTER 5 
 
MODERATE HYPOTHERMIA AS A RESCUE  
TREATMENT FOR ADULT INTESTINAL  
ISCHAEMIA AND REPERFUSION INJURY 
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CHAPTER 5 
MODERATE HYPOTHERMIA AS A RESCUE TREATMENT FOR 
ADULT INTESTINAL ISCHAEMIA AND REPERFUSION INJURY 
 
5.1 BACKGROUND 
 
Therapeutic hypothermia is beneficial in animal models of cerebral (Kollmar 
et al, 2002), cardiac (Hale et al, 2003), hepatic (Choi et al, 2005)  and renal (Zager 
et al, 1989) ischaemia, and clinical evidence suggests that rescue hypothermia can 
improve outcome after cardiac arrest (The Hypothermia after Cardiac Arrest Study 
Group, 2002; Bernard et al, 2002) and neonatal hypoxic-ischaemic encephalopathy 
(Shankaran et al, 2005; Gluckman et al, 2005). Experimental studies have shown 
that moderate hypothermia, when applied throughout intestinal I/R, can prevent 
mortality (Vejchapipat et al, 2001; Kalia et al, 2002b). This hypothermic protection 
is associated not only with a reduction in intestinal injury (Hassoun et al, 2002; 
Vejchapipat et al, 2002; Hassoun et al, 2003; Attuwaybi et al, 2003), but also with 
prevention of hepatic bioenergetic failure (Vejchapipat et al, 2001), preservation of 
myocardial metabolism (see Chapter 3), reduction in lung neutrophil infiltration 
(Vinardi et al, 2003), and decreased oxidative stress in plasma, lungs and kidneys 
(see Chapter 3). However, hypothermia throughout I/R injury can only be applied 
in elective procedures where mesenteric ischaemia can be predicted in advance 
(e.g. cardiac surgery using cardiopulmonary bypass, aortic aneurysm repair and 
intestinal transplantation). In the majority of clinical conditions associated with 
intestinal I/R, therapy can be commenced only after intestinal ischaemia, thus 
therapy must be effective when applied at or after the time of reperfusion. 
Investigation of a possible rescue therapy for acute intestinal I/R injury is of 
clinical relevance, and an experimental study was therefore designed to assess the 
effects of moderate hypothermia, applied as a rescue therapy at the beginning of 
reperfusion, in a rat model of intestinal I/R injury.  
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5.2 MATERIAL AND METHODS 
 
5.2.1 Study design 
Young adult male Sprague-Dawley rats weighing between 250 and 300g 
were used. Animals were kept under standard conditions for food, water, light and 
temperature, and had access to standard rat chow and water ad libitum until the 
beginning of the experiment. 
 
Study A 
Animals were randomly assigned to one of five experimental groups (n=6 per 
group): 
A) Control Normothermia: sham operation and observation for 360min at 
normothermia  
B) I/R Normothermia: 60min intestinal ischaemia at normothermia, followed by 
300min normothermic reperfusion  
C) Control Hypothermia: sham operation and observation; 60min at 
normothermia, followed by 300min at hypothermia  
D) I/R Hypothermia: 60min intestinal ischaemia at normothermia, followed by 
300min hypothermic reperfusion 
E) I/R Hypothermia with Rewarming: 60min intestinal ischaemia at 
normothermia, followed by 120min hypothermic reperfusion, and 180min 
rewarming. 
 
Study B 
Animals were randomly assigned to one of four experimental groups (n=8 per 
group): 
A) Control Normothermia: sham operation and observation for 180min at 
normothermia  
B) I/R Normothermia: 60min intestinal ischaemia at normothermia, followed by 
120min normothermic reperfusion  
C) Control Hypothermia: sham operation and observation; 60min at 
normothermia, followed by 120min at hypothermia  
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D) I/R Hypothermia: 60min intestinal ischaemia at normothermia, followed by 
120min hypothermic reperfusion 
 
Rectal temperature was monitored continuously throughout the experiment 
from induction of anaesthesia. Normothermia (rectal temperature between 36 and 
38°C) was maintained by use of a heating blanket and lamp as discussed in 
Chapter 2. Moderate hypothermia (rectal temperature between 30 and 32ºC) was 
induced at the beginning of reperfusion by cooling the animals with a fan in an 
environmental temperature of 22 to 23ºC; target temperature (32ºC) was reached 
within 20 to 30min (median 26min), and warming applied as necessary to prevent 
excessive cooling (Figure 5.1). Rewarming was achieved in the I/R Hypothermia 
with Rewarming group over 60min and animals maintained between 36 and 38°C 
until the end of the experiment.  
 
5.2.2 Surgical Procedure 
Inhalation of isoflurane in an oxygen and nitrous oxide mixture was used for 
general anaesthesia as discussed in Chapter 2.  
A pulse oximeter (NonIn Medical, Minneapolis, MN) was placed on the right 
foot to monitor peripheral oxygen saturation. A tracheostomy was then performed 
by inserting a 16G cannula (BD Neoflon, Helsinborg, Sweden) into the trachea 
through a midline cervical incision. Animals were then ventilated with a small 
animal ventilator (CWE, Ardmore, PA) and gas flow was adjusted in order to 
maintain peripheral oxygen saturation >95%. Ventilatory requirements in the 
different groups, as well as accuracy of the pulse oximeter, were assessed in a 
preliminary set of experiments by monitoring arterial blood gases (iStat 
Corporation, Princeton, NJ, USA). 
 
Study A 
Once animals were stabilised, the right femoral vessels were exposed with a 
longitudinal incision. A 24G cannula (BD Neoflon, Helsinborg, Sweden) was 
inserted into the right femoral artery, and the line was maintained patent by 
continuous infusion of 0.9% normal saline (10ml/kg/h). Arterial pressure and heart 
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rate were monitored throughout with a transducer connected to the arterial line. 
Data were recorded and analysed with a Transonic T206 (Transonic Systems Inc., 
Ithaca, NY), and mean arterial pressure (MAP) was calculated; results were 
recorded at 15min intervals.  
After insertion of the femoral line, intestinal ischaemia and reperfusion or 
sham operation were performed as described in Chapter 2. 
Survival was then monitored for up to 300min from the onset of reperfusion, 
and experimental animals were considered dead when systolic pressure was 
<20mmHg and heart rate was <50bpm; survival time from the beginning of 
reperfusion was recorded. Rats that were still alive at the end of the experiment 
were killed by exsanguination under terminal anaesthesia. 
Resuscitation with boluses of normal saline through the arterial femoral line 
was performed at the following time points: immediately after femoral line 
insertion (3ml/kg); 30 min after the beginning of ischaemia (1.5ml/kg); and 5, 60, 
120, 180, and 240 min after the beginning of reperfusion (3ml/kg each).  
 
Study B 
Once animals were stabilised, the right femoral vessels were exposed with a 
longitudinal incision. A 24G cannula (BD Neoflon, Helsinborg, Sweden) was 
inserted into the right femoral vein, and the line was maintained patent by 
continuous infusion of 0.9% normal saline (10ml/kg/h).  
After insertion of the femoral line, sham operation and superior mesenteric 
artery occlusion-deocclusion were performed as described in Chapter 2.  
Resuscitation with boluses of normal saline through the venous femoral line 
was performed at the following time points: immediately after femoral line 
insertion (3ml/kg); 30min after the beginning of ischaemia (1.5ml/kg); and 5, and 
60min after the beginning of reperfusion (3ml/kg each).  
One min before the end of the experiment, animals were heparinised by 
infusion of 1,000 IU/kg sodium heparin in 5ml/kg 0.9% saline via the femoral line. 
Animals were then sacrificed by exsanguination under terminal anaesthesia. A liver 
sample was freeze-clamped in liquid nitrogen for measurements of 
phosphoenergetics. The heart was removed and placed in ice-cold medium for total 
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CPT activity measurement. A blood sample was collected from the thorax, 
transferred into a heparin tube and centrifuged (3000rpm for 5min at 4ºC), and 
plasma was stored at -70°C until analysis. Small intestine (10-25cm from the 
ileocaecal valve) and lungs were also removed and stored at -70°C. Terminal ileum 
(5 to 10cm from the ileocaecal valve) was fixed in 10% formaldehyde for 24 hours 
and embedded in paraffin. 
 
5.2.3 Tissue extraction and metabolite measurement 
Liver phosphoenergetics were quantified by HPLC. Myeloperoxidase 
activity in ileum and lungs was measured by spectrophotometry. Levels of 
malondialdehyde in terminal ileum, lungs and heart were determined by HPLC. 
The concentration of reduced and oxidised glutathione in ileum was measured by 
HPLC. Plasma concentration of nitrate plus nitrite, reflecting systemic production 
of nitric oxide, was quantified by HPLC. Total carnitine palmitoyl transferase 
activity in the heart was measured by radiochemical assay. Assays for 
phosphoenergetics, MDA, glutathione, nitrate plus nitrite, and total CPT activity 
were performed as described in Chapter 2. 
Haematoxylin and eosin staining was performed on 5m sections from 
paraffin embedded samples of terminal ileum as described in Chapter 2. The 
degree of histological injury was assessed semi-quantitatively as specified in 
Chapter 2. 
 
5.2.4 Statistical analysis 
Survival from the beginning of reperfusion is expressed as median [range], 
and results compared by Log rank test. Repeated measures ANOVA with 
Bonferroni post-test was used to compare values of MAP and heart rate with 
baseline values within the same experimental group. Histological injury is 
presented as median [range] and compared by Kruskal-Wallis with Dunn’s post-
test. All other data are expressed as mean  SEM, and 1-way ANOVA with Tukey 
post-test was used for comparisons. Results showing p values <0.05 were 
considered significant.  
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5.3 RESULTS 
 
Study A 
5.3.1 Survival 
All control animals, normothermic and hypothermic, were alive after 300min 
reperfusion (Figure 5.2). Conversely, intestinal I/R at normothermia induced death 
of all experimental animals at 97 to197min (average 148min) from the beginning 
of reperfusion. However, moderate hypothermia applied at reperfusion, even when 
followed by rewarming, abolished mortality: all hypothermic I/R rats with or 
without rewarming, were alive at 300min reperfusion (p=0.0005 vs. I/R 
normothermia). 
 
5.3.2 Haemodynamics 
Mean arterial pressure and heart rate remained at baseline level (around 
100mmHg and 350bpm respectively) throughout the experiment in normothermic 
animals undergoing sham operation (Figure 5.3 A, 5.4 A). However, reduction of 
body temperature in control animals was associated with a significant reduction in 
heart rate and, to a lesser extent, in MAP, with values reaching a nadir 60min after 
the beginning of cooling and then remaining around 280bpm and 90mmHg until 
sacrifice (Figure 5.3 B, 5.4 B).  
In rats undergoing normothermic I/R, heart rate increased and MAP 
decreased progressively from the beginning of reperfusion despite fluid 
resuscitation (Figure 5.3 C, 5.4 C). Although a high variability was observed 
between individual animals, at 3 hours from the beginning of reperfusion average 
heart rate was as high as 450bpm, and MAP as low as 50mmHg. All animals in 
this group developed progressive severe hypotension and tachycardia, ultimately 
resulting in cardiovascular failure and death.  
Interestingly, haemodynamic changes in hypothermic I/R rats did not differ 
significantly from those of hypothermic controls, with heart rate decreasing to 
approximately 270bpm and MAP to 85mmHg over the first hour of reperfusion 
(Figure 5.3 D, 5.4 D). In the next four hours of reperfusion, only a marginal 
decrease in MAP was observed, with no rats developing tachycardia or 
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hypotension. Rewarming of hypothermic I/R animals after 120min of hypothermic 
reperfusion was followed by a rapid increase in both heart rate and MAP, so that at 
the end of rewarming haemodynamics were restored to baseline levels in all 
experimental animals (Figure 5.3 E, 5.4 E). Animals remained haemodynamically 
stable thereafter, and at sacrifice after 300min reperfusion animals in this group 
averaged 350bpm and 90mmHg, with little variability within the group. 
 
Study B 
5.3.3 Histological injury in ileum 
Ileum histology showed normal mucosa or minimal epithelial slough at 
villous tips in both normothermic and hypothermic controls (Figure 5.5; Figure 5.6 
A, C). Intestinal architecture was profoundly damaged following normothermic I/R 
(Figure 5.5, p<0.001 vs. controls): deep damage to the mucosa with complete 
disruption of intestinal villi, and congestion of blood vessels in the submucosa 
were visible in all specimens (Figure 5.6 B), whereas signs of haemorrhage and 
damage to the lamina propria, and considerable infiltration of leukocytes in the 
submucosa were present in half of the sections.  Hypothermia afforded partial 
protection to mucosal injury in I/R animals (Figure 5.5, p=n.s. vs. controls, p=n.s. 
vs. I/R Normothermia):  damage was limited to the tip or the core of the villi, 
without involving the crypts or the base of villi (Figure 5.6 D), with only modest 
hyperaemia and few leukocytes infiltrating the submucosa. 
 
5.3.4 Neutrophil infiltration 
Intestinal I/R at normothermia was characterised by a huge increase in the 
degree of neutrophil infiltration in both ileum (Figure 5.7 A) and lungs (Figure 5.7 
B). Moderate hypothermia following intestinal I/R effectively reduced neutrophil 
infiltration in both organs as compared to I/R at normothermia. This effect was 
more marked in the ileum, where MPO activity in hypothermic I/R rats was as low 
as in controls.  
Assessment of neutrophil infiltration by MPO activity in the intestine was 
supported by microscopic evaluation of specimens from terminal ileum, with rats 
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showing the highest values of MPO in the intestine also presenting a considerable 
number of leukocytes visible at haematoxylin and eosin staining. 
 
5.3.5 Lipid peroxidation 
Lipid peroxidation developed as a consequence of intestinal I/R in plasma 
(Figure 5.8 A), ileum (Figure 5.8 B) and lungs (Figure 5.8 C) of normothermic rats 
compared to controls. Moderate hypothermia counteracted the increase of lipid 
peroxidation in the ileum, but systemic and pulmonary levels of MDA were similar 
in I/R rats at either normothermia or hypothermia. The degree of lipid peroxidation 
in the heart was similar in all experimental groups and unaffected by either 
mesenteric ischaemia or change in body temperature (Figure 5.8 D). 
 
5.3.6 Glutathione content 
Intestinal I/R at normothermia was associated with a substantial decrease of 
antioxidant potential in the ileum, as suggested by the drastic decrease in the 
concentrations of reduced (Figure 5.9 A), oxidised (Figure 5.9 B) and total 
glutathione (Figure 5.9 C) with respect to controls, suggesting severe antioxidant 
depletion. Rescue hypothermia conferred only limited protection, preventing the 
decrease in oxidised and, to some extent, reduced glutathione. However, only a 
non-significant trend to improvement was observed in levels of total glutathione of 
hypothermic I/R rats compared to I/R at normothermia (Figure 5.9 C). No changes 
in glutathione redox state in the ileum were seen between the four experimental 
groups (Figure 5.9 D). 
 
5.3.7 Systemic nitric oxide production 
Systemic nitric oxide production was increased following intestinal I/R at 
normothermia compared to normothermic controls (Figure 5.10), but this effect 
was not observed in hypothermic I/R rats.  
A highly significant positive correlation (r2=0.2085; p=0.0086) was observed 
between systemic NO production and plasma levels of MDA between all samples 
(Figure 5.11). 
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5.3.8 TNF-α production 
Plasma levels of TNF-α were undetectable in all normothermic and all but 
one hypothermic controls (Figure 5.12), reflecting low systemic release following 
sham operation. Reperfusion of the intestine induced a marked increase in TNF-α 
concentration in plasma, suggesting an intense inflammatory response, with similar 
levels in both normothermic and hypothermic rats. 
 
5.3.9 Liver phosphoenergetics 
 Intestinal I/R at normothermia caused a significant decrease in hepatic ATP 
(Figure 5.13 A), with a parallel rise in AMP (Figure 5.13 C) and inorganic 
phosphate (Figure 5.13 E). Depletion in high energy phosphates was confirmed by 
the drop in liver energy charge (Figure 5.13 F), whereas total adenine nucleotides 
(ATP+ADP+AMP) were unaffected by normothermic intestinal I/R (Figure 5.13 
D). Moderate hypothermia completely prevented the development of hepatic 
energy failure: there was no alteration in ATP, ADP, AMP, energy charge or 
inorganic phosphate compared to controls. 
 
5.3.10 Carnitine palmitoyl transferase activity in the heart 
Intestinal ischaemia and reperfusion at normothermia significantly inhibited 
heart total CPT activity compared to normothermic control animals (Figure 5.14). 
Even though initiation of hypothermia was delayed until the beginning of the 
reperfusion phase, and not completed until about 30min of reperfusion, total CPT 
activity in I/R animals at hypothermia was significantly higher than in I/R animals 
at normothermia, and comparable to controls at both normothermia and 
hypothermia. 
 
5.4 DISCUSSION 
 
Moderate hypothermia has been shown to provide robust protection to distant 
organs, as shown in Chapter 3, and improve survival (Vejchapipat et al, 2001; 
Kalia et al, 2002b) from intestinal I/R, but only when applied throughout both 
ischaemia and reperfusion. In the present study, I have shown therapeutic 
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hypothermia to be effective when applied as a rescue therapy after the onset of 
intestinal reperfusion. This may make the clinical use of moderate hypothermia 
applicable to conditions in which patients can only be treated after the reperfusion 
phase, rather than before the onset of ischaemia. In my study, although I started to 
cool animals at the time of reperfusion, target temperature was achieved only after 
20-30min, suggesting that there may be a “window of opportunity” following 
initiation of reperfusion during which intervention can be effective. The results 
indicate that rescue moderate hypothermia applied after reperfusion following 
normothermic ischaemia can dramatically improve survival and maintain adequate 
cardiovascular function, preventing development of severe tachycardia and 
hypotension. This suggests that a considerable part of damage is exerted during the 
reperfusion phase rather than during ischaemia, as in other ischaemia and 
reperfusion models. Importantly, these beneficial effects remained even when 
animals were slowly rewarmed, and there did not appear to be any deleterious 
rebound effect caused by rewarming, such as peripheral vasodilatation with 
lowered blood pressure (Thoresen et al, 2000).  
Although in previous experiments of hypothermia I have used spontaneously 
breathing animals, as have other groups (Kalia et al, 2002b; Hassoun et al, 2002), 
in preliminary experiments of hypothermia applied at reperfusion, animals that 
were not ventilated experienced fatal respiratory arrest. This could be due to a 
decreased spontaneous respiratory activity when body temperature falls below 
32ºC, resulting both in severe hypercapnia with respiratory acidosis, and in 
profound hypoxia (Connolly et al, 2000). Clearly, in clinical application of 
therapeutic hypothermia, all patients would be ventilated and closely monitored 
during the cooling phase. 
Intestinal I/R produces a systemic inflammatory response with multiple 
organ failure. The beneficial effects observed in this study could have resulted 
from direct protection of distant organs and/or from the reduction of systemic 
inflammatory response secondary to effects on reperfused intestine. Hypothermia 
partially prevented gut histological injury and completely prevented neutrophil 
infiltration, consistent with attenuation of leukocyte endothelial adherence and 
chemotactic activity by hypothermia (Kimura et al, 2002; Kalia et al, 2002b). 
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Hypothermia also protected against oxidative stress in the ileum, which could be 
due to reduced recruitment of neutrophils, or impairment in free radical production 
by activated leukocytes (Frohlich et al, 2004). When hypothermia was applied 
throughout I/R, intestinal glutathione was maintained by hypothermia (see Chapter 
3), whereas in the current study, there was only a minimal effect of hypothermia on 
gut glutathione concentration, suggesting that the decrease in glutathione occurs 
during ischaemia or early reperfusion, and that glutathione is not fundamental in 
the mechanism of protection. Prevention of oxidative stress following I/R may 
depend more on decreased free radical production than on increased antioxidant 
potential. 
Hepatic failure is a component of multiple organ failure following intestinal 
reperfusion injury, and it has been shown that development of liver energy failure 
immediately precedes death of animals undergoing intestinal I/R (Exon et al, 
1975), suggesting coupling of hepatic energy status to multiple organ failure. 
Maintenance of ATP production is key to an organ with a high metabolic activity 
such as the liver (Jaeschke et al, 2003), and decrease of hepatic ATP levels is an 
early indicator of liver injury and a predictor of outcome in acute liver failure in 
rats (Corbin et al, 2003). Rescue hypothermia completely prevented development 
of hepatic energy failure observed after two hours of normothermic reperfusion.. 
This protective effect could be due to improvement in hepatic haemodynamics: 
during intestinal reperfusion, total hepatic blood inflow is reduced by 
approximately 66% mostly due to a reduction in arterial blood supply, which 
would contribute to hepatic dysfunction (Turnage et al, 1996). Alternative 
mechanisms possibly responsible for hepatic protection include inhibition of pro-
apoptotic and pro-inflammatory transcriptional factors, which are modulated by 
hypothermia when applied throughout intestinal ischaemia and reperfusion 
(Parkinson et al, 2004). 
Propagation of a systemic inflammatory response from gut and liver to other 
organs could be mediated via cytokines or other factors (Oberholzer et al, 2000). In 
these experiments, hypothermia did not reduce systemic TNF-levels, although I 
did not measure other cytokines. Activation of nitric oxide synthase and/or 
endothelium are crucial aspects of a systemic inflammatory response, and 
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increased nitric oxide production is associated with organ failure (Doughty et al, 
1998; Brealey et al, 2004) and poor outcome (Brealey et al, 2002; Langouche et al, 
2005). Systemic nitric oxide production was greatly increased by intestinal I/R, and 
this increase was prevented by hypothermic reperfusion. Although the role of NO 
during intestinal reperfusion is multi-faceted and includes beneficial effects such as 
reduction of leukocyte adhesion and vasodilatation (Kalia et al, 2001; Horie et al, 
1998), overproduction of NO is deleterious and leading to formation of 
peroxynitrite (Cuzzocrea et al, 2000). 
Compromise of respiratory function due to capillary leak and pulmonary 
oedema is frequent following intestinal I/R (Harward et al, 1993). Lung neutrophil 
infiltration is a major determinant of microvascular leak following intestinal 
reperfusion (Kadesky et al, 1995; Koike et al, 1995; Terada et al, 1992) and acute 
respiratory distress syndrome (Pugin et al, 1999; Ishizaka et al, 2001; Steinberg et 
al, 1994),  contributing to capillary leak by producing reactive oxygen species, 
proteolytic enzymes, and a range of mediators that enhance the inflammatory 
response (Ley, 2004; Hansen, 1995). Rescue hypothermia dramatically decreased 
pulmonary neutrophil infiltration, potentially preventing development of 
respiratory failure. Although free radical production by neutrophils contributes to 
the development of oxidative stress, reduction in pulmonary neutrophil infiltration 
by rescue hypothermia was not associated with decreased lipid peroxidation, 
suggesting that other sources of reactive species  are unaffected by hypothermia. 
Primary respiratory failure with impaired gas exchange could have 
contributed to progressive deterioration of cardiovascular function despite 
adequate ventilatory support. However, other mechanisms could also be 
responsible for the observed development of cardiovascular derangement. Primary 
dysfunction of both myocardial contraction and relaxation has been reported 
following intestinal I/R, and this can be prevented by free-radical scavengers and 
inhibitors of neutrophil adherence (Horton et al, 1991; Horton et al, 1993a; Horton 
et al, 1993b). Although in my previous experiments cardiac energy failure does not 
occur within 2 hours of reperfusion (see Chapter 3), I have previously shown that 
CPT activity, crucial for the control of mitochondrial utilisation of fatty acids (the 
major fuel source for the myocardium) is decreased following intestinal I/R (see 
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Chapter 4) and sepsis (Fukumoto et al, 2002a) due to peroxynitrite (Fukumoto et 
al, 2004). Total CPT activity was decreased by I/R at normothermia, and this effect 
was prevented by rescue hypothermia, which would allow a normal rate of fatty 
acid oxidation and could help to prevent later cardiac energy failure.  
In the current experiment, I measured total CPT activity (i.e. CPT I plus CPT 
II) as hearts were frozen before analysis, making it impossible to evaluate CPT I 
and CPT II activity separately. In previous experiments, CPT I activity was 
measured separately from CPT II, and a decrease in CPT I activity with unaltered 
CPT II activity was found (see Chapter 4; Fukumoto et al, 2004; Fukumoto et al, 
2002a). It is therefore likely that changes in total CPT activity in the current study 
reflect changes in CPT I rather than CPT II activity. 
 
5.5 CONCLUSIONS 
 
This study demonstrates that whole-body moderate hypothermia applied as a 
rescue therapy at the beginning of reperfusion improves outcome and prevents 
cardiovascular failure in a rat model of acute intestinal ischaemia and reperfusion 
injury. Importantly, hypothermia did not appear to just delay cardiovascular 
failure, as rewarmed rats also survived to the end of experiment. Investigation of 
the early reperfusion phase showed that protection provided by rescue hypothermia 
could result from the modulation of several different pathways involved in 
determining not only injury to the reperfused ileum, but also multiple organ 
dysfunction syndrome. Rescue hypothermia proved a robust method to prevent 
development of energy failure in the liver, systemic overproduction of nitric oxide, 
infiltration of inflammatory cells in the lungs and impaired cardiac fatty acid 
utilisation. These observations suggest that moderate hypothermia could 
potentially be beneficial as a treatment for clinical conditions associated with acute 
intestinal I/R injury, even when initiated after the ischaemic insult has been 
established. 
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Figure 5.1. Core body temperature during the cooling phase. 
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Core body temperature of rats in the hypothermia groups (n=18) during the 
cooling phase. Cooling was started at the onset of reperfusion, and target 
temperature (dotted line) was reached within 30min in all animals. Data are 
reported as mean  SEM. 
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Figure 5.2.  Survival of experimental animals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Animals (n=6 per group) underwent sham operation (Control) or intestinal 
ischaemia and reperfusion (I/R) at either normothermia (Normothermia) or 
moderate hypothermia (Hypothermia) with or without rewarming. Survival time is 
calculated from the beginning of reperfusion; results were compared by Log rank 
test.  
* I/R Normothermia: p=0.0005 vs. Control Normothermia; p=0.0005 vs. Control 
Hypothermia; p=0.0005 vs. I/R Hypothermia; p=0.0005 vs. I/R Hypothermia 
with Rewarming. 
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Figure 5.3. Mean arterial pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Mean arterial pressure (MAP) was measured invasively in the right femoral 
artery. Animals (n=6 per group) underwent: sham operation at normothermia 
(Control Normothermia) [A]; sham operation at hypothermia (Control 
Hypothermia) [B]; intestinal ischaemia and reperfusion at normothermia (I/R 
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Normothermia) [C]; intestinal ischaemia and reperfusion at moderate hypothermia 
(I/R Hypothermia) [D]; or intestinal ischaemia and reperfusion at moderate 
hypothermia with rewarming (I/R Hypothermia with Rewarming) [E]. MAP is 
expressed as mmHg. Results are reported as mean  SEM and were compared by 
repeated measurements ANOVA with Bonferroni post hoc test.  
* P<0.05 vs. baseline. 
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Figure 5.4. Heart rate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Heart rate was measured invasively in the right femoral artery. Animals (n=6 
per group) underwent: sham operation at normothermia (Control Normothermia) 
[A]; sham operation at hypothermia (Control Hypothermia) [B]; intestinal 
ischaemia and reperfusion at normothermia (I/R Normothermia) [C]; intestinal 
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ischaemia and reperfusion at moderate hypothermia (I/R Hypothermia) [D]; or 
intestinal ischaemia and reperfusion at moderate hypothermia with rewarming (I/R 
Hypothermia with Rewarming) [E]. Heart rate is expressed as beats per minute 
(bpm). Results are reported as mean  SEM and were compared by repeated 
measurements ANOVA with Bonferroni post hoc test.  
* P<0.05 vs. baseline. 
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Figure 5.5.  Histological injury in the ileum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Grade of histological injury in the ileum (5=maximum, 1=minimum). 
Animals (n=8 per group) underwent sham operation (Control) or intestinal 
ischaemia and reperfusion (I/R) at either normothermia (Normothermia) or 
moderate hypothermia (Hypothermia) with or without rewarming. Results were 
compared using Kruskal-Wallis with Dunn’s multiple comparison test.  
*  I/R Normothermia: p<0.01 vs. Control Normothermia, p<0.01 vs. Control 
Hypothermia 
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Figure 5.6. Histological appearance of terminal ileum.  
 
 
 
Specimens of terminal ileum were stained with haematoxylin and eosin and 
are from: Control Normothermia [A]; I/R Normothermia [B]; Control Hypothermia 
[C]; I/R Hypothermia [D]. Magnification is x100. 
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 Figure 5.7.  Neutrophil infiltration in ileum and lungs. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Neutrophil infiltration, assessed as myeloperoxidase activity (MPO) in ileum 
[A], and lungs [B]. Animals (n=8 per group) underwent sham operation (Control) 
or intestinal ischaemia and reperfusion (I/R) at either normothermia 
(Normothermia) or moderate hypothermia (Hypothermia). Results are reported as 
mean  SEM; one-way ANOVA with Tukey post hoc test was used for group 
comparison.  
[A]: * I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia; p<0.001 vs. I/R Hypothermia. 
[B]: * I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia; p=0.004 vs. I/R Hypothermia. 
  †  I/R Hypothermia: p=0.024 vs. Control Normothermia. 
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Figure 5.8.  Malondialdehyde concentration in plasma, ileum, lungs and 
heart. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of malondialdehyde (MDA) in plasma [A], ileum [B], lungs 
[C], and heart [D]. Animals (n=8 per group) underwent sham operation (Control) 
or intestinal ischaemia and reperfusion (I/R) at either normothermia 
(Normothermia) or moderate hypothermia (Hypothermia). Concentration of MDA 
is expressed as μmol/l for plasma, and as nmol/mg protein for ileum, lungs and 
heart. Results are reported as mean  SEM. One-way ANOVA with Tukey post 
hoc test was used for group comparison. 
[A]: * I/R Normothermia: p=0.011 vs. Control Normothermia; p=0.015 vs. 
Control Hypothermia.  
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 †  I/R Hypothermia: p=0.023 vs. Control Normothermia; p=0.031 vs. 
Control Hypothermia.  
[B]: * I/R Normothermia: p=0.001 vs. Control Normothermia; p=0.001 vs. 
Control Hypothermia. 
[C]: * I/R Normothermia: p=0.041 vs. Control Normothermia 
 † I/R Hypothermia: p=0.006 vs. Control Normothermia. 
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Figure 5.9.  Glutathione concentration in ileum. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of reduced (GSH) [A], oxidised (GSSG) [B], and total 
(calculated as GSH + 2*GSSG) [C] glutathione, and glutathione redox state 
(calculated as GSH/2*GSSG) [D] in ileum. Animals (n=8 per group) underwent 
sham operation (Control) or intestinal ischaemia and reperfusion (I/R) at either 
normothermia (Normothermia) or moderate hypothermia (Hypothermia). 
Concentrations of GSH, GSSG and total glutathione are expressed as nmol/g wet 
weight. Results are reported as mean  SEM; one-way ANOVA with Tukey post 
hoc test was used for group comparison.  
[A]: * I/R Normothermia: p=0.004 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia. 
  † I/R Hypothermia: p=0.001 vs. Control Hypothermia.  
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[B]: * I/R Normothermia: p=0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia. 
[C]: * I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia. 
  †  I/R Hypothermia: p=0.034 vs. Control Normothermia; p=0.001 vs. 
Control Hypothermia. 
 Chapter 5: Moderate Hypothermia as a Rescue Treatment for Adult Intestinal I/R Injury 
 180
Figure 5.10. Concentration of nitrate plus nitrite in plasma. 
 
 
 
 
 
 
 
 
 
 
 
 
Systemic production of nitric oxide measured as concentration of nitrate plus 
nitrite in plasma. Animals (n=8 per group) underwent sham operation (Control) or 
intestinal ischaemia and reperfusion (I/R) at either normothermia (Normothermia) 
or moderate hypothermia (Hypothermia). Data are expressed as μmol/l and results 
are reported as mean  SEM. One-way ANOVA with Tukey post hoc test was used 
for group comparison.  
*  I/R Normothermia: p=0.014 vs. Control Normothermia. 
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Figure 5.11. Correlation between nitrate plus nitrite and malondialdehyde 
concentration in plasma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Correlation between nitrate plus nitrite (expressed as μmol/l) and 
malondialdehyde (MDA, expressed as μmol/l) in plasma (linear regression analysis 
indicated a correlation with r2=0.2085; p=0.0086).  
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Figure 5.12. Concentration of TNF-α in plasma. 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of TNF-α in plasma. Animals (n=8 per group) underwent sham 
operation (Control) or intestinal ischaemia and reperfusion (I/R) at either normothermia 
(Normothermia) or moderate hypothermia (Hypothermia). Data are expressed as pg/l and 
results are reported as mean  SEM. One-way ANOVA with Tukey post hoc test was 
used for group comparison. 
*  I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. Control 
Hypothermia. 
†  I/R Hypothermia: p=0.018 vs. Control Normothermia; p=0.032 vs. Control 
Hypothermia.  
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Figure 5.13. Concentration of phosphoenergetics and energy charge in liver. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of ATP [A], ADP [B], AMP [C], total adenine nucleotides 
(calculated as ATP+ADP+AMP) [D], and inorganic phosphate [E], and energy charge 
(calculated as [(ATP+½ADP)/(ATP+ADP+AMP)]) [F] in liver. Animals (n=8 per group) 
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underwent sham operation (Control) or intestinal ischaemia and reperfusion (I/R) at either 
normothermia (Normothermia) or moderate hypothermia (Hypothermia). Concentrations 
of ATP, ADP, AMP, total adenine nucleotides, and inorganic phosphate are expressed as 
mol/g wet weight and results are reported as mean  SEM. One-way ANOVA with 
Tukey post hoc test was used for group comparison. 
[A]: * I/R Normothermia: p=0.002 vs. Control Normothermia; p=0.001 vs. Control 
Hypothermia; p=0.013 vs. I/R Hypothermia. 
[C]: * I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. Control 
Hypothermia; p<0.001 vs. I/R Hypothermia. 
[E]: * I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. Control 
Hypothermia; p<0.001 vs. I/R Hypothermia. 
[F]:  * I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. Control 
Hypothermia; p<0.001 vs. I/R Hypothermia.  
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Figure 5.14. Total carnitine palmitoyl transferase in the heart. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total carnitine palmitoyl transferase (CPT) activity in the heart. Animals 
underwent sham operation (Control) or intestinal ischaemia and reperfusion (I/R) 
at either normothermia (Normothermia) or moderate hypothermia (Hypothermia). 
Data are expressed as mmol/min/U citrate synthase (CS) and results are reported as 
mean  SEM. One-way ANOVA with Tukey post hoc test was used for group 
comparison.  
* I/R Normothermia: p=0.009 vs. Control Normothermia; p<0.001 vs. Control 
Hypothermia; p<0.001 vs. I/R Hypothermia. 
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MODERATE HYPOTHERMIA AS A RESCUE 
TREATMENT FOR INFANT INTESTINAL  
ISCHAEMIA AND REPERFUSION INJURY 
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CHAPTER 6 
 
MODERATE HYPOTHERMIA AS A RESCUE TREATMENT FOR 
INFANT INTESTINAL ISCHAEMIA AND REPERFUSION INJURY 
 
6.1 BACKGROUND 
 
Previous reports have shown that moderate hypothermia improves survival in 
adult animals when applied during both the ischaemic and the reperfusion phase 
(see Chapter 3; Vejchapipat et al, 2001; Kalia et al, 2002b). Interestingly, this 
hypothermic protection appears to be mediated by preventing  MODS through 
reduction in lung neutrophil infiltration (Vinardi et al, 2003), prevention of liver 
bioenergetic failure (Vejchapipat et al, 2001), preservation of myocardial energy 
metabolism (see Chapter 3) as well as decreased oxidative stress in plasma, lungs 
and kidneys (see Chapter 3). However, in the clinical scenario of neonatal and 
paediatric conditions associated with intestinal I/R, therapy can usually only be 
applied after the ischaemic insult has occurred, and any potential treatment should 
therefore prove to be effective when initiated as a rescue during the reperfusion 
phase. In Chapter 5, I have shown that the beneficial effects of hypothermia are 
preserved even when applied as a rescue at reperfusion in an adult animal model. 
Although little is known regarding gut I/R injury in developing animals, it has been 
highlighted that the response to a reduced mesenteric flow is substantially different 
in neonates or infants compared with adults (Luo et al, 2004; Nankervis et al, 
2000; Crissinger et al, 1989), suggesting that the beneficial effects of hypothermia 
observed in adults may not apply to developing animals.  
Aim of the current study was therefore to investigate the effects of moderate 
hypothermia applied as a rescue therapy in an infant model of mesenteric 
ischaemia and reperfusion. 
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6.2 MATERIAL AND METHODS 
 
6.2.1 Study design 
 Suckling mixed-sex Sprague-Dawley rats of 11-13 days of age weighing 
between 18 and 30g were used. The suckling rats were kept with their dams and 
allowed to suckle freely until anaesthetised. The family groups were kept under 
standard conditions for food, light and temperature. 
  
Study A 
Animals were randomly assigned to one of four experimental groups (n=8 
per group): 
A) Control Normothermia: sham operation and observation for 285min at 
normothermia  
B) I/R Normothermia: 45min intestinal ischaemia at normothermia, followed by 
240min normothermic reperfusion  
C) I/R Hypothermia: 45min intestinal ischaemia at normothermia, followed by 
240min hypothermic reperfusion 
D) I/R Hypothermia with Rewarming: 45min intestinal ischaemia at 
normothermia, followed by 120min hypothermic reperfusion, and 120min 
rewarming 
 
Study B 
 Animals were randomly assigned to one of four experimental groups (n=10 
per group): 
A) Control Normothermia: sham operation and observation for 135min at 
normothermia  
B) I/R Normothermia: 45min intestinal ischaemia at normothermia, followed by 
90min normothermic reperfusion  
C) Control Hypothermia: sham operation and observation; 45min at 
normothermia, followed by 90min at hypothermia 
D) I/R Hypothermia: 45min intestinal ischaemia at normothermia, followed by 
90min hypothermic reperfusion 
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Rectal temperature was monitored continuously throughout the experiment 
from induction of anaesthesia. Normothermia [rectal temperature between 34 and 
36°C, which represents the physiological range for suckling rats of this age (Bertin 
et al, 1993)] was maintained by use of a heating blanket and lamp as described in 
Chapter 2. Moderate hypothermia (rectal temperature between 30 and 32ºC) was 
induced at the beginning of reperfusion by cooling the animals with a fan in an 
environmental temperature of 22 to 23ºC; target temperature (32ºC) was reached 
within 12min (median 7min, Figure 6.1), and warming applied as necessary to 
prevent excessive cooling. Rewarming was achieved in the I/R Hypothermia with 
Rewarming group over 30min and animals maintained between 34 and 36°C until 
the end of the experiment.  
 
6.2.2 Surgical Procedure 
General anaesthesia was induced and maintained by inhalation of isoflurane 
in an oxygen and nitrous oxide mixture in spontaneously breathing animals as 
described in Chapter 2. 
 Mesenteric ischaemia and reperfusion and sham operation were performed 
under microscopic view as discussed in Chapter 2.  
Immediately after closure of the abdomen, the right femoral vessels were 
exposed through a longitudinal incision, a 0.16mm polyimide catheter (Cole-
Parmer, Vernon Hills, IL, USA) was inserted in the right femoral vein, and 5ml/kg 
normal saline was infused.  
At the end of ischaemia time, the abdominal wound was re-opened and 
reperfusion was performed as described in Chapter 2.  
 
Study A 
Fluid resuscitation with 0.9% normal saline was administered through the 
right femoral vein in animals from all groups with 5ml/kg boluses after 60, 120, 
and 180min from the beginning of reperfusion.   
Survival was then monitored for up to 240min from the onset of reperfusion, 
and experimental animals were considered dead after 5min of uninterrupted 
cardiorespiratory arrest. Survival time from the beginning of reperfusion was 
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recorded, and animals that were still alive at the end of the experiment were killed 
by exsanguination under terminal anaesthesia. 
In a preliminary set of experiments during the setup of the animal model, I 
attempted to insert an arterial line for continuous measurement of heart rate and 
blood pressure as described in adult animals (see Chapter 5). After exposing the 
femoral vessels through a longitudinal incision, a 0.16mm polyimide catheter was 
inserted into the femoral artery, and connected to a transducer. Unfortunately, the 
very small internal diameter of the catheter resulted in a high resistance system 
with unreliable measurements of both blood pressure and heart rate. An additional 
attempt was made to cannulate the abdominal aorta at the bifurcation with a 26G 
cannula (BD Neoflon, Helsinborg, Sweden), which resulted in exsanguination of 
the animals. Invasive measurement of haemodynamics was therefore not 
performed in the experimental animals of Study A and B. 
 
Study B 
 Rats were resuscitated with 0.9% normal saline through the right femoral 
vein with 5ml/kg each after 5 and 60min from the onset of reperfusion.   
One min before the end of the experiment, animals were heparinised by 
infusion of 1,000 IU/kg sodium heparin (Sigma-Aldrich Co., Poole, UK) in 5ml/kg 
0.9% saline via the femoral line. Animals were sacrificed by exsanguination under 
terminal anaesthesia.  
 
6.2.3 Tissue extraction and metabolite measurement 
At sacrifice, a liver sample was freeze-clamped in liquid nitrogen for 
measurements of phosphoenergetics. A blood sample was collected from the 
thorax, transferred into a heparin tube and centrifuged (3,000rpm for 5min at 4ºC), 
and plasma was stored at -70°C until analysis. Small intestine (10-25cm from the 
ileocaecal valve) and lungs were also removed and stored at -70°C. Terminal ileum 
(5 to 10cm from the ileocaecal valve) was fixed in 10% neutral buffered 
formaldehyde for 24 hours and embedded in paraffin. 
Liver phosphoenergetics were quantified by HPLC. Myeloperoxidase 
activity in ileum and lungs was measured by spectrophotometry. Levels of 
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malondialdehyde in terminal ileum, lungs and heart were determined by HPLC. 
The concentration of reduced and oxidised glutathione in ileum was measured by 
HPLC. Plasma concentration of nitrate plus nitrite, reflecting systemic production 
of nitric oxide, was quantified by HPLC. Determination of phosphoenergetics, 
MDA, glutathione, nitrate plus nitrite was performed as described in Chapter 2. 
Haematoxylin and eosin staining, and immunostaining for P-Selectin, and 
ICAM-1 were performed on 5m sections from paraffin embedded samples of 
terminal ileum as described in Chapter 2. The degree of histological injury and the 
level of expression of each adhesion molecule were assessed semi-quantitatively as 
specified in Chapter 2. 
 
6.2.4 Statistical analysis 
Survival from the beginning of reperfusion is expressed as median [range], 
and results compared by Kaplan-Meier logrank test. Data regarding the severity of 
histological injury and expression of adhesion molecule in the ileum are expressed 
as median [range]; comparison between the groups was by Kruskal-Wallis with 
Dunn’s post-test. All other data are expressed as means  SEM, and one-way 
analysis of variance (ANOVA) with Tukey post-test was used for group 
comparison. Results showing p values <0.05 were considered significant.  
 
6.3 RESULTS 
 
Study A 
6.3.1 Survival 
Animals receiving sham operation were all still alive after 240min of sham 
reperfusion, whereas animals undergoing normothermic I/R developed tachycardia 
and tachypnoea during reperfusion, which became progressively more severe and 
were followed by death of all experimental rats after 119min from the beginning of 
reperfusion [range 82-145min] (p<0.0001 vs. Control Normothermia, Figure 6.2). 
However, hypothermia applied at the beginning of reperfusion delayed the 
development of tachycardia and tachypnoea, and significantly increased survival 
time to 224min [187-240min]. Interestingly, hypothermic protection persisted in 
 Chapter 6: Moderate Hypothermia as a Rescue Treatment for Infant Intestinal I/R Injury 
 192
animals undergoing rewarming after 120min hypothermic reperfusion: no signs of 
distress developed during rewarming and half of the animals in this group were 
still alive at the end of the experiment, with a median survival of 233min [169-
240min]. 
 
Study B 
6.3.2 Histological injury in ileum 
Samples from all control animals at either normothermia or hypothermia 
showed completely preserved intestinal architecture, with villi of appropriate 
length and an intact epithelial layer even at the tip of the villi (Figure 6.3, 6.4 A, 
6.4 C). Although tissue injury developed as a consequence of reperfusion in all 
samples from I/R rats at both normothermia and hypothermia (Figure 3), in both 
groups disruption was limited to the epithelium and the core of the villi, whereas 
the crypts, the lamina propria and the submucosa appeared virtually unaffected, 
and no signs of conspicuous haemorrhage or spontaneous perforation were visible 
(Figure 6.4 B, 6.4 D). 
 
6.3.3 P-Selectin expression 
P-Selectin expression was not detectable in most specimens from 
normothermic and hypothermic controls, with absent or only weak staining visible 
on a limited number of vessels in the remaining samples (Figure 6.5, 6.6 A). 
However, substantial upregulation of P-Selectin was observed following intestinal 
reperfusion at both normothermia and hypothermia (Figure 6.5): immunostaining 
was particularly intense in medium-sized vessels of the submucosa, with positive 
vessels located throughout the specimens (Figure 6.6 B).  
 
6.3.4 ICAM-1 expression 
A similar pattern of expression was observed for ICAM-1, with weak 
constitutive expression on scattered blood vessels of the submucosa in animals 
subjected to sham operation (Figure 6.7, 6.8 A). Intestinal reperfusion at 
normothermia caused a marked increase in ICAM-1 expression (Figure 6.7), 
mostly on medium sized vessels but also on the microcirculation of the submucosa 
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(Figure 6.8 B, 6.8 C). ICAM-1 expression was similarly intense and similarly 
distributed following hypothermic reperfusion (Figure 6.7).  
 
6.3.5 Neutrophil infiltration  
Intestinal reperfusion at normothermia was characterised by a marked 
increase in the number of neutrophils infiltrating both the ileum (Figure 6.9 A) and 
the lungs (Figure 6.9 B) as assessed by myeloperoxidase activity. However, 
moderate hypothermia applied at reperfusion completely prevented this migration 
of inflammatory cells not only in the gut, but also in the lungs. 
 
6.3.6 Lipid peroxidation  
Concentrations of MDA in plasma, ileum and lungs were significantly higher 
in I/R rats at normothermia as compared to controls (Figure 6.10), suggesting that 
reperfusion of the ileum at normothermia greatly enhanced lipid peroxidation of 
biological membranes. Rescue hypothermia effectively reduced the extent of lipid 
peroxidation in both lungs (Figure 6.10 C) and plasma (Figure 6.10 A), although 
the high levels of MDA found in the ileum of hypothermic IR animals (Figure 6.10 
B) indicate that lipid peroxidation was unaffected in the gut. 
 
6.3.7 Glutathione content 
The depletion of reduced glutathione levels (Figure 6.11 A) together with the 
decrease in glutathione redox state (Figure 6.11 D) observed in the ileum following 
I/R at normothermia  reflect the loss of reducing equivalents due to the 
development of oxidative stress associated with normothermic reperfusion. In 
addition, reduced levels of oxidised (Figure 6.11 B) and total glutathione (Figure 
6.11 C) in this group  imply irreversible degradation of glutathione caused by high 
amounts of free radicals produced during reperfusion of the gut (Gibson et al, 
1993). Although rescue moderate hypothermia did not affect consumption of the 
pool of total glutathione, nor it abolished oxidation of reduced glutathione in the 
intestine, it prevented the drop in glutathione redox state. No differences in 
glutathione levels or redox state were seen in the lungs (Figure 6.12). 
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6.3.8 Systemic nitric oxide production 
Intestinal I/R at both normothermia and hypothermia induced a similar 
increase in systemic NO synthesis as measured by plasma nitrate plus nitrite 
concentration (Figure 6.13). Once again, a significant positive correlation was 
found between nitrate plus nitrite levels and malondialdehyde in plasma 
(r2=0.1700; p=0.0091, Figure 6.14) 
 
6.3.9 Liver phosphoenergetics 
Normothermic intestinal I/R was also associated with a slight (although non-
significant) decrease in hepatic ATP levels (Figure 6.15 A), and a marked increase 
in the concentrations of liver ADP, AMP, and inorganic phosphate (Figure 6.15 B; 
Figure 6.15 C; Figure 6.15 E respectively), suggesting a reduction in the 
availability of high energy phosphates. Development of hepatic energy failure was 
confirmed by the fall in energy charge in the liver following normothermic 
intestinal I/R (Figure 6.15 F). However, rescue moderate hypothermia prevented 
the occurrence of hepatic energy failure: in hypothermic I/R rats AMP and 
inorganic phosphate levels did not increase, and most importantly energy charge 
was restored to normal levels. Finally, the total concentration of adenine 
nucleotides was similar in the different groups (Figure 6.15 D), indicating that, as 
expected, no consumption of the total pool of adenine nucleotides occurred due to 
either I/R injury or temperature.  
 
6.4 DISCUSSION 
 
Despite the high relevance to paediatric clinical practice, characterisation of 
intestinal I/R injury in developing animals has been scarcely investigated, and only 
a few studies have been published regarding therapeutic interventions that could 
improve outcome in this setting (Chan et al, 2002; Lelli, Jr. et al, 1993). The 
present study shows that moderate hypothermia significantly improves survival 
when applied as a rescue at the beginning of reperfusion, and that these benefits are 
maintained even after rewarming. These findings are particularly interesting in 
view of potential clinical application, since they suggest that hypothermia could be 
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advantageous when applied to clinical conditions where the ischaemic insult has 
already occurred at the time of diagnosis.  
The improvement in survival observed in hypothermic animals undergoing 
rewarming after hypothermic reperfusion is also of significant clinical relevance. 
Rewarming is a crucial phase which can lead to cardiocirculatory instability, or can 
cause a rebound systemic inflammatory response (Thoresen et al, 2000). Although 
very little is known regarding the consequences of rewarming following 
mesenteric reperfusion, experiments in adult rats have shown that rewarming does 
not affect outcome when hypothermia is applied from the beginning of ischaemia 
(see Chapter 5; Kalia et al, 2002b), and I have confirmed these findings in 
developing rats. 
My results also indicate that protection afforded by rescue hypothermia is 
exerted early during the reperfusion phase, since no additional benefit in survival 
was observed in rats maintained hypothermic for the whole duration of reperfusion 
as compared to those who underwent rewarming after 120min of hypothermic 
reperfusion. Investigation of the early reperfusion phase showed that hypothermia 
effectively minimised injury to vital organs such as lungs and liver, suggesting that 
prevention of MODS could account for this improved outcome. Such beneficial 
effects could derive from direct protection of distant organs, or they may result 
from the reduction of systemic inflammatory response elicited in the intestine. 
The respiratory system is most frequently affected in clinical conditions 
associated with intestinal I/R in both neonates (Morecroft et al, 1994a; Sonntag et 
al, 1998) and adults (Harward et al, 1993), and experimental models have shown 
that development of respiratory failure is closely correlated with mortality  
following intestinal I/R (Ito et al, 2005). In our infant animal model, mesenteric 
reperfusion caused both migration of neutrophils and accumulation of lipid 
peroxidation end-products into the lungs, suggesting the presence of a conspicuous 
pulmonary inflammatory reaction accompanied by a state of oxidative stress. 
Application of hypothermia at reperfusion completely abolished sequestration of 
neutrophils, which is a crucial event in the establishment of lung injury and 
respiratory failure following intestinal I/R (Ito et al, 2005; Schmeling et al, 1989). 
Indeed, priming and infiltration of circulating neutrophils into the lungs results in 
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damage to the pulmonary alveolar capillary bed, with endothelial cell injury and 
increased vascular permeability (Koike et al, 1995; Schmeling et al, 1989).  
The development of oxidative damage to DNA, proteins, and lipids induced 
by overproduction of reactive oxygen species has also been shown to play a pivotal 
role in the pathogenesis of pulmonary failure during intestinal reperfusion (Galili et 
al, 1998), which can be prevented by administration of free radical scavengers such 
as edaravone (Ito et al, 2005), methylene blue (Galili et al, 1998), and FeTMPyP 
(Chapter 4). Oxidative stress was prevented by hypothermia in the current study, as 
suggested by levels of lipid peroxidation end-product MDA. This is more likely to 
be due to a reduced free radical production rather than to an increase in antioxidant 
defences, since no difference was observed in pulmonary levels of the major 
antioxidant glutathione. In fact, inflammatory cells are known to be one of the 
main sources of reactive oxygen species following reoxygenation of ischaemic 
tissue (Cuzzocrea et al, 2001b), and the concomitant reduction in pulmonary 
neutrophil infiltrate could contribute to explain the decreased extent of oxidative 
stress observed in hypothermic rats.  
Interestingly, intestinal concentrations of reduced appeared to be 
significantly lower in my infant rat model (approximately 150 nmol/g wet weight 
in normothermic controls) as compared to adult rats (approximately 220 nmol/g 
wet weight in normothermic controls, see Chapter 5). Glutathione redox state in 
the ileum was also significantly lower in newborn animals (approximately 0.4 in 
normothermic control infants vs. 2.7 in mormothermic control adults, see Chapter 
5). This age-dependent increase of glutathione antioxidant system seems to be 
supported by the findings of both lower levels of reduced glutathione and 
glutathione redox state in human plasma from newborns and infants compared to 
older children and adults (Di Giuseppe at al, 2004). Although the reasons for these 
differences are unclear, experimental evidence suggests that lower levels of tissue 
glutathione and glutathione peroxidase activity  in newborn rats compared to adults 
may reflect an enhanced tissue oxidative capacity in adults compared to newborns 
(Lattari et al, 1997). 
Rescue hypothermia did not affect nitrosative stress following normothermic 
ischaemia in my animal model of neonatal mesenteric reperfusion injury, as 
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instead is the case for adult animals (see Chapter 5). This may reflect the numerous 
differences in nitric oxide metabolism and function between the neonatal and adult 
period (including the different plasma levels of nitrate plus nitrite measured in 
infant and adult animals) or alternatively it could depend on the different time 
frame adopted between my adult and neonatal model. Baseline levels of nitrate 
plus nitrite averaged 50mol/L in control adult rats (see Chapter 5), and more than 
twice in infant rats in the current experiment.  This finding is consistent with the 
higher production of nitric oxide previously reported in human infants compared to 
adults, as assessed by measurement of urinary nitrate excretion (Honold et al, 
2000). Hepatic failure is a common complication of conditions associated with 
mesenteric reperfusion, and is observed in up to 44% of neonates with NEC 
(Sonntag et al, 1998). In my animal model, profound liver energy failure developed 
in the early phase of normothermic reperfusion of the ileum. This is an early 
marker of hepatic injury and an accurate predictor of survival in rats with acute 
liver failure (Corbin et al, 2003). It has been previously shown that therapeutic 
hypothermia applied from the beginning of mesenteric ischaemia improves 
survival by preventing hepatic energy failure (Vejchapipat et al, 2001), and this has 
been confirmed when hypothermia is applied as a rescue at reperfusion in adult rats 
(Chapter 5). The present study shows that the same protection on liver energy 
status can be achieved in infant animals when hypothermia is applied during 
reperfusion only. A reduced energy requirement during hypothermia could explain 
the maintenance of an adequate energy charge (Jalan et al, 1999), which is crucial 
in an organ with a high metabolic activity such as the liver (Jaeschke et al, 2003). 
In addition, preservation of hepatic energy status could result from down-
regulation of pro-inflammatory and pro-apoptotic transcription factors (Parkinson 
et al, 2004) or from maintenance of an adequate hepatic blood inflow during 
reperfusion (Turnage et al, 1996).  
Although hypothermia did not protect from the development of histological 
injury in the reperfused gut, which was characterised by a profound disruption in 
tissue architecture, it completely abolished neutrophil infiltration in the ileum. The 
reperfused intestine is known to act as a priming site for circulating neutrophils; 
activated neutrophils are then able to migrate through the endothelial barrier and 
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infiltrate the lung and other distant organs, inducing tissue injury by release of 
proteolytic enzymes and reactive oxygen species (Koike et al, 1992; Moore et al, 
1994). Our findings are consistent with this hypothesis and the prevention of 
inflammatory cell infiltrate and oxidative stress observed in the lungs could in fact 
be the consequence of a reduced neutrophil sequestration and priming in the gut, 
which could also account for the decreased extent of lipid peroxidation in plasma. 
This is supported by the finding that topical hypothermia applied during mesenteric 
ischaemia effectively reduces neutrophil priming in the gut in a canine model 
(Hassoun et al, 2003). Interestingly, this reduction in inflammatory cell infiltrate 
was not mediated by a down-regulation in expression of endothelial adhesion 
molecules expression, which is consistent with previous reports (Hill et al, 1992), 
and may result from a reduced production of chemoattractants or impaired 
chemotaxis by leukocytes (Fairchild et al, 2000; Kimura et al, 2002).  
Oxidative stress also developed in the ileum, as proved by the increase in 
lipid peroxidation and by the concomitant impairment of cellular antioxidant 
potential, which were not affected by changes in body temperature. Since the 
number of infiltrating neutrophils was reduced by hypothermia, and their activity is 
also predicted to be decreased at lower temperatures (Kimura et al, 2002), this state 
of oxidative stress is likely due to free radicals release by alternative sources 
including xanthine oxidase (Terada et al, 1992), mitochondria and other 
intracellular sites (Li et al, 2002).  
 
6.5 CONCLUSIONS 
 
In the current study, I have shown that total-body moderate hypothermia 
improves survival when applied as a rescue therapy after the end of ischaemia in 
an infant model of mesenteric reperfusion injury. Moreover, rewarming of 
hypothermic animals was uneventful and did not hamper the beneficial effects on 
survival achieved by hypothermic reperfusion. Rescue hypothermia prevented the 
development of multiple organ failure early during the reperfusion phase by 
minimising inflammatory cells infiltration in intestine and lungs, oxidative stress in 
plasma and lungs, and energy failure in the liver. These beneficial effects could 
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result from direct protection of vital organs such as lungs and liver, and/or from 
reduced priming of neutrophils in the gut. Our results suggest that therapeutic 
hypothermia could be beneficial in neonatal conditions characterised by mesenteric 
ischaemia and reperfusion injury, even when treatment is commenced after the 
ischaemic injury has been fully established.  
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Figure 6.1. Core body temperature during the cooling phase. 
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Core body temperature of rats in the hypothermia groups (n=16) during the 
cooling phase. Cooling was started at the onset of reperfusion, and target 
temperature (dotted line) was reached within 12min in all animals. Data are 
reported as mean  SEM. 
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Figure 6.2.  Survival of experimental animals. 
 
 
 
 
 
 
 
 
 
 
 
 
Animals (n=8 per group) underwent sham operation (Control) or intestinal 
ischaemia and reperfusion (I/R) at either normothermia (Normothermia) or 
moderate hypothermia (Hypothermia) with or without rewarming. Survival time is 
calculated from the beginning of reperfusion; results were compared by Kaplan-
Meier logrank test.  
* I/R Normothermia: p<0.0001 vs. Control Normothermia; p<0.0001 vs. I/R 
Hypothermia; p<0.0001 vs. I/R Hypothermia Rewarming. 
†  I/R Hypothermia: p=0.0085 vs. Control Normothermia. 
‡ I/R Hypothermia Rewarming: p=0.025 vs. Control Normothermia. 
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Figure 6.3.  Histological injury in ileum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Grade of histological injury in the ileum (5=maximum, 1=minimum). 
Animals (n=10 per group) underwent sham operation (Control) or intestinal 
ischaemia and reperfusion (I/R) at either normothermia (Normothermia) or 
moderate hypothermia (Hypothermia) with or without rewarming. Results were 
compared using Kruskal-Wallis with Dunn’s multiple comparison test.  
*  I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. Control 
Hypothermia. 
†  I/R Hypothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. Control 
Hypothermia. 
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Figure 6.4. Histological appearance of terminal ileum.  
 
 
 
Specimens of terminal ileum were stained with haematoxylin and eosin and 
are from: Control Normothermia [A]; I/R Normothermia [B]; Control Hypothermia 
[C]; I/R Hypothermia [D]. Magnification is x100. 
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Figure 6.5. P-Selectin expression in ileum.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Grade of P-Selectin expression in the ileum. Animals (n=10 per group) 
underwent sham operation (Control) or intestinal ischaemia and reperfusion (I/R) 
at either normothermia (Normothermia) or moderate hypothermia (Hypothermia) 
with or without rewarming. Results were compared using Kruskal-Wallis with 
Dunn’s multiple comparison test.  
*  I/R Normothermia: p<0.01 vs. Control Normothermia; p<0.05 vs. Control 
Hypothermia. 
†  I/R Hypothermia: p<0.05 vs. Control Normothermia. 
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Figure 6.6. Histological appearance of P-Selectin expression in ileum.  
 
 
 
Specimens of terminal ileum were immunostained for P-Selectin and 
counterstained with haematoxylin as described in Chapter 2. Specimens are from: 
Control Normothermia [A]; I/R Normothermia [B]. Magnification is x400. 
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Figure 6.7. ICAM-1 expression in ileum.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Grade of ICAM-1 expression in the ileum. Animals (n=10 per group) 
underwent sham operation (Control) or intestinal ischaemia and reperfusion (I/R) 
at either normothermia (Normothermia) or moderate hypothermia (Hypothermia) 
with or without rewarming. Results were compared using Kruskal-Wallis with 
Dunn’s multiple comparison test.  
*  I/R Normothermia: p<0.01 vs. Control Normothermia; p<0.01 vs. Control 
Hypothermia. 
†  I/R Hypothermia: p<0.05 vs. Control Normothermia; p<0.05 vs. Control 
Hypothermia. 
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Figure 6.8. Histological appearance of ICAM-1 expression in ileum. 
 
 
 
 
Specimens of terminal ileum were immunostained for ICAM-1 and 
counterstained with haematoxylin as described in Chapter 2. Specimens are from: 
Control Normothermia [A]; I/R Normothermia [B,C]. Magnification is x400. 
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Figure 6.9.  Neutrophil infiltration in ileum and lungs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neutrophil infiltration, assessed as myeloperoxidase activity (MPO) in ileum 
[A] and lungs [B]. Animals (n=10 per group) underwent sham operation (Control) 
or intestinal ischaemia and reperfusion (I/R) at either normothermia 
(Normothermia) or moderate hypothermia (Hypothermia). Results are reported as 
mean  SEM; one-way ANOVA with Tukey post hoc test was used for group 
comparison.  
[A]: *  I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia; p<0.001 vs. I/R Hypothermia. 
[B]: *  I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia; p<0.001 vs. I/R Hypothermia. 
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Figure 6.10. Malondialdehyde  concentration in plasma, ileum and lungs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of malondialdehyde (MDA) in plasma [A], ileum [B], and 
lungs [C]. Animals (n=10 per group) underwent sham operation (Control) or 
intestinal ischaemia and reperfusion (I/R) at either normothermia (Normothermia) 
or moderate hypothermia (Hypothermia). Concentration of MDA is expressed as 
μmol/l for plasma, and as nmol/mg protein for ileum and lungs. Results are 
reported as mean  SEM. One-way ANOVA with Tukey post hoc test was used for 
group comparison. 
[A]: * I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia; p=0.017 vs. I/R Hypothermia. 
[B]: * I/R Normothermia: p<0.001 vs. Control Normothermia; p=0.001 vs. 
Control Hypothermia. 
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  †  I/R Hypothermia: p=0.009 vs. Control Normothermia; p=0.032 vs. 
Control Hypothermia. 
[C]: * I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia; p=0.009 vs. I/R Hypothermia. 
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Figure 6.11.  Glutathione concentration in ileum. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of reduced (GSH) [A], oxidised (GSSG) [B], and total 
(calculated as GSH + 2*GSSG) [C] glutathione, and glutathione redox state 
(calculated as GSH/2*GSSG) [D] in ileum. Animals (n=10 per group) underwent 
sham operation (Control) or intestinal ischaemia and reperfusion (I/R) at either 
normothermia (Normothermia) or moderate hypothermia (Hypothermia). 
Concentrations of GSH, GSSG and total glutathione are expressed as nmol/g wet 
weight. Results are reported as mean  SEM; one-way ANOVA with Tukey post 
hoc test was used for group comparison.  
 [A]: * I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia. 
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 † I/R Hypothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia. 
[B]: * I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia. 
 † I/R Hypothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia. 
[C]: * I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia. 
 † I/R Hypothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. 
Control Hypothermia. 
[D]: * I/R Normothermia: p=0.028 vs. Control Normothermia. 
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Figure 6.12. Glutathione concentration in lungs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of reduced (GSH, Figure 16A), oxidised (GSSG, Figure 16B) 
and total (Figure 16C) glutathione, and glutathione redox state (Figure 16D) in 
lungs. Animals (n=10 per group) underwent sham operation (Control) or intestinal 
ischaemia and reperfusion (I/R) at either normothermia (Normothermia) or 
moderate hypothermia (Hypothermia). Concentrations of GSH, GSSG and total 
glutathione are expressed as nmol/g wet weight. Results are reported as mean  
SEM; one-way ANOVA with Tukey post hoc test was used for group comparison.  
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Figure 6.13. Concentration of nitrate plus nitrite in plasma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Systemic production of nitric oxide measured as concentration of nitrate plus 
nitrite in plasma. Animals (n=10 per group) underwent sham operation (Control) 
or intestinal ischaemia and reperfusion (I/R) at either normothermia 
(Normothermia) or moderate hypothermia (Hypothermia). Data are expressed as 
μmol/l and results are reported as mean  SEM. One-way ANOVA with Tukey 
post hoc test was used for group comparison.  
*  I/R Normothermia: p=0.008 vs. Control Normothermia. 
† I/R Hypothermia: p=0.013 vs. Control Normothermia. 
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Figure 6.14. Correlation between nitrate plus nitrite and malondialdehyde 
concentration in plasma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Correlation between nitrate plus nitrite (expressed as μmol/l) and 
malondialdehyde (MDA, expressed as μmol/l) in plasma after removal of one 
single outlier (linear regression analysis indicated a correlation with r2=0.1700; 
p=0.0091).  
 
0 100 200 300
0.0
0.5
1.0
1.5
2.0
2.5
3.0
Nitrate + nitrite (mol/l)
M
D
A
 (
m
ol
/l)
 Chapter 6: Moderate Hypothermia as a Rescue Treatment for Infant Intestinal I/R Injury 
 216
Figure 6.15. Concentration of phosphoenergetics and energy charge in liver. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of ATP [A], ADP [B], AMP [C], total adenine nucleotides 
(calculated as ATP+ADP+AMP) [D], and inorganic phosphate [E], and energy charge 
(calculated as [(ATP+½ADP)/(ATP+ADP+AMP)]) [F] in liver. Animals (n=10 per 
group) underwent sham operation (Control) or intestinal ischaemia and reperfusion (I/R) 
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at either normothermia (Normothermia) or moderate hypothermia (Hypothermia). 
Concentrations of ATP, ADP, AMP, total adenine nucleotides, and inorganic phosphate 
are expressed as mol/g wet weight and results are reported as mean  SEM. One-way 
ANOVA with Tukey post hoc test was used for group comparison. 
[B]: *  I/R Normothermia: p=0.014 vs. Control Normothermia. 
  † I/R Hypothermia: p=0.025 vs. Control Normothermia. 
[C]: *  I/R Normothermia: p<0.001 vs. Control Normothermia; p=0.001 vs. 
Control Hypothermia; p=0.008 vs. I/R Hypothermia. 
[E]: *  I/R Normothermia: p=0.002 vs. Control Normothermia; p=0.005 vs. Control 
Hypothermia; p=0.019 vs. I/R Hypothermia. 
[F]: *  I/R Normothermia: p<0.001 vs. Control Normothermia; p<0.001 vs. Control 
Hypothermia; p=0.016 vs. I/R Hypothermia.  
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CHAPTER 7 
ADHESION MOLECULE EXPRESSION AND INFLAMMATORY CELL 
INFILTRATE IN HUMAN NECROTIZING ENTEROCOLITIS 
 
7.1 BACKGROUND 
 
Despite advances in preventative strategies and clinical management, NEC 
remains the most common surgical emergency in newborn infants, accounting for 
1 to 3% of admissions to neonatal intensive care units (Neu, 1996) and requiring 
surgical intervention in up to 63% of cases (Lee et al, 2003; Pierro et al, 2003). 
Inflammation is a nearly ubiquitous histological finding in NEC, with features of 
acute inflammation such as infiltration of leukocytes present in the vast majority of 
intestinal specimens (Ballance et al, 1990). 
Although many aspects of the pathogenesis of NEC are still unclear, recent 
evidence from experimental models of NEC suggests that activation of 
inflammatory cascade with recruitment of inflammatory cells and production of 
soluble mediators plays a major role in promoting tissue injury in the intestine 
(Caplan et al, 1990; Ng et al, 2003; Kozol, 1992; Ford et al, 1996). In particular, 
migration and activation of neutrophils and macrophages is believed to be one of 
the main pathways leading to mucosal and submucosal degradation in NEC 
(Pender et al, 2003). This is confirmed by the findings that inhibition of neutrophils 
by pre-treatment with vinblastine (Musemeche et al, 1991), and of macrophages by 
semapimod (Zamora et al, 2005) reduced the extent of intestinal injury and the 
severity of disease in animal models of NEC. 
However, the pattern of inflammatory cell infiltrate in the intestine has been 
poorly investigated in human NEC, and the mechanisms regulating their 
recruitment and activation is largely unknown. In particular, no studies are reported 
in the English literature regarding the role of endothelial adhesion molecules P-
Selectin, ICAM-1, or E-Selectin in NEC.   
P-selectin, an adhesion molecule expressed by activated endothelial cells and 
platelets, mediates the early phases of leukocyte adherence to the endothelium. 
Expression of P-selectin has been shown to be crucial to leukocyte recruitment in 
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many human inflammatory processes (Bevilacqua et al, 1994) as well as in animal 
models of intestinal ischaemia and reperfusion, intestinal transplantation and sepsis 
(Hayward et al, 1999; Davenpeck et al, 1994; Carmody et al, 2004; Riaz et al, 
2002; Farmer et al, 2002; Opal et al, 2001). E-Selectin expression on endothelial 
cells involves transcriptional mechanisms (Bevilacqua et al, 1989), and mediates 
the transition from slow rolling to firm leukocyte arrest (Smith et al, 2004). 
Blockade of E-Selectin prevents leukocyte infiltration and reduces tissue injury in 
experimental models of myocardial and cerebral ischaemia (Carter et al, 2002; 
Huang et al, 2000; Carter et al, 2000), and reduces reperfusion-induced neutrophil 
recruitment in the intestine (Russell et al, 2000). ICAM-1 mediates firm adhesion 
of leukocytes to, as well as migration through, endothelial cells  (Schenkel et al, 
2004), and represents an essential step in leukocyte infiltration into different 
organs in experimental sepsis or mesenteric ischaemia and reperfusion (Raeburn et 
al, 2002; Beck-Schimmer et al, 2002; Ilhan et al, 2003). 
The aim of the present study was to evaluate the expression of endothelial 
adhesion molecules in intestinal specimens from neonates with NEC, and to 
investigate their role in the development of inflammation and tissue injury. 
 
7.2 MATERIALS AND METHODS 
 
The study protocol was approved by the Great Ormond Street Hospital for 
Children and Institute of Child Health Research Ethics Committee. 
 
7.2.1 Patients 
A retrospective review of the neonatal intensive care register was performed 
and infants who had undergone bowel resection between September 2000 and 
April 2002 were identified. Histopathology records were also reviewed to identify 
those diagnosed with necrotizing enterocolitis and those with other conditions.  
A senior consultant pathologist selected representative specimens from small 
and large bowel of 13 of the NEC patients and 7 controls from neonates with non-
inflammatory conditions (ileal atresia: n=5; ileal stenosis: n=1; anorectal 
malformation: n=1), and tissue sections were obtained from paraffin embedded 
 Chapter 7: Adhesion molecule Expression and Inflammatory Cell Infiltrate in Human NEC 
 221
blocks. In 9 NEC patients sections were taken from both severely affected areas 
and resection margins, providing 22 sections from 13 patients. In control patients, 
one section per individual was evaluated. Demographics and information regarding 
clinical conditions at the time of surgery were retrieved from the patients’ records 
by aconsultant intensivist, and are shown in Table 8.1. Data relative to blood tests 
(full blood count and coagulation study) immediately before surgery, also retrieved 
by a consultant intensivist, are shown in Table 8.2. 
 
7.2.2 Histological injury  
Intestinal specimens were fixed in 10% formaldehyde buffered solution for 
24 h followed by paraffin-embedding, and tissue sections (4μm thick) were cut. 
Following dewaxing, sections were stained with haematoxylin and eosin for 
histological evaluation.  
To evaluate the severity of histological injury, haematoxylin and eosin 
stained sections of NEC and control patients were scored using a semi-quantitative 
scale adapted from Ade-Ajayi (Ade-Ajayi et al, 1996): 
- Grade 1: Normal (no inflammation) 
- Grade 2: Mild NEC (inflammatory changes confined to the mucosa)  
- Grade 3: Moderate NEC (changes affecting the mucosa and submucosa)  
- Grade 4: Severe NEC (inflammation involving mucosa, submucosa and serosa)  
- Grade 5: Very severe NEC (transmural necrosis including perforation) 
 
Three control samples were considered ‘normal’ by all investigators and 
served as references for comparison to the remaining sections, which were scored 
independently in a blinded fashion by myself and another observer. Quality control 
was achieved by assessment of random samples by two additional investigators.  
 
7.2.3 Polymorphonuclear cells infiltration 
Immunostaining of 4μm paraffin embedded sections for neutrophil elastase 
was used to detect infiltration of polymorphonuclear cells into intestinal tissue. 
After blocking endogenous peroxidase by incubation in 3% H2O2 in PBS for 
20min, primary antibody (neutrophil elastase, DakoCytomation, Cambridge, UK; 
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1:1000 dilution in PBS) was incubated for 30min, and secondary incubation with 
labelled polymer HRP (EnVision, DakoCytomation, Cambridge, UK) was 
subsequently allowed for 30min. Sections were stained with DAB before 
counterstaining with haematoxylin. 
Neutrophil infiltrate in the mucosa was quantified by measuring the number 
of neutrophil elastase positive cells. Tissue sections were evaluated blindly. For 
each specimen, neutrophil elastase positive cells on 20 high power fields (x400 
magnification) representative of the whole section were counted, and the mean was 
calculated. The degree of neutrophil infiltration in the mucosa was expressed on a 
five-point scale: 
- Grade 1: 0-10 positive cells per field 
- Grade 2: 11-25 positive cells per field 
- Grade 3: 26-100 positive cells per field  
- Grade 4: 101-200 positive cells per field 
- Grade 5: >200 positive cells per field 
 
7.2.4 Macrophage infiltration 
Infiltration of macrophages in intestinal tissue was assessed by 
immunostaining of 4μm paraffin embedded sections for pan-macrophage marker 
CD68 (cluster of differentiation 68). 
After antigen retrieval, achieved by microwaving for 10min in 1% citrate 
buffer, specimens were incubated with 3% H2O2 for 20min, and with primary 
mouse anti-human CD68 (PG-M1, DakoCytomation, Cambridge, UK; 1:200 
dilution) for 30min. Following secondary incubation with labelled polymer HRP, 
sections were stained with DAB and counterstained with haematoxylin.  
The extent of macrophage infiltration was quantified by measuring the 
number of CD68 positive cells in tissue. Specimens were assessed in a blinded 
fashion. For each specimen, the number of CD68 positive cells in 20 high power 
fields (x400 magnification) in the mucosa, submucosa and serosa were counted, 
and the average was calculated. 
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7.2.5 Adhesion molecule expression 
  Immunostaining for CD62P was performed to identify P-selectin 
expression, and double staining for CD62P and CD41 (cluster of differentiation 
41) allowed differential evaluation of P-selectin expression on platelets and 
endothelial cells; ICAM-1 expression was identified by immunostaining for CD54; 
immunohistochemistry for CD62E allowed recognition of E-Selectin expression. 
 
P-Selectin (CD62P). Antigen retrieval was achieved by heating the tissue sections 
in 1% citrate buffer (pH 6.0) for 10min. After blockade of endogenous peroxidase 
activity, incubation with 10% normal goat serum was performed to minimise 
nonspecific binding. Primary anti-human CD62-P (P-selectin) antibody (BD 
Biosciences, San Jose, CA, USA; 1:200 dilution in PBS) was incubated overnight 
at 4°C. Following secondary incubation with labelled polymer HRP, sections were 
stained with DAB and counterstained with haematoxylin.   
 The expression of P-selectin was assessed by grading the intensity of ring-
shaped vessels expressing CD62P on DAB stained sections. The specimens were 
scored independently and blindly by myself and two other investigators. P-selectin 
expression on large and medium-sized vessels and on the microcirculation were 
evaluated separately. Intensity of the staining was expressed on a semi-quantitative 
scale: 
- Grade 1: Weak staining (0-10% of vessels stained) 
- Grade 2: Mild staining (10-25% of vessels stained) 
- Grade 3: Moderate staining (25-50% of vessels stained) 
- Grade 4: Strong staining (50-75% of vessels stained) 
- Grade 5: Very strong staining (75-100% of vessels stained) 
 
Dual staining for P-Selectin (CD62P) and CD41.  A representative sample of 
specimens from NEC patients (n=12) was processed with dual staining for CD41-
CD62P in order to assess the selective expression of P-selectin on endothelial cells 
or on platelets. The sections were digested in 0.02% protease at 37°C for 10min for 
antigen retrieval of CD41. Tissue sections were incubated with 10% normal goat 
serum, and subsequently with primary anti-CD41 antibody (DakoCytomation, 
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Cambridge, UK; 1:50 dilution in PBS) for 30 min. Sections were incubated with 
labelled polymer HRP and stained with DAB. After incubation with levamisole for 
5min, primary anti-human CD62-P (P-selectin) antibody (1:200 dilution in PBS) 
was applied overnight at 4°C. Following incubation with labelled polymer alkaline 
phosphatase (AP, DakoCytomation, Cambridge, UK), staining with fast red and 
counterstaining with haematoxylin were performed. 
Vessels expressing P-selectin on endothelial cells had a pink coloured, ring-
shaped appearance, whereas a brown-orange granular staining filling the lumen of 
a blood vessel corresponded to activated platelets coexpressing both CD41 and 
CD62P (Figure 7.13). 
 
ICAM-1 (CD54). Antigen retrieval was by microwaving for 10min in 1% citrate 
buffer solution. Slides were incubated with 3% H2O2 for 20min, and then with 10% 
normal rabbit serum (DakoCytomation, Cambridge, UK). Primary anti-human 
ICAM-1 (CD54, R&D Systems, Ltd., Abingdon, UK, 1:200 dilution) was applied 
for 30min, followed by incubation with biotinylated anti-goat secondary antibody 
(Vectastain ABC kit, Vector Laboratories, Ltd., Peterborough, UK). Sections were 
stained with DAB before counterstaining with haematoxylin.  
Expression of ICAM-1 on the endothelium was evaluated separately in the 
mucosa, submucosa and serosa. Sections were scored independently and blindly by 
myself and two other investigators. Intensity of the staining was expressed on a 
semi-quantitative scale:  
- Grade 1: Weak staining (0-10% of vessels stained) 
- Grade 2: Mild staining (10-25% of vessels stained) 
- Grade 3: Moderate staining (25-50% of vessels stained) 
- Grade 4: Strong staining (50-75% of vessels stained) 
- Grade 5: Very strong staining (75-100% of vessels stained) 
 
E-Selectin (CD62E). After microwaving for 10min in 1% citrate buffer solution, 
3% H2O2 was applied for 20min, followed by 10% normal rabbit serum. Slides 
were then incubated with goat anti-human E-selectin (CD62E, R&D Systems, Ltd., 
Abingdon, UK, 1:180 dilution) for 60min, followed by biotinylated anti-goat 
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secondary antibody (Vectastain ABC kit, Vector Laboratories, Ltd., Peterborough, 
UK). Sections were stained with DAB and counterstained with haematoxylin. 
Unlike P-Selectin and ICAM-1, E-Selectin expression was limited to few 
specimens from NEC patients, and was absent on the remaining sections from 
NEC patients, and from controls (see paragraph 8.3.6). No grading system could 
therefore be applied, and staining for E-selectin was classified as present or absent. 
 
Dual staining for P-Selectin (CD62P) and CD68. Dual staining for P-Selectin and 
pan-macrophage marker CD68 was performed in order to identify macrophages 
adherent to blood vessels expressing P-Selectin.  
Antigen retrieval was achieved by microwaving tissue sections in 1% citrate 
buffer for 10min. 3% H2O2 was then applied for 20min, followed by 10% normal 
rabbit serum to minimise nonspecific binding. Primary anti-human CD62-P (P-
selectin) antibody (1:200 dilution in PBS) was incubated overnight at 4°C. After 
secondary incubation with labelled polymer HRP, sections were stained with DAB. 
Specimens were then incubated with levamisole for 5min, and with primary mouse 
anti-human CD68 (1:200 dilution) for 30min. Labelled polymer AP was then 
added, followed by staining with fast red and counterstaining with haematoxylin. 
 
Dual staining for ICAM-1 (CD54) and CD68. Dual staining for ICAM-1 and pan-
macrophage marker CD68 allowed identification of macrophages adherent to 
blood vessels expressing ICAM-1.  
Antigen retrieval was by microwaving for 10min in 1% citrate buffer 
solution. Slides were incubated with 3% H2O2 for 20min, and then with 10% 
normal rabbit serum. Primary anti-human ICAM-1 (CD54, 1:200 dilution) was 
applied for 30min, followed by incubation with biotinylated anti-goat secondary 
antibody and staining with DAB. After incubation with levamisole for 5min, 
primary mouse anti-human CD68 (1:200 dilution) was applied for 30min. 
Specimens were then incubated with labelled polymer AP, stained with fast red 
and counterstained with haematoxylin. 
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7.2.6 Statistical analysis 
Results are expressed as median [interquartile range]. Mann-Whitney U test 
and Fisher’s exact test were used for group comparison as appropriate. Spearman 
rank test was used to investigate the correlation between the degree of expression 
of adhesion molecules, and leukocyte infiltration. A model of linear regression was 
used to assess the influence of leukocyte infiltration and adhesion molecule 
expression, and the degree of histological injury as well as clinical outcome 
(number of organs in failure, development of sepsis, and survival). Before a model 
of linear regression was built, correlation between single variables was investigated 
by Spearman rank test. The expression of P-Selectin on the microcirculation and 
on large calibre vessels were excluded from the model because of significant 
multi-colinearity (R2>0.9). Differences were considered statistically significant for 
p values <0.05. 
 
7.3 RESULTS 
 
7.3.1 Histological injury 
The degree of histological injury was significantly higher in sections from 
NEC patients as compared to control patients (Figure 7.1). Various degrees of 
histological injury were present in specimens of NEC patients, with most NEC 
patients presenting features of severe to very severe histological injury on 
haematoxylin and eosin of at least one stained section (Figure 7.2  C, D). Only 
three NEC patients showed mildly to moderately affected intestine (Figure 7.2 B). 
Microscopic appearance of the intestine was unaffected in the majority of control 
patients (Figure 7.2 A), although in three specimens there were mild features of 
inflammation. 
 
7.3.2 Polymorphonuclear cell infiltration 
Neutrophil infiltration in the mucosa was also much higher in NEC patients 
than in controls (Figure 7.3). Most sections from NEC patients showed a diffused 
infiltration of polymorphonuclear cells in the mucosa with over 100 neutrophils per 
high power field (Figure 7.4 C, D). Accumulation of neutrophils was more evident 
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in the most damaged areas, where conspicuous sloughing of the mucosal layer and 
ulceration or exposure of the submucosa with vessel congestion were present. 
There was a strong positive correlation (p<0.001, r=0.644) between the severity of 
histological injury and neutrophil infiltration in the mucosa.  
 
7.3.3 Macrophage infiltration 
Very few macrophages were visible in the mucosa, submucosa, and serosa of 
control patients, with none of the sections showing more than 15 CD68 positive 
cells per HPF (Figure 7.5). However, specimens from NEC patients presented a 
significantly higher number of infiltrating macrophages scattered in the mucosa 
and submucosa (Figure 7.6 B, 7.7 B). The pattern of macrophage infiltration was 
somehow different in the serosa, with clusters of CD68 positive cells located in 
adipose tissue surrounding large arteries and veins (p=0.003 vs. controls, Figure 
7.8 B). 
 
7.3.4 P-selectin expression 
Dual staining for CD41 and P-selectin allowed differentiation of P-selectin 
expression between endothelial cells and platelets. Vessels expressing P-selectin 
on endothelial cells had a pink coloured, ring-shaped appearance, whereas a 
brown-orange granular staining filling the lumen of a blood vessel corresponded to 
activated platelets co-expressing both CD41 and CD62P. In sections from control 
patients, expression of P-selectin was limited to the endothelium, with no evidence 
of staining on platelets. Specimens of NEC patients also showed a predominant 
expression on the endothelium. However, in several sections from NEC patients, 
aggregates of activated platelets co-expressing CD41 and P-selectin were present 
in a minority of medium and small vessels, particularly in areas characterised by 
severe tissue injury and necrosis (Figure 7.13). 
P-selectin expression was most evident on endothelium of large vessels 
located in the submucosa and subserosa, with intense staining on a significant 
proportion of veins and arteries of both NEC and control patients (Figure 7.9 A, 
7.10). A high expression was observed also on medium-sized vessels of many 
NEC patients, whereas staining in control patients was weaker and limited to a 
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minority of the medium-sized vessels (Figure 7.9 B, 7.11). Expression of P-selectin 
was overall weaker on the microcirculation, but the number of positive vessels was 
significantly higher in NEC patients than in control patients (Figure 7.9 C, 7.12). In 
addition, expression of P-selectin on medium-sized vessels and on the 
microcirculation in specimens from control patients was limited to the mucosa and 
submucosa, whereas in NEC patients with strong or very strong expression of P-
selectin a diffuse staining was noticed on blood vessels of all layers, including the 
muscle.  
Expression of P-selectin was also noticed to be particularly high in 
specimens with severe histological damage. However, in sections with severe 
histological injury P-selectin positive vessels were particularly abundant in areas 
with features of strong active inflammation but with no evidence of advanced 
tissue damage or necrosis (Figure 7.16 B). On the contrary, in adjacent areas where 
mucosal and submucosal layers were disrupted or frankly necrotic staining for P-
selectin was significantly weaker (Figure 7.16 A). 
A high number of leukocytes were observed inside blood vessels in sections 
from NEC patients. In these patients, evaluation of fast-red stained sections on 
high-power magnification revealed the presence of numerous leukocytes, 
particularly polymorphonuclear cells, adhering to the endothelium of vessels 
expressing P-selectin (Figure 7.14). The amount of neutrophils infiltrating the 
mucosa was strongly correlated with the degree of P-selectin expression on both 
medium-sized vessels (p=0.004, r=0.513) and the microcirculation (p=0.001, 
r=0.578), but not on large vessels (p=0.31). Analysis of sections stained for P-
Selectin and CD68 under high-power magnification showed that macrophages 
were also adhering to P-Selectin expressing blood vessels, particularly small and 
medium calibre veins (Figure 7.15). However, no significant correlation was found 
between the degree of expression of P-Selectin on large, medium-sized vessels, or 
the microcirculation, and the number of macrophages infiltrating the mucosa, 
submucosa, or serosa.  
Also, P-Selectin expression on medium-sized vessels did not significantly 
influence the degree of histological injury, or the development of clinical sepsis, 
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the severity of organ failure, or survival when a multiple regression model was 
applied. 
 
7.3.5 ICAM-1 expression 
Specimens from control patients showed very limited staining for ICAM-1 
on blood vessels located in the mucosal and serosal layers, whereas a slightly 
higher level of expression was observed in medium-sized and large vessels of the 
submucosa (Figure 7.19). Although expression of ICAM-1 was overall higher on 
small mucosal vessels of NEC patients as compared to controls (Figure 7.17 A), 
the pattern of expression varied from diffuse staining of more than 75% of blood 
vessels in some specimen, to weak staining with only few positive vessels in others 
(Figure 7.18). A similar variability was observed in the serosa of specimens from 
NEC patients, although the great majority of serosal ICAM-1 positive vessels were 
large or medium-sized arteries and veins, with limited staining on the 
microcirculation (p=0.015 vs. controls, Figure 7.17 C, 7.20 B). In specimens from 
NEC patients, staining for ICAM-1 was highest in the submucosa, particularly on 
large and medium-sized vessels (p=0.010 vs. controls, Figure 7.17 B, 7.19 B). 
Interestingly, ICAM-1 positive vessels located not only in connective tissue but 
also in the muscle. 
A high number of leukocytes was seen adhering to several ICAM-1 positive 
vessels, mostly veins of small and medium calibre located in the submucosa 
(Figure 7.21). While several of these adherent leukocytes presented features 
suggestive for polymorphonuclear (neutrophil) granulocytes, numerous others 
were identified as macrophages after staining for CD68 (Figure 7.22). These 
observations were supported by the positive correlation found between the number 
of neutrophils infiltrating the mucosa and the degree of ICAM-1 expression on the 
submucosa (p=0.0008, r=0.59) and serosa (p=0.031, r=0.40), and between the 
degree of ICAM-1 expression and the number of infiltrating macrophages in the 
mucosa (p=0.009, r=0.48) and submucosa (p=0.0013, r=0.57). 
Similarly to what observed for P-Selectin, ICAM-1 expression was also 
observed to be reduced in areas with features of necrosis, and much higher in areas 
with active inflammation. 
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ICAM-1 expression on the mucosa, submucosa, or serosa was not positively 
correlated to the severity of histological injury, or to clinical measures of outcome 
(sepsis, number of organs in failure, or survival) on multiple regression analysis.  
 
7.3.6 E-Selectin expression 
Expression of E-selectin was either absent or extremely low on all specimens 
from control patients and on most specimens from NECs, with only five specimens 
from four NEC patients showing strong staining for E-Selectin. E-Selectin 
expression was particularly strong on medium and large calibre vessels of the 
submucosa (Figure 7.23). Some E-Selectin positive blood vessels showed 
leukocytes adhering to the endothelium on high power magnification (Figure 7.24), 
although this was not as frequent as for P-Selectin and ICAM-1. 
Interestingly, review of clinical data showed that such up-regulation of E-
Selectin was associated with severe and rapidly evolving NEC. These four patients 
were all classified as Bell’s stage 3 disease, required surgery one to three days after 
NEC was diagnosed, and presented failure of 6, 4, 4 and 3 organs respectively. 
When the impact of E-Selectin on clinical outcome was assessed by multiple 
regression analysis, E-Selectin was found to be the only factor influencing the 
number of organs in failure (p=0.0005) and survival (p=0.0026). 
 
7.4 DISCUSSION 
 
Inflammation is a dominant histological feature in intestinal specimens from 
patients with NEC, with up to 78% of specimens presenting microscopic signs of 
acute inflammation including predominance of neutrophil infiltrate (Ballance et al, 
1990). The development of an inflammatory response has often been regarded as 
an appropriate host response to tissue necrosis and bacterial overgrowth in the 
intestine (Ballance et al, 1990). However, in recent years inflammatory mediators 
(e.g. PAF, TNF-α IL-2, IL-6, IL-12 and IL-18 have been shown to play a central 
role in the development of tissue injury in experimental (Ewer et al, 2004; Hsueh et 
al, 1986a; Sun et al, 1988; Halpern et al, 2002) and clinical (Morecroft et al, 
1994b; Caplan et al, 1990; Ng et al, 2003) NEC. Activated neutrophils and 
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macrophages release a wide array of proteolytic enzymes (including elastase, 
gelatinase and collagenase; Moraes et al, 2003) and reactive oxygen species 
(Cuzzocrea et al, 2001b), necessary for transepithelial migration and bacterial 
killing. This may result in excessive host tissue damage, so that infiltration of 
leukocytes in the intestine may actively contribute to the development of tissue 
damage in NEC. This is supported by the decreased degree of intestinal injury in a 
rat model of NEC where neutropenia was induced with vinblastine (Musemeche et 
al, 1991), or where macrophages were inhibited with semapimod (Zamora et al, 
2005). 
Expression of adhesion molecules on the surface of endothelial cells, in 
response to interleukins, TNF-α, LPS, histamine, PAF and other soluble mediators 
(Pettersen et al, 2002), mediates both initial rolling of leucocytes along the 
endothelium, and their subsequent firm adhesion followed by transendothelial 
migration (Ebnet et al, 1996). P-selectin, a transmembrane protein stored in 
Weibel-Palade bodies of endothelial cells, is responsible for the early stages of 
leukocyte-endothelial interaction. Within 10-30min after exposure to appropriate 
inflammatory stimuli, P-selectin is mobilised and exposed on the cell surface, 
where its interaction with PSGL-1, a specific ligand expressed by leukocytes, 
determines tethering and rolling of neutrophils along the endothelium (Ley et al, 
1995). Sustained P-Selectin expression from de-novo synthesis occurs within a few 
hours from the initial stimulus (Eppihimer et al, 1997).  
Expression of E-Selectin requires de-novo synthesis, and follows prompt 
release of P-Selectin on endothelial cell membrane, reducing rolling velocity of 
leukocytes, and mediating the transition from slow rolling to firm leukocyte arrest, 
which are mediated by different ligands on leukocyte surface (Xia et al, 2002; 
Smith et al, 2004; Hidalgo et al, 2007).  
The role of P-Selectin and ICAM-1 in leukocyte migration through the 
endothelium has been extensively investigated in experimental models relevant to 
human NEC, such as ischaemia and reperfusion injury, whereas there are relatively 
few data that support a role for E-selectin in the same recruitment process. This 
may result both from  the fact that most studies focus on the inflammatory events 
that occur within the first hour after reperfusion, and from the use of anti-human 
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monoclonal antibodies with limited binding affinity to rodent E-selectin. In fact, 
immunostaining for E-Selectin was attempted in the experimental studies described 
in Chapter 4, 5, and 6 with the same goat anti-human E-Selectin antibody 
successfully used for the experiments on human NEC described in this chapter, but 
no satisfactory staining was obtained probably due to poor cross reactivity with the 
rat epitopes. Blockade of neutrophil adhesion to monolayers of TNF-activated 
endothelial cells by an anti-murine E-selectin monoclonal antibody proved to 
inhibit accumulation of neutrophils in mice small intestine following mesenteric 
reperfusion (Russell et al, 2000). As for P-Selectin, upregulation of E-Selectin 
appears to be triggered by reactive oxygen species (particularly superoxide) and 
cytokine release (including TNF-) via activation of the nuclear transcription 
factor NF-kB (Ichikawa et al, 1997; Russell et al, 2000). 
Following tethering and rolling along the vessel wall, leukocytes can adhere 
to and subsequently migrate through the endothelium, mediated by other adhesion 
molecules expressed by activated endothelium (ICAM-1, VCAM-1), and their 
specific counterparts on leucocytes.  
My results from resected bowel in neonates with advanced NEC support the 
hypothesis of an upregulation of endothelial adhesion molecules P-selectin and 
ICAM-1. Expression of P-selectin was substantially increased on both medium-
sized vessels and on the microcirculation of NEC patients, and was not limited to 
the mucosa and submucosa but extended to the muscular and subserosal layer. 
Both neutrophils and macrophages were found adhering to endothelial cells 
expressing P-selectin, supporting the role of this adhesion molecule in promoting 
neutrophil rolling and firm adhesion to the endothelium.  
The primary role for P-Selectin in allowing neutrophil rolling was confirmed 
by the strong correlation found between the degree of neutrophil infiltration in the 
mucosa and the intensity of expression of P-selectin on both medium-sized vessels 
and on the microcirculation. On the contrary, no correlation was found between 
expression of P-Selectin and number of infiltrating macrophages. Although P-
Selectin is believed to be one of the fundamental ligands regulating trafficking of 
monocytes in intestinal microvasculature (Ishii et al, 2004), these findings may 
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reflect the importance of alternative mechanisms regulating monocyte rolling, 
including E- and L-Selectin (Sperandio, 2006).  
Upregulation of ICAM-1 was also substantially enhanced on the endothelium 
of mucosal, serosal, and in particular submucosal blood vessels of NEC patients. 
Similarly to P-Selectin, ICAM-1 positive vessels showed numerous adhering 
leukocytes, including both neutrophils and macrophages, and there was a strong 
correlation between ICAM-1 expression and neutrophil and macrophage infiltrate, 
particularly for submucosal vessels.  
Maximal expression of P-selectin and ICAM-1, associated with a 
conspicuous amount of leukocytes infiltrating the mucosa, was observed in areas 
characterised by active inflammation but limited injury, whereas in severely 
damaged tissue diffuse neutrophil and macrophage infiltration was present, but 
staining for P-selectin and ICAM-1 was consistently weak. This finding supports a 
role for leukocytes in actively contributing to the pathogenesis of intestinal 
damage. However, as the specimens in this study were from advanced NEC 
(resected bowel), we do not know at which stage during the development of the 
disease increased adhesion molecule expression occurs. In areas where severe 
histological damage has occurred, down-regulation of P-selectin and ICAM-1 
surface expression may prevent further migration of leukocytes and limit the extent 
of inflammatory response. Whether this decreased adhesion molecule expression is 
a regulated process or merely a consequence of proteolysis and necrosis is 
unknown. 
The pattern of expression of E-Selectin appeared to be different from that of 
ICAM-1 and P-Selectin, being present in only five specimens from four NEC 
patients, and virtually absent in all other NEC specimens, as well as in controls. 
Interestingly, patients with strong intestinal expression of E-Selectin presented 
with rapidly evolving and severe NEC, as indicated by the presence of Bell’s stage 
3 disease, presence of multiple organ dysfunction syndrome, need for early 
surgery, and adverse outcome. This was confirmed by the fact that E-Selectin (but 
not P-Selectin or ICAM-1) expression was found to be the only single factor 
influencing distant organ failure and survival in a multiple regression analysis 
model. Endothelial expression of E-Selectin may reflect a particularly intense 
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inflammatory response resulting in enhanced recruitment of inflammatory cells and 
subsequent development of local and distant organ injury. However, activated and 
soluble E-Selectin have recently been shown to initiate intracellular signalling, and  
E-Selectin upregulation may act through pathways independent from simple 
leukocyte infiltration. In fact, activation of E-Selectin by specific ligands has been 
shown to induce phosphorilation of extracellular signal-regulated kinase (ERK) in 
human colon cancer cells (Suzuki et al, 2007). E-selectin has also been involved in 
induction of apoptosis in endothelial cells induced by allergenic blood perfusion in 
a model of mouse isolated lung, which occurred through activation of  Fas ligand 
(FasL) and protein tyrosine phosphatase pathways (Joucher et al, 2005). Soluble E-
Selectin, which is shed from its transmembrane counterpart on endothelial cells, 
can activate neutrophil Src family tyrosine kinases in response to PAF, regulating 
permissive store-operative calcium entry (McMeekin et al, 2006).  
 
7.5 CONCLUSIONS 
 
The present study has shown that necrotizing enterocolitis is associated with 
the development of a substantial inflammatory response in the affected gut, which 
is characterised by great numbers of infiltrating inflammatory cells, mostly 
neutrophils and macrophages. These inflammatory changes were associated with 
the presence of substantial tissue injury, suggesting that leukocytes may actively 
contribute to the development of intestinal damage. Upregulation of P-Selectin on 
medium-sized vessels and on the microcirculation, and of ICAM-1 on blood 
vessels of the mucosa, submucosa, and serosa was observed in the majority of 
specimens from NEC patients. Increased expression of these adhesion molecules 
seems to play a crucial role in regulating leukocyte trafficking, with P-Selectin 
mostly mediating infiltration of neutrophils, and ICAM-1 regulating both 
neutrophil and macrophage influx. Finally, endothelial upregulation of E-Selectin 
occurs in a minority of patients, and seems to be associated with rapidly evolving 
NEC and distant organ failure, although the mechanisms underlying this effect are 
unclear. 
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Table 7.1.  Demographics and clinical conditions of NEC and control 
patients at the time of surgery.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are expressed as median [IQ range], and were compared by Chi-
Square (*) and Mann-Whitney U test (†). 
 NEC Patients 
(n=13) 
Control Patients 
(n=7) 
P value
Males (patients) 6 (46%) 2 (29%) 0.444* 
Gestational age at birth 
(weeks) 
26 [25-29] 38 [34-40] 0.002† 
Birth weight (grams) 1000 [720-1140] 2660 [1857-3325] 0.004† 
Age at surgery (days) 32 [11-40] 2 [1-5] 0.001† 
Sepsis (patients) 8 (62%) 0 (0%) 0.015* 
Organs in failure (number) 2 [1-2.5] 0 [0-0] 0.002† 
Respiratory failure (patients) 12 (92%) 1 (14%) 0.001* 
Cardiovascular failure 
(patients) 
5 (38%) 0 (0%) 0.114* 
Haematological failure 
(patients) 
8 (62%) 0 (0%) 0.015* 
Renal failure (patients) 1 (8%) 0 (0%) 1.0* 
Hepatic failure (patients) 1 (8%) 0 (0%) 1.0* 
Microvascular failure 
(patients) 
3 (23%) 0 (0%) 0.521* 
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Table 7.2. Full blood test values and coagulation study of NEC and control 
patients prior to surgery.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are expressed as median [IQ range], and were compared by Mann-
Whitney U test. PT: prothrombin time; a-PTT: activated partial thromboplastin 
time; TT: thrombin time. 
 
 
 NEC Patients 
(n=13) 
Control Patients 
(n=7) 
P value 
Haemoglobin 
(g/100ml) 
11.8 [8.9-12.7] 15.3 [13.3-16.6] 0.006 
White blood cells  
(109cells/l) 
5.7 [3.7-8.9] 11.2 [7.4-12.9] 0.428 
Neutrophils (109/l) 2.5 [0.9-3.7] 4.6 [2.1-6.2] 0.634 
Lymphocytes 
(109/l) 
1.3 [0.9-1.9] 2.9 [2.1-6.6] 0.047 
Monocytes (109/l) 1.0 [0.3-1.5] 0.9 [0.3-1.2] 0.812 
Platelets (109/l) 82 [36-162] 227 [197-363] 0.003 
PT (s) 17.6 [14.4-19.4] 14.3 [13.0-18.4] 0.428 
a-PTT (s) 63.9 [47.6-84.2] 54.3 [46.4-62.9] 0.579 
TT (s) 13.7 [13.0-14.9] 14.0 [13.6-14.2] 0.726 
Fibrinogen (g/l) 2.2 [1-2.7] 1.5 [0.9-1.7] 0.074 
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Figure 7.1. Histological injury. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Degree of histological injury in specimens from NEC patients (NEC) and 
control patients (Controls). Grade 1 corresponds to minimal injury; Grade 5 to 
maximal injury. Median is shown as a line. Results were compared using Mann-
Whitney U test. 
*  NEC: p=0.0003 vs. Control. 
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Figure 7.2. Histological appearance. 
 
 
Specimens of terminal ileum were stained with H&E and are from: Control 
[A]; NEC [B, C, D]. Magnification is x100. 
 
A 
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Figure 7.3.  Neutrophil infiltration in the mucosa. 
 
  
 
 
 
 
 
 
 
 
 
 
 
Degree of neutrophil infiltration in specimens from NEC patients (NEC) and 
control patients (Controls). Grade 1 corresponds to minimal infiltration; Grade 5 to 
maximal infiltration. Median is shown as a line. Results were compared using 
Mann-Whitney U test. 
*  NEC: p=0.0068 vs. Control. 
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Figure 7.4. Histological appearance of neutrophil infiltration in the mucosa. 
 
 
 
Specimens of terminal ileum (stained with anti-neutrophil elastase antibodies 
and counterstained with haematoxylin) are from: Control [A, B]; NEC [C, D]. 
Magnification is x200. 
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Figure 7.5. Macrophage infiltration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Macrophage infiltration in the mucosa [A], submucosa [B], and serosa [C] in 
specimens from NEC patients (NEC) and control patients (Controls). Results are 
expressed as average number of cells/high power field (cells/hpf) counted on 20 
different fields in each specimen. Median is shown as a line. Results were 
compared using Mann-Whitney U test. 
[A]: *  NEC: p=0.0002 vs. Control. 
[B]: *  NEC: p<0.0001 vs. Control. 
[C]: *  NEC: p=0.0034 vs. Control. 
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Figure 7.6. Histological appearance of macrophage infiltration in the 
mucosa. 
 
 
 
Specimens of terminal ileum (stained with anti-CD68 antibodies and 
counterstained with haematoxylin) are from: Control [A]; NEC [B]. Magnification 
is x200. 
A 
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Figure 7.7. Histological appearance of macrophage infiltration in the 
submucosa. 
 
 
 
Specimens of terminal ileum (stained with anti-CD68 antibodies and 
counterstained with haematoxylin) are from: Control [A]; NEC [B]. Magnification 
is x200. 
A 
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Figure 7.8. Histological appearance of macrophage infiltration in the serosa. 
 
 
 
Specimens of terminal ileum (stained with anti-CD68 antibodies and 
counterstained with haematoxylin) are from: Control [A]; NEC [B]. Magnification 
is x200. 
A 
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Figure 7.9. P-Selectin expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P-Selectin expression on large vessels [A], medium-sized vessels [B], and 
microcirculation [C] in specimens from NEC patients (NEC) and control patients 
(Controls). Grade 1 corresponds to minimal expression; Grade 5 to maximal 
expression. Median is shown as a line. Results were compared using Mann-
Whitney U test.  
[B]: *  NEC: p=0.0298 vs. Control. 
[C]: *  NEC: p=0.0259 vs. Control. 
Controls NEC
1
2
3
4
5
G
ra
de
Controls NEC
1
2
3
4
5
G
ra
de
*
Controls NEC
1
2
3
4
5
G
ra
de
*
C
A B
 Chapter 7: Adhesion molecule Expression and Inflammatory Cell Infiltrate in Human NEC 
 246
Figure 7.10. Histological appearance of P-Selectin expression on large 
vessels. 
 
 
Expression of P-Selectin on large vessels in intestinal specimens from 
Control [A] and NEC [B] patients. Sections were stained for P-Selectin and 
counterstained with haematoxylin.  Magnification is x100. 
A 
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 Figure 7.11. Histological appearance of P-Selectin expression on medium-
sized vessels. 
 
 
Expression of P-Selectin on medium-sized vessels in intestinal specimens 
from Control [A] and NEC [B] patients. Sections were stained for P-Selectin and 
counterstained with haematoxylin.  Magnification is x100. 
A 
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Figure 7.12. Histological appearance of P-Selectin expression in the 
microcirculation. 
 
 
  
 
Expression of P-Selectin on the microcirculation in intestinal specimens from 
Control [A] and NEC [B] patients. Sections were stained for P-Selectin and 
counterstained with haematoxylin.  Magnification is x400. 
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Figure 7.13. P-selectin and CD41 expression in NEC patients. 
 
 
 
  
P-Selectin (fast red) and CD41 (DAB) expression on dual stained sections in 
specimens from NEC patients. Solid lines indicate selective expression of P-
selectin on endothelial cells resulting in pink-coloured, ring-shaped appearance of 
blood vessels. Dashed lines indicate co-expression of P-selectin and CD41 on 
activated platelets, resulting in a brown-orange staining within blood vessels. 
Magnification is x1,000. 
A
B
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Figure 7.14. P-Selectin expression and leukocyte adherence. 
 
 
 
  
 Specimens from NEC patients stained for P-Selectin (fast red) and 
counterstained with haematoxylin. Arrows indicate leukocytes adhering to P-
Selectin positive vessels.  Magnification is x1,000. 
A 
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Figure 7.15. P-Selectin expression and macrophage adherence. 
 
 
 
Specimens from NEC patients dual stained for P-Selectin (DAB) and CD68 
(fast red), and counterstained with haematoxylin. Macrophages adhering to P-
Selectin positive vessels are indicated by arrows.  Magnification is x1,000. 
A
B
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Figure 7.16. P-Selectin expression in areas with severe and mild injury. 
 
 
 
Sections from a single NEC patient were stained for P-Selectin and 
counterstained with haematoxylin.  [A]: mild (large and medium-sized vessels) and 
weak (microcirculation) staining in an area with very severe injury. [B]: very 
strong (large vessels), and strong (medium-sized vessels and microcirculation) 
staining in an area with mild injury. Magnification is x100. 
A 
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Figure 7.17. ICAM-1 expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ICAM-1 expression in the mucosa [A], submucosa [B], and serosa [C] in 
specimens from NEC patients (NEC) and control patients (Controls). Grade 1 
corresponds to minimal expression; Grade 5 to maximal expression. Median is 
shown as a line. Results were compared using Mann-Whitney U test. Results were 
compared using Mann-Whitney U test. 
[A]: *  NEC: p=0.0381 vs. Control. 
[B]: *  NEC: p=0.0099 vs. Control. 
[C]: *  NEC: p=0.0153 vs. Control. 
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Figure 7.18. Histological appearance of ICAM-1 expression in the mucosa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expression of ICAM-1 on the microcirculation in intestinal specimens from 
Control [A] and NEC [B, C] patients. Sections were stained for ICAM-1 and 
counterstained with haematoxylin.  Magnification is x200 [B] and x400 [A, C]. 
A B
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A 
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Figure 7.19. Histological appearance of ICAM-1 expression in the 
submucosa. 
 
 
 
Expression of ICAM-1 on the submucosa in intestinal specimens from 
Control [A] and NEC [B] patients. Sections were stained for ICAM-1 and 
counterstained with haematoxylin.  Magnification is x200.  
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 Figure 7.20. Histological appearance of ICAM-1 expression in the serosa. 
 
 
 
Expression of ICAM-1 on the serosa in intestinal specimens from Control 
[A] and NEC [B] patients. Sections were stained for ICAM-1 and counterstained 
with haematoxylin.  Magnification is x200.  
A 
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Figure 7.21. ICAM-1 expression and leukocyte adherence. 
 
 
  
 Specimens from NEC patients stained for ICAM-1 and counterstained with 
haematoxylin.  Leukocytes adhering to ICAM-1 positive vessels are indicated by 
arrows.  Magnification is x1,000. 
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Figure 7.22. ICAM-1 expression and macrophage adherence. 
 
 
 
Specimens from NEC patients dual stained for ICAM-1 (DAB) and CD68 
(fast red), and counterstained with haematoxylin. Macrophages adhering to ICAM-
1 positive vessels are indicated by arrows.  Magnification is x1,000. 
A 
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Figure 7.23. E-Selectin expression in specimens from NEC patients. 
 
 
  
Specimens from NEC patients stained for E-Selectin and counterstained with 
haematoxylin. Magnification is: x100 [A] and x200 [B]. 
A 
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Figure 7.24. E-Selectin expression and leukocyte adherence. 
 
 
 
Specimens from NEC patients stained for E-Selectin and counterstained 
with haematoxylin. Leukocytes adhering to E-Selectin positive vessels are 
indicated by arrows.  Magnification is x1,000.  
B
D 
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CHAPTER 8 
CONCLUSIONS AND FUTURE WORK 
 
8.1 CONCLUSIONS 
 
My experiments have shown that both moderate hypothermia and the 
peroxynitrite decomposition catalyst FeTMPyP exert beneficial effects when 
applied as therapeutic strategies for experimental intestinal ischaemia and 
reperfusion. Investigation of the inflammatory response in human NEC has 
contributed to characterise the role of inflammatory cells and endothelial adhesion 
molecules in determining tissue injury and influencing clinical outcome. In 
addition, insight into the inflammatory response in newborns with NEC has 
revealed the similarities between our experimental model and human disease, 
suggesting that moderate hypothermia and FeTMPyP could represent novel 
therapies for this condition.   
In the first set of experiments (see Chapter 3), I have characterised the 
effects of intestinal ischaemia and reperfusion on oxidative and nitrosative stress in 
adult rats. My results show that reperfusion-induced oxidative stress is particularly 
profound in the intestine, lungs, and heart, whereas kidneys and liver are relatively 
unaffected. The severity of oxidative and nitrosative stress at a systemic level is 
confirmed by the increase in plasma malondialdehyde and nitric oxide. Application 
of whole body moderate hypothermia before the onset of mesenteric ischaemia 
effectively prevented the changes induced by reperfusion. Evidence from this 
study suggests that this hypothermic protection is due to modulation of several 
different pathways in the affected organs, including a reduction in the release of 
reactive oxygen species, enhancement of endogenous anti-inflammatory defences, 
and a decrease in systemic nitrosative stress. These findings may explain some 
aspects of the pathophysiology underlying the beneficial effects of hypothermia on 
animal survival and organ injury previously demonstrated in a similar model 
(Kalia et al, 2002b; Vejchapipat et al, 2001).  
The results from this first set of experiments support the potential application 
of whole body hypothermia in reducing intestinal reperfusion injury when the 
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ischaemic injury can be foreseen and hypothermia can be applied from the 
beginning of mesenteric ischaemia. In the clinical scenario, such situations include 
intestinal transplantation and cardiovascular procedures associated with aortic 
clamping. However, in the majority of clinical conditions characterised by 
mesenteric reperfusion injury, treatment can be applied only after the ischaemic 
injury has been established. This factor appears to be critical, since no studies 
investigating the potential effects of hypothermia when applied as a rescue therapy 
after the establishment of intestinal ischaemia have been published to date. In fact, 
it could be argued that some benefits of hypothermia exerted during the ischaemic 
phase (such as a reduction in basal metabolism) might be lost when cooling is 
applied as a rescue at reperfusion. In addition, the consequences of rewarming after 
a period of whole-body hypothermia should also be addressed before any clinical 
application can be considered: not only the protection offered by  hypothermia 
might be lost after restoration of normothermia, but the process of rewarming 
could also be associated with severe adverse cardiovascular effects (Thoresen et al, 
2000), especially if too rapid. 
I therefore designed the first experimental study to investigate the use of 
whole body hypothermia when applied as a rescue therapy after the onset of 
mesenteric reperfusion (see Chapter 5). The animal model used in this series of 
experiments was modified to resemble an intensive care unit setting, including 
invasive monitoring of vital functions, aggressive fluid resuscitation, tracheostomy 
and mechanical ventilation, in order to reflect the severity of conditions associated 
with mesenteric reperfusion in humans. This was also necessary because the 
combination of reperfusion and hypothermia caused respiratory depression and 
death in non-ventilated animals. The results from this experiment show that even 
when applied at the onset of reperfusion, hypothermia prevents cardiovascular 
failure and abolishes mortality, and that these effects are maintained after 
rewarming. This is similar to findings of Kalia et al. in a rat model of mesenteric 
reperfusion where hypothermia was applied as a preventative treatment throughout 
both the ischaemic and the reperfusion phase (Kalia et al, 2002b), suggesting that a 
considerable part of hypothermic protection occurs during the reperfusion phase 
rather than during ischaemia. In fact, investigation of the early reperfusion phase in 
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my study revealed that even when applied as a rescue, hypothermia could 
modulate many of the protective pathways involved in the protection of the 
intestine and distant organs, including inflammatory cells infiltration, oxidative 
and nitrosative stress, and energy metabolism.  
These findings support the potential application of rescue moderate 
hypothermia in clinical conditions associated with mesenteric reperfusion injury in 
adult patients, such as acute mesenteric arterial occlusion. However, some 
evidence exists to suggest that the response to intestinal I/R of mature animals 
differs to some extent from that of developing animals. For instance, sustained 
hypoperfusion of the intestine followed by normoperfusion induces a marked 
impairment of vascular response to endothelin-1 in 3-day old piglets, resulting in 
an increase in vascular resistance and a reduction in both oxygen delivery and 
consumption in the mesenteric circulation (Nankervis et al, 2000). However, 35-
day old piglets are significantly more resistant to mesenteric hypoperfusion, and 
can maintain a normal level of oxygen consumption due to a reduced mesenteric 
vascular resistance and increased oxygen delivery. Similarly, there are some 
significant differences in the pattern and severity of evolution of MODS in adult 
and paediatric patients. For example, adult patients with severe sepsis initially 
experience severe cardiopulmonary compromise, which is then followed by 
pulmonary, renal and hepatic impairment (Brun-Buisson et al, 1995). In contrast, 
severely septic paediatric patients develop sequential respiratory, hepatic and renal 
failure, with cardiovascular collapse usually ensuing as a consequence of failure of 
the other organs (Doughty et al, 1998).   
Using a model of 11-13 day old rats, I demonstrated that mesenteric 
reperfusion elicits both intestinal injury and impairment of distant organs 
(including lungs and liver), eventually resulting in death of experimental animals. 
The metabolic pathways involved in the development of such MODS are 
comparable to those observed in adult animals, including neutrophil infiltration 
and oxidative stress in intestine and lungs, systemic overproduction of nitric oxide, 
and hepatic energy failure (see Chapters 4 and 6). When applied at the onset of 
reperfusion, hypothermia proved to modulate these pathways in infant rats to a 
 Chapter 8: Conclusions and Future Work 
 265
similar extent as in adult animals, and results in a significant improvement in 
mortality that persists after rewarming (see Chapter 6).  
In a separate set of experiments using this infant model of mesenteric 
reperfusion injury, I tested whether inhibition of the harmful free radical 
peroxynitrite by administration of a selective decomposition catalyst (FeTMPyP) 
at reperfusion could lead to improvement of intestinal injury and protection to 
distant organs (see chapter 5). FeTMPyP proved to be effective in preventing 
oxidative and nitrosative stress in the ileum and distant organs, confirming the 
significant role of peroxynitrite in the pathogenesis of reperfusion injury. Our 
results suggest that this protection is mediated at least in part by inhibition of P-
Selectin upregulation and neutrophil recruitment in the intestine, although other 
pathways are likely to be implicated. The results of this and other studies appear 
encouraging in suggesting a role for selective peroxynitrite decomposition 
catalysts in ameliorating reperfusion injury.  
After establishing the effects of hypothermia and peroxynitrite 
decomposition catalyst FeTMPyP in an animal model of mesenteric reperfusion 
injury, I investigated the pattern of the inflammatory response in the intestine of 
patients with NEC. Few studies have been published to date characterising the 
intestinal inflammatory process in human NEC, although it is generally accepted 
that an excessive activation of systemic inflammation plays a crucial role in the 
pathogenesis of MODS in this disease. As previously discussed, the beneficial 
effects of both whole-body hypothermia and peroxynitrite decomposition catalyst 
FeTMPyP appeared to be mediated, at least in part, via blunting of the 
inflammatory response in the intestine. Description of the inflammatory process in 
the gut of newborns with NEC, in particular inflammatory cell infiltrate and 
adhesion molecule expression, reinforces the relevance of the experimental 
findings in our animal model in view of a potential clinical application of these 
therapeutic strategies. My studies on intestinal specimens from human NEC 
confirmed the importance of both neutrophil and macrophage infiltration in 
determining tissue injury, which appears to be mediated via endothelial expression 
of P-Selectin and ICAM-1. Thus, P-selectin expression and neutrophil infiltration 
appear to play a central role in human NEC as well as in animal intestinal I/R 
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injury. This suggests that therapeutic strategies which I showed to be beneficial in 
an animal model of NEC may also warrant investigation in human disease in order 
to prevent P-Selectin activation and neutrophil infiltration in the intestine. 
Furthermore, blunting of the inflammatory response in the gut could prevent the 
generation of a systemic inflammatory response and the subsequent development 
of MODS as previously discussed.  
Interestingly, upregulation of E-selectin on intestinal vascular endothelium 
proved to be strongly associated with the failure of multiple organs and poor 
outcome that characterised fulminate NEC. Such E-Selectin upregulation is known 
to be mediated via overproduction of ROS and RNS, as discussed in Chapter 7 
(Ichikawa et al, 1997; Russell et al, 2000). Although I was unable to characterise 
E-Selectin expression in intestinal specimens from our experimental animals 
undergoing intestinal I/R because of the absence of suitable antibodies, it may be 
speculated that the observed protection against oxidative and nitrosative stress by 
both hypothermia and FeTMPyP would result in inhibition of E-Selectin 
upregulation. This would further support the potential clinical application of both 
hypothermia and FeTMPyP, regardless of whether E-Selectin overexpression 
represents a simple marker of rapidly evolving NEC or it plays an active role in 
promoting systemic inflammation. 
 
9.2 FUTURE WORK 
 
As discussed in the previous section, I have provided convincing evidence 
for a potential use of both whole-body hypothermia and FeTMPyP as a rescue 
therapy for human conditions associated with intestinal I/R injury, and particularly 
NEC.  
FeTMPyP application has so far been limited to pre-clinical trials, and 
long-term clinical studies are therefore necessary before their safety for use in 
paediatric patients is established. On the other hand, therapeutic whole-body 
hypothermia has been used in a large number of neonatal patients for the treatment 
of intrapartum asphyxia (Jacobs et al, 2007) and other conditions (see Chapter 1), 
and its side effects (including haemodynamic instability and coagulopathy)  appear 
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to be rare and controllable. This would suggest that hypothermia is perhaps the 
most promising of the therapeutical strategies we evaluated in our experimental 
studies. 
Since one of the major issues with NEC patients is the severe comorbidity 
observed in long-term survivors, especially intestinal failure secondary to short 
bowel syndrome and impaired neurodevelopmental outcome (Casey et al, 2008; 
Rees et al, 2007),  further studies should be aimed at investigating whether the 
protective effect of hypothermia during the acute phase also leads to a reduction in 
the long-term sequelae. It would be extremely interesting to establish a long-term 
survivable neonatal model of intestinal I/R injury, where rats are returned to their 
dams after a period of normothermic or hypothermic intestinal reperfusion. This 
would allow investigation of long-term survival and developmental outcome. 
Survivors could be investigated at various time points during their development, 
and intestinal absorption and length could be measured. Neurological outcome 
could also be assessed, with particular attention to visual and psychomotor 
functions.  
Given the expanding indications of hypothermia in the treatment of various 
human conditions, and the robust benefits observed in experimental studies as 
explained in this thesis, reaserchers from my unit considered investigating 
hypothermia as an experimental treatment for neonates with necrotizing 
enterocolitis. However, the subjects of clinical trials and preliminary studies of 
safety and efficacy of moderate hypothermia previously published concerned full 
term infants, and no data were available regarding the safety of therapeutic 
moderate hypothermia when applied to infants born prematurely or with very low 
birth weight. Before the potential clinical benefits of moderate hypothermia on 
patient outcome could be assessed in a randomised controlled trial, it was first be 
necessary to demonstrate that this intervention is feasible and that it does not have 
obvious adverse consequences in a cohort of preterm infants with NEC and 
MODS.  
After completion of the research described in this thesis, investigators from 
my same group have therefore designed a pilot study to evaluate the feasibility and 
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safety of hypothermia in preterm neonates with advanced necrotizing enterocolitis 
(Hall et al, 2010). 
A prospective, nonrandomized pilot study was designed. Fifteen neonates 
who were referred for surgical management of acute NEC at Great Ormond Street 
Hospital, London, between October 2004 and October 2006 were studied. A 
historical comparison group.of 10 infants who were admitted immediately before 
(April 2004 to October 2004) commencement of the study served as a control 
group. All infants with a clinical diagnosis of NEC (pneumatosis intestinalis on 
abdominal radiograph and at least Bell stage II) and evidence of MODS were 
considered. Infants with bilateral grade 4 intraventricular hemorrhage (IVH) were 
excluded due to the expectedly increased risk of bleeding. 
Three groups of infants were studied sequentially:  
- Group 1: 35.5 ± 0.5°C core temperature for 48 hours (n = 5)  
- Group 2: 34.5 ± 0.5°C core temperature for 48 hours (n = 5)  
- Group 3: 33.5 ± 0.5°C core temperature for 48 hours (n = 5)  
Whole-body cooling was achieved by ambient temperature adjustment with 
or without cooling mattress, and all infants were then slowly rewarmed to 37°C at 
the end of the cooling period. 
Patients were monitored for adverse effects that have been previously 
associated with hypothermia (including bradycardia, hypotension, hypokalemia, 
thrombocytopenia, and sepsis). 
Results of this study showed that whole body hypothermia can be achieved 
simply; lowering incubator temperature or reducing radiant warmer output was 
adequate to achieve target temperature in all but 2 infants, both of whom weighed 
>1500 g and were easily cooled with a cooling mattress. Target temperature was 
achieved after a median of 2.25 hours and time spent within target range was over 
90%. Although this was achieved without servocontrol, this was labor-intensive 
and small fluctuations of temperature outside the target range were observed. The 
use of servocontrol in the future is recommended in order to reduce workload, 
improve temperature control, and limit potential adverse effects. 
There were no clinically significant differences in hematologic or 
biochemical parameters (including haemoglobin concentration, white blood cell 
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and platelet count, coagulation parameters, electrolytes and renal function) 
throughout the study period. Sodium concentrations were statistically significantly 
lower in the control group compared with each of the study groups such that 
control infants tended to have hyponatremia. 
Analysis of plasma cytokines showed that IL-1β and IL-10 both were 
significantly lower during the first 24 hours of hypothermia compared with 
enrollment, and IL-10 but not IL-1β was significantly lower after rewarming 
compared with the second 24 hours of hypothermia. IL-6 concentration did not 
change significantly during induction of hypothermia or during rewarming. 
 Although there were no statistically significant differences in blood or 
blood product requirements between the study and control groups, there was a 
trend toward higher requirements in group 3. This may reflect the temperature-
dependent impairment of coagulation (including significantly longer time to initial 
clot formation, slower rate of clot formation, and decrease in clot strength) 
observed in hypothermic patients as assessed by thromboelastography. 
Minor physiologic changes related to hypothermia were observed, 
(including a decrease in heart rate by 3.5 beats per minute per 1°C), but none had 
clinical consequence. No changes in extent of preexisting IVH and no new 
intracranial hemorrhage occurred in any study infant. 
Comparison of the modified organ scores between the study and control 
groups suggests that a similar clinical course was followed in both groups, 
although this study was neither designed nor powered to determine efficacy of 
hypothermia. Importantly, there was neither a clinically significant increase in 
clinical scores indicating deterioration during hypothermia nor a rebound increase 
after rewarming. This is supported by the absence of a rebound increase in the 
levels of the inflammatory cytokine concentrations after rewarming.  
Two infants in the study groups died, in both cases from underlying disease 
rather than hypothermia; this compares favourably with the three deaths observed 
in the control group as well as with the expected survival of this cohort of patients.  
This pilot study demonstrated that cooling preterm infants with NEC 
complicated by MODS for periods of up to 48 hours is feasible and safe. A 
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randomized study is being designed by the same authors to investigate efficacy of 
hypothermia in infants with NEC, and to monitor safety. 
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